Pandora Report: 12.9.2022

Happy National Influenza Vaccination Week! This edition is heavily COVID-19-focused, discussing China’s rollback of its Zero-COVID policy, probes into government handling of the COVID-19 responses in the US and New Zealand, and how the pandemic has influenced slang terms. We also cover several new publications, newly available research resources, and an exciting upcoming event with the National Academies. Have a great weekend and get your flu shot now if you haven’t already and are able to do so!

Three Years Wasted? China Lifts Zero-COVID Policies

Nearly three years into this pandemic, China is abandoning its Zero-COVID policy. Zero-COVID or Dynamic Clearing aimed to eliminate transmission of the virus in the country through strict testing requirements and lockdowns. This included whole-building lockdowns when one person in an apartment complex tested positive, long lines for COVID-19 testing, and negative QR code requirements to enter everything from coffee shops to public toilets. The Party claimed this harsh system was justified as, supposedly, the country had just two COVID-19 deaths in the 18 months after initial containment. China’s shockingly low case counts and deaths have frequently been the subject of suspicion in the last few years. Interestingly, China went this hard on lockdowns and testing, but did not centrally mandate vaccinations.

The vaccine strategy the country did employ has also been heavily criticized. Today, 89% of the population is estimated to have received their initial COVID-19 vaccine with about 57% having received a booster. However, this doesn’t tell the whole story. While the government initially claimed it was close to producing its own mRNA offerings and that it would approve the BioNTech offering, today there are no mRNA COVID-19 vaccines approved for use in the PRC. (Interestingly, Indonesia has granted Walvax Biotechnology’s mRNA vaccine an emergency use authorization.) China’s vaccination campaign has instead depended on two domestically-produced inactivated offerings-Sinopharm BIBP and CoronaVac.

Mathieu, E., Ritchie, H., Ortiz-Ospina, E. et al. A global database of COVID-19 vaccinations. Nat Hum Behav (2021)

In mid-2021, the WHO approved these offerings for emergency use based on limited clinical-trial data indicating that CoronaVac was about 51% effective while Sinopharm was about 79% effective. This was alright relative to the 63% efficacy reported for AstraZeneca’s viral-vector vaccine, but it was not as effective as the 90%+ reported for the Pfize-BioNTech and Moderna mRNA offerings. Nature News explained the initial criticism of China’s vaccines, writing “Both the Chinese vaccines are inactivated vaccines, which use killed SARS-CoV-2 virus. Researchers say this type of vaccine seems to be less potent because it triggers an immune response against many viral proteins. By contrast, mRNA and viral-vector vaccines target the response to the spike protein, which is what the virus uses to enter human cells.”

Then the Omicron variant came…This created a situation in which the country had a particularly vulnerable elderly population with very low trust in the government, a Party caught up in its own vaccine nationalism, and a more transmissible variant. As we have discussed previously, this eventually led to even more lockdowns and forced relocations to isolation center than before, eventually leading to widespread protests. Now, after three years, the government is rolling back its strict Zero-COVID policy as concerns about a coming massive wave of cases and deaths grow.

Now people are being encouraged to stay home if they are sick unless they are severely ill as rising case counts threaten to overwhelm hospitals. When people do arrive at hospitals, workers screen them for fevers and more severe symptoms, turning away those with milder symptoms. This is especially problematic as a large part of the public-facing justification for Zero-COVID was that infection often leads to severe illness, conflicting with what the public is being told now.

The New York Times quoted Dr. Zhong Nanshan, a prominent Chinese pulmonologist, saying “The infections are not scary. Ninety-nine percent of the people who get infected can fully recover within 7 to 10 days. As long as we get plenty of rest, isolate ourselves and stay at home, we can recover quickly.” However, this ignores the risk of things like Long COVID and is contradictory to models many are now pointing to.

Science Insider explained earlier this month that, “A study based on vaccination rates in March, published in Nature Medicine in May, found that lifting zero-COVID restrictions at that point could “generate a tsunami of COVID-19 cases” over a 6-month period, with 112 million symptomatic cases, 2.7 million intensive care unit (ICU) admissions, and 1.6 million deaths. Peak demand for ICU beds would hit 1 million, more than 15 times the current capacity.” The Economist released a more conservative estimate predicting 680,000 COVID-19 deaths in the absence of Zero-COVID in China. However, their model depended on everyone who needs an ICU bed getting one, “which they would not,” according to the publication.

So, in the face of a potential “winter of death,” many are asking now why the country did not better prepare for this reopening in the three years it spent shutting the country down. Others are asking what this means for Xi Jinping and the Party as it seems likely they will have caved to public demand in a way that will lead to mass suffering in death. While the Party is likely to spin the narrative in whatever way benefits it most no matter what happens next, this is shaping up to be an even more eventful next couple of months for the PRC.

On a related note, James Fallows, President Carter’s speechwriter, interviewed long-term Mandarin translator Brendan O’Kane about ProPublica’s disputed piece on the Wuhan Institute of Virology we covered previously. The interview is fantastic and expertly explains the variety of problems in Toy Reid’s translations and why they fundamentally effect the integrity of the piece.

Senate Homeland Security Committee Majority Releases Report on Federal COVID-19 Response

This week Senate Democrats released their 241-page report covering the Trump administration’s early response to COVID-19, identifying both missteps on the part of the administration and multiple systemic issues in the federal government. The report, released by the Homeland Security Committee majority, relies on “documents and interviews with key Trump administration officials, including Dr. Deborah L. Birx, the White House coronavirus response coordinator, and Dr. Robert R. Redfield, who served as director of the Centers for Disease Control and Prevention,” according to The New York Times.

The report identifies several issues like that “a public health emergency fund created to support state and local health systems had received no new appropriations since 1999 and had been “virtually empty” since 2012,” and that preparedness planning from 2005 through 2019 was too narrowly focused on influenza. Of the COVID-19 response, Committee Chairman Senator Gary Peters said, “There’s no question that political decisions were being made and that those decisions were unfortunately considered more important than what was being put out by public health officials.” He added, “And so that got politicized in a way that it should have never been politicized — and lives would have likely been saved.”

New Zealand Announces Inquiry Into COVID-19 Response

Prime Minister Jacinda Adern announced Monday this week a Royal Commission of Inquiry into Wellington’s COVID-19 response. Led by Australia-based epidemiologist Tony Blakely, the inquiry has 17 months to conduct research and form its report. New Zealand was both praised and criticized in its initial response to the pandemic, which focused on elimination and included closing the country’s borders and imposing strict lockdowns for much of the first two years. In August 2021, amid community transmission of the Delta variant in Auckland and Wellington, the country abandoned its elimination strategy and accelerated its vaccine rollout.

So far, beyond questions of the efficacy of the country’s lockdowns, a major point of criticism focuses on the country planning for a single disease. AP reports that “COVID-19 Response Minister Dr. Ayesha Verrall said one of the lessons was that having a prescriptive pandemic plan, like New Zealand’s influenza-based plan before COVID-19 hit, was not much use. “I imagine the lesson has been learned that just looking at the characteristics of one bug isn’t going to cut it,” Verrall said. “You have to look much more broadly.”

WHO Members States to Develop Zero Draft of Pandemic Accord

This week, the WHO announced that member states have agreed to develop a first draft of what will eventually become a legally binding agreement rooted in the WHO constitution to help protect the world from future pandemics. The draft will be prepared so it can be discussed in February 2023 at the fourth Intergovernmental Negotiating Body meeting. According to WHO, “This draft will be based on the conceptual zero draft and the discussions during this week’s INB meeting. The INB Bureau is comprised of six delegates, one from each of the six WHO regions, including the Co-Chairs Mr Roland Driece of the Netherlands and Ms Precious Matsoso of South Africa.”

“The impact of the COVID-19 pandemic on human lives, economies and societies at large must never be forgotten,” said Ms Matsoso. “The best chance we have, today, as a global community, to prevent a repeat of the past is to come together, in the spirit of solidarity, in a commitment to equity, and in the pursuit of health for all, and develop a global accord that safeguards societies from future pandemic threats.” 

Going Goblin Mode

Coronacation, Miss Rona, the panini/pandemi lovato/✨panorama✨…the COVID-19 pandemic brought lots of interesting new slang. One such term, goblin mode, is getting special attention, however. If you gained a favorite sweatshirt over the course of the pandemic that you don’t wash as often as you probably ought to, this one’s for you. “Goblin mode,” a slang term for a “type of behavior which is unapologetically self-indulgent, lazy, slovenly, or greedy, typically in a way that rejects social norms or expectations,” was recently named Oxford Languages’ 2022 Word of the Year. The term dates back to at least 2009, but it wasn’t until this year that it went viral. “It captured the prevailing mood of individuals who rejected the idea of returning to ‘normal life’, or rebelled against the increasingly unattainable aesthetic standards and unsustainable lifestyles exhibited on social media,” Oxford Languages said in a press release.

NPR writes, “The slang particularly struck a chord with people who felt disillusioned by the third year of the pandemic and the ongoing political upheavals around the world. In response, they are rejecting societal expectations and making their own rules of how to live. The trend is marked by a departure from respectability and aesthetic. Instead, it encourages people to lean into their uncurated, self-indulgent and sometimes mischievous ways.”

Now, if you’re saying “But I’ve never heard of goblin mode,” here are some examples: Academic types-there is at least a 50% chance your office qualifies as being in goblin mode.

Cat parents-you know what we’re talking about here.

“Biodefense and Emergency Use Authorization: Different Originations, Purposes, and Evolutionary Paths of Institutions in the United States and South Korea”

Biodefense Program alumnus Dr. HyunJung Kim recently published this article in Globalization and Health. Abstract: “Background: Emergency-use-authorization (EUA) is the representative biodefense policy that allows the use of unlicensed medical countermeasures or off-label use of approved medical countermeasures in response to public health emergencies. This article aims to determine why the EUA policies of the United States and South Korea produced drastically different outcomes during the COVID-19 pandemic, and how these outcomes were determined by the originations and evolutionary paths of the two policies.”

“Method: Historical institutionalism (HI) explains institutional changes—that is, how the institution is born and how it evolves—based on the concept of path dependency. However, the HI analytical narratives remain at the meso level of analysis in the context of structure and agency. This article discusses domestic and policy-level factors related to the origination of the biodefense institutions in the United States and South Korea using policy-learning concepts with the Event-related Policy Change Model.”

“Results: The 2001 anthrax letter attack (Amerithrax) and the 2015 Middle East Respiratory Syndrome (MERS) outbreak prompted the establishment of biodefense institutions in the United States and South Korea, respectively. Due to the different departure points and the mechanism of path dependency, the two countries’ EUAs evolved in different ways—the United States EUA reinforced the Post-Exposure Prophylaxis (PEP) function, while the South Korea EUA strengthened the Non-Pharmaceutical Intervention (NPI) function.”

“Conclusion: The evolution and outcomes of the two EUAs are different because both policies were born out of different needs. The United States EUA is primarily oriented toward protecting homeland security against CBRN (chemical, biological, radiological, and nuclear) threats, whereas the South Korea EUA is specifically designed for disease prevention against infectious disease outbreak.”

“Preparing for Twenty-First-Century Bioweapons”

Biodefense Program alumnus Dr. Yong-Bee Lim recently co-authored this piece with Dr. Kathleen Vogel and David Gillum using the ongoing BWC RevCon to discuss the roles NGOs can play in advancing security. They write, “As the BWC enters its 50th year, it’s time to prepare for a future world with weapons and wars that do not look like those that the treaty was designed to prevent. In this complex process, NGOs can play vital, diverse roles in strengthening the BWC and enlarging the field of global actors that engage with nonproliferation and disarmament. NGOs can bring new resources and perspectives to a daunting task of envisioning how the life sciences themselves may evolve to permit new threats, as well as new means of control. By deliberately engaging participants from the entire world, particularly the Global South, the BWC has an opportunity to gain trust and cooperation at the grassroots level. In these capacities, NGOs may be indispensable in establishing global norms and policies against biological weapons threats and continuing the considerable success of the BWC in an unknown future.”

“Recounting the Top IPC Stories of 2022”

Biodefense Program alumna and Assistant Professor Dr. Saskia Popescu recently authored this piece for Infection Control Today summarizing top stories from 2022 and what to expect next year. In it she covers everything from polio, to mpox, to RSV, to Russia’s BW disinformation, so be sure to give it a read.

“Uncovering the Hard Work Behind the World’s Push for an Ebola Sudan Vaccine”

In this piece, Dr. Caitlin Rivers interviews Dr. Andrew Kilianski (an Adjunct Professor who teaches biosurveillance at the Schar School and Senior Director for Emerging Infectious Disease Vaccines at the International AIDS Vaccine Initiative (IAVI)) on his organization’s efforts to develop a vaccine candidate for Ebola Sudan virus. In it, Kilianski discusses IAVI and his role in it, the process of bringing a vaccine candidate through preclinical and clinical phases, and challenges organizations are facing in trying to respond to the current Ebola outbreak in Uganda.

2022 Bioeconomy Executive Order White Papers

From the Engineer Biology Research Consortium: “On September 12, 2022, President Biden released an Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy. This Executive Order calls for “a whole-of-government approach to advance biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience, and national and economic security.” The Executive Order follows additional action by the United States Congress to support the bioeconomy and biomanufacturing, most notably the passage of Title IV—Bioeconomy Research and Development in the Chips and Science Act.”

“To capitalize on this moment of importance and enthusiasm for a growing and robust U.S. bioeconomy, EBRC is publishing a series of policy white papers on topics of importance to EBRC members and the engineering biology community that we believe can provide guidance and recommendations to the federal agencies tasked with responding to the Executive Order.” These white papers are available here. Biodefense Program Director Dr. Gregory Koblentz serves on the EBRC Security Working Group and contributed to the “Biosafety & Biosecurity Innovation Initiative” white paper.

“Stakeholder Perspectives on the Biological Weapons Convention”

From UNIDIR: “Efforts to enhance biological disarmament and build biosecurity can no longer be achieved by States alone. It will require support from stakeholders around the globe if we are to achieve progress in the Biological Weapons Convention and wider efforts to strengthen biological security. Unfortunately, stakeholder perspectives are not necessarily always well understood or reflected in biological disarmament diplomacy. And some sectors are almost entirely absent from discussions.”

“To address this challenge, UNIDIR invited a diverse range of stakeholders and representatives from around the world and with diverse backgrounds to contribute their insights to this report. The contributions reflect activities they had undertaken in support of the BWC, what more their respective communities could do, and provide recommendations on what States Parties to the BWC should do (or not do) to advance the BWC. Collectively, these contributions provide several concrete ideas for BWC States Parties to consider in seeking to strengthen the Convention.” Read here.

Disarmament, Security and Development Nexus: Compendium of UNIDIR Annual Youth Disarmament Essay Competition’s Best Essays

“The first annual UNIDIR Global Youth Disarmament Essay competition was launched in 2022, responding to the calls for giving a voice to young people on the connections between disarmament and development. The Republic of Korea generously supported this essay competition. The theme of the first UNIDIR Global Youth Disarmament Essay competition was the ‘Disarmament, Security and Development Nexus’. Students and young professionals aged between 18 to 29 years old were invited to submit an essay that explored one of the following areas: Disarmament, economic growth, and inequalities; Disarmament for sustainable cities; Innovative disarmament efforts in light of the 21st century’s environmental challenges; Gender mainstreaming for sustainable disarmament and development.” Check out the top five essays from the competition here.

“The Future Home of the World’s Most Dangerous Pathogens”

Sarah Scoles’ recent piece for Coda Media discusses the National Bio and Agro-Defense Facility’s (NBAF) struggle to balance the important work it is designed to do with genuine and ingenuine community and broader concerns, writing, “In high-containment biology labs like NBAF, though, the line between antagonistic misinformation and grounded concern is thin. And that means NBAF has to balance (at least) three things: the value of its research, the real risks of keeping big-time germs around and public concerns, both real and imagined.”

Scoles covers the story of microbiologist Lisa Hensley’s journey to NBAF, the security features of the facility, and the public discussion about the lab fraught with fears ranging from “I don’t want my cattle to get sick because of an accident” and “they are planning the next great pandemic.” You won’t want to miss this one!

“Operational Evaluation of the FDA Human Foods Program”

From the Reagan-Udall Foundation: “On December 6, 2022, the Independent Expert Panel for Foods submitted its report on the Operational Evaluation of FDA’s Human Foods Program to FDA Commissioner Dr. Robert Califf. The evaluation and report were facilitated by the Reagan-Udall Foundation at Dr. Califf’s request.”

“The evaluation of FDA’s Human Foods Program launched on September 8, 2022. The evaluation focused on structure/leadership, authorities, resources, and culture, expecting to provide recommendations that would equip FDA to carry out its regulatory responsibilities, strengthen its relationships with state and local governments, and secure the nation’s food supply for the future. (The review excludes cosmetic and dietary supplement responsibilities.)”

Improving the IC’s Leveraging of the Full S&T Ecosystem

From the National Academies: “The U.S. Intelligence Community (IC) depends on knowledge of cutting edge science and technology (S&T) to inform intelligence missions and compete with its adversaries. At the request of the Office of the Director of National Intelligence, the National Academies established a committee to explore ways in which the intelligence community might best leverage the S&T ecosystem.”

“Please join us for a webinar on our new report, Improving the Intelligence Community’s Leveraging of the Full Science and Technology Ecosystem, on Wednesday, December 14 at 11 am ET. During the webinar, members of the committee will present the report’s key findings and discuss how the IC can better leverage S&T knowledge that exists across the broader government, domestic, and global environments.” Register here.

Call for Nominations: Future of the Nation’s Laboratory Systems for Health Emergency Response: A Workshop

“A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize and convene a two-day public workshop. During this workshop, invited participants from government, non-governmental organizations, and private sector organizations will explore the United States’ laboratory and testing responses to past, present, and potential health emergencies (e.g., COVID-19; monkey pox; chemical, radiological or nuclear threats), and will discuss the future of laboratory capabilities, capacities, and coordination for health emergencies response across public and private entities nationally. This workshop will focus on operational aspects of laboratory response, rather than technology development, including topics such as collaboration, coordination, information sharing, workforce, capacities and capabilities, and access.” Learn more and submit nominations here.

Violent Non-State Actor Chemical, Biological Radiological, and Nuclear (CBRN) Data Portal Goes Live

The National Consortium for the Study of Terrorism and Responses to Terrorism (START) Unconventional Weapons & Technology Division has launched its new Violent Non-State Actor Chemical, Biological Radiological, and Nuclear (CBRN) Data Portal. START explains that, “In order to provide a basis for rigorous empirical analysis of the CBRN terrorism phenomenon, UWT developed three databases: Profiles Of Incidents involving CBRN and Non-state actors (POICN); Chemical And Biological Non-State Adversaries Database (CABNSAD); and Radiological And Nuclear Non-State Actor Database (RANNSAD). These databases represent the largest open source publicly available databases on ideologically motivated CBRN events and individuals who pursue and/or use CBRN weapons.”

NCSC Safeguarding Science Toolkit

The National Counterintelligence and Security Center and its partners recently announced “a unique collaboration between elements of the U.S. intelligence and scientific communities to help the U.S. research enterprise mitigate the broad spectrum of risk it faces from nation-state, criminal, and other threat actors…The Safeguarding Science online toolkit is designed for individuals and organizations in the U.S. scientific, academic, and emerging technology sectors who are seeking to develop their own programs to protect research, technology, and personnel from theft, abuse, misuse, or exploitation.”

“The Safeguarding Science toolkit was designed with the scientific community for the scientific community. It provides research stakeholders with a single location to access security best practices from across government and academia and to select those tools tailored for their individual needs. NCSC and its partners seek to promote a robust and resilient U.S. research ecosystem that emphasizes integrity, collaboration, openness, and security, all of which facilitate innovation.”

The Pandora Report Wants to Hear from Biodefense Program Alumni!

Calling all graduates of the Biodefense Program-do you have any news to share from this year? We want to hear from you! The Pandora Report will be creating a year-in-review for our late December issue, and we want to include updates from current students and alumni alike. It can be anything from promotions, publications, new jobs, etc. that you would like to share. Share your updates with us at biodefense@gmu.edu before December 23 to be featured in the year-in-review and anytime you want to stay in touch.

Weekly Trivia Question

You read the Pandora Report every week and now it’s time for you to show off what you know! The first person to send the correct answer to biodefense@gmu.edu will get a shout out in the following issue (first name last initial). For this week: In 1979, there was a suspicious outbreak of anthrax that killed over 60 people in a town located near a military research complex. For years, authorities blamed this outbreak on consumption of contaminated meat, though it was actually the result of an accidental release of Bacillus anthracis. What town did this happen in? (City Name, Country)

Shout out to Georgios P. for winning last week’s trivia! The correct answer to “Which country most recently became a State Party to the Biological Weapons Convention?” is Namibia.

Pandora Report: 12.2.2022

What a week it has been! This time we cover the first week of the Biological Weapons Convention Review Conference, China’s Zero COVID protests, and more. We also have a number of new publications and a new video from INTERPOL about weaponizable chemicals. Make sure to read to the end too for a fun new way to engage with the Pandora Report!

The Biological Weapons Convention Review Conference Gets Underway

It was never any secret that this RevCon was going to be one for the history books, but this first week has delivered on that promise and then some. Of course, the Russian Federation brought plenty of drama to the Palais des Nations, withdrawing from the Eastern European Group and voicing complaints that its invasion of Ukraine, which was referenced in numerous national statements, is outside the scope of the conference and that only Western countries describe its numerous false claims as groundless. In response to the former, Czechia responded with “If Russia doesn’t like it, they should simply not invade their neighbors.” Other countries have taken to selectively switching to speaking in Russian while delivering statements about who the aggressor in this situation is, giving a sense of schadenfreude reality TV could never.

The US used the right of reply to respond to Russia early this week, with US Special Representative Kenneth Ward explaining “During the Article V Formal Consultative Meeting, the United States, jointly with Ukraine, fully addressed the unfounded concerns raised by the Russian Federation. However, it was clear from the outset of the Article V process that Russia never intended to engage constructively with Ukraine and the United States. It came to our attention on the very first day of the meeting that the Russian delegation had already made up its mind and circulated a draft of a proposed “joint statement” to select delegations regarding the outcome of this Article V Consultation. In this draft joint statement, the Russian Federation explicitly concluded that Ukraine and the United States had failed to answer questions regarding the activities of biological laboratories in Ukraine – a conclusion it reached before the United States and Ukraine even began our joint presentation.”

The US also pushed back on Russia’s withdrawal from the Eastern European Group (which, by the way, was done because an unnamed member of the group blocked Russia’s nominations), stating “There is a final issue which I would like to briefly address. As we are all aware, the BWC forum operates based on a three-group system. Yesterday, a State Party indicated that it was withdrawing from its current group and forming a new “Group of One.” This is a new situation, and the United States reserves its position with respect to the implications of any new group for geographical rotation, vice-chair positions, etc. Any departure from current arrangements based on the existing three-group system would require a consensus decision by all States Parties.”

It hasn’t all been drama, however, with several productive side events and remarks from relevant organizations focused on everything from disinformation to discussion of new approaches to protecting the world from biological weapons.

Biodefense Program Students and Alumni Speak at BWC

Naturally, a number of current students and alumni of our program are making their mark at RevCon. Biodefense PhD student Ryan Houser delivered remarks on behalf of the Global Biolabs Initiative, led by Biodefense Program Director Dr. Gregory Koblentz and Dr. Filippa Lentzos of King’s College London. The Schar School recently posted about Houser’s remarks here, explaining “Houser’s statement called on nations where high-risk pathogen work is conducted to have laws and regulations that provide adequate oversight and to update them frequently. He also called for cooperation among the labs to share best practices and participate in peer reviews.”

Biodefense PhD student Ryan Houser delivering remarks at RevCon in Geneva

Dr. Yong-Bee Lim, an alumnus of the program and the current Deputy Director of the Janne E. Nolan Center on Strategic Weapons at the Council on Strategic Risks (CSR), also delivered remarks this week. Dr. Lim spoke on behalf of CSR, acknowledging the importance of this particular RevCon. He said in part, “This Review Conference alone will not solve these issues. Yet what happens here will mark a historic point of departure where the community can choose to go down one of two paths. The first path leads towards a future where nations pursue mutual security through international cooperation and put in the hard work necessary to reduce biological threats together. The second path leads toward a future of even greater mistrust and further fracturing of international norms and practices. For the Council on Strategic Risks, it is our firm belief that the first path, where nations pursue mutual security through international collaboration, is the only pathway towards true security for all.”

Dr. Yong-Bee Lim delivering remarks at RevCon in Geneva

If you’re looking to keep up with RevCon, you can watch public sessions on UN WebTV and summaries of each day’s events on CBW Events’ website.

CWC Coalition Wins The Hague Aware at Chemical Weapons Convention 27th CSP

The 27th Conference of the States Parties of the Chemical Weapons Convention is wrapping up today in The Hague. The winners of the prestigious The Hague Award were announced in conjunction with the event, with this year’s winners including the Special Risks Brigade of the Federal Police of Argentina, the Chemical Weapons Convention Coalition, and the Population Protection Institute of the Fire Rescue Service of the Czech Republic. The CWC Coalition, which Biodefense Program Director Dr. Gregory Koblentz is a member of, “is an independent, international civil society network committed to supporting the aims and universalization of the CWC and supplementing the work of the member states of the OPCW. The Coalition’s work is made possible by the support of the Global Affairs Canada Weapons Threat Reduction Program and the Arms Control Association.”

Dr. Koblentz was also recently quoted in Politico‘s coverage of concerns about Russia using CW in Ukraine. The piece explains “Experts and officials said tracking pharmaceutical-based agents and gathering intelligence about their development, particularly for offensive purposes, has become increasingly difficult. The substances used to develop chemical weapons are concealed easily and can be embedded within legitimate industries, said Gregory Koblentz, director of the Biodefense Graduate Program at George Mason University.” He also told Politico, “Our traditional intelligence methods that we’re really good at, like satellite imagery and signals intelligence, aren’t really that useful for telling you what’s going on inside one of these core biological facilities,” Koblentz said. “You really need human intelligence to do that, which is very hard to get.”

Between a Rock and a Hard Place-Will China Pick COVID-19 Control or Political Control?

In an especially eventful couple weeks, Jiang Zemin, former General Secretary of the Chinese Communist Party and President of the People’s Republic of China died aged 96, the infamous “CRISPR baby” scientist He Jiankui announced the establishment of his new laboratory in Beijing after his release from prison, and Rao Yi praised UK Biobank and called for more genetic information sharing in China–all as the government grappled with growing protests and backlash against its Zero COVID policies. Oh, and ProPublica doubled down on its widely criticized article on the Wuhan Institute of Virology it co-published with Vanity Fair.

Lockdown Protests Across China

As images of people across China holding up blank sheets of white paper flood the internet, speculation about protesters’ ultimate desires have swirled as attention has been draw to pushback on the PRC’s Zero COVID policies. China’s approach to COVID-19 control has been incredibly strict, frequently forcing people to remain at home for months with inadequate access to food and other necessities. These are not people protesting normal public health measures-they are pushing back against an authoritarian government that has upended their lives repeatedly while failing to adequately invest in long-term solutions like effective vaccines. Furthermore, Chinese nationalism can be complicated and it is important to consider it in a non-comparative context.

In a wide display of civil disobedience that has been largely absent from the country in recent years, protesters have taken to the streets to call for the end of such draconian policies. This has been fueled in part by access to western media and shots of crowds at events like the FIFA World Cup, and it is especially risky business in the PRC. This is because of the scope of surveillance in the country, with police stations using facial recognition software to identify people captured on the countless surveillance cameras across the country. While the protests do seem to have spurred some relaxation in Zero COVID policies, it has not been without consequences as the police are cracking down on protesters.

China’s New “People First” Approach to COVID-19, Policy Rollbacks in Major Population Centers

Beyond actual outbreak control and prevention, China’s Zero COVID policies have been intertwined with efforts to further narratives that the PRC is more orderly and successful than the West. For example, official publications have contrasted the “rule of China” with the “chaos in the West” throughout the COVID-19 pandemic, using this narrative to counter perceived western political globalization. Xi Jinping has also repeatedly stressed that China’s post-COVID recovery will be “a time of opportunity when “the East is rising and the West is declining.”‘ Zero COVID policies are clearly high stakes political tools that the government has increasingly relied on in the face of poor vaccination rates and struggles with new variants.

However, this has all seemingly been thrown out the window this week as policymakers make major shifts to epidemic control and prevention measures across the country. On November 11, China’s National Health Commission announced its much anticipated 20 measures to further optimize COVID prevention and control, in which it was reiterated that Beijing was not backing down or relaxing its measures at all. However this proved to not be the case.

For example, just three days later, Shijiazhuang (a city of over 11 million and the capital of Hebei province) became the first city to cancel mass PCR testing. However, on November 20, the city restored mass PCR testing in six districts and restricted residents in high-risk areas from leaving their homes, advising others to stay home unless absolutely necessary. Yesterday, China Daily reported that Shijiazhuang will “…gradually resume normal production and life order starting Thursday as the chain of transmission during an ongoing COVID-19 epidemic has been basically cut, a top official of the city said at a news conference on Wednesday night.”

This new brand of optimism has been echoed elsewhere, including in a recent speech by Vice Premier Sun Chunlan, in the relaxation of restrictions in other major cities like Guangzhou and Chongqing (despite rising infections), and in less prominent publications that recently claimed the Omicron subvariant is not very serious and that there is no evidence of Long COVID. These are bold claims that reflect changing policies as the government tries to adapt to the precarious situation unfolding currently. Zhejiang’s CCP Provincial Committee even published a post on WeChat this week titled ‘”People First,” not “Epidemic Control First”‘ claiming, among other things, that “Epidemic prevention and control is about keeping out viruses, not about keeping out people. It has always been about “people first,” not any so-called “epidemic prevention first.”’

Of course, this isn’t entirely a political issue. There are real people’s lives at stake, a fact that is likely to become even more clear as this rollback clashes with the fact that the PRC lags on COVID-19 vaccinations. The country’s vaccination rates have struggled, with just 40% of those over 80 having received a booster shot as of November 11. The government is currently touting its big push to get more people, especially the elderly, vaccinated and boosted, but is it too little too late? The country is still relying on its domestic vaccines, which have proven substantially less effective than foreign offerings, including mRNA versions. During Hong Kong’s Omicron surge earlier this year, two doses of China’s Sinovac proved to be only 58% effective in preventing severe disease or death in those over 80 (in contrast to 87% with two doses of the Pfizer-BioNTech offering). Furthermore, a The New York Times notes, “…China’s last major vaccination push was in the spring, an interval of eight months or more since the last dose for many recipients.”

The lackluster efficacy combined with low interest in the vaccine, in part because Beijing’s strategy opted to focus so heavily on lockdowns and widespread testing, are a dangerous combination. This also looks to be poised to cause more issues as, in a rush to vaccinate a hesitant elderly population, the recommended time between the initial series of Sinovac and the first booster dose is also being reduced from six months to three. Whatever happens next, it is likely to be very interesting…

ProPublica Doubles Down on Heavily Criticized Article

Last month, we discussed ProPublica’s article about supposed CCP dispatches from the Wuhan Institute of Virology (WIV), explaining the flawed translations and mischaracterization of the website in question. ProPublica has now released an editor’s note discussing criticisms aimed at the October 28 piece that, unfortunately, fails to adequately address the issues raised with the piece. ProPublica’s Stephen Engelberg explains in the note “Over the past several weeks, reporters and editors at both publications have taken a hard look at those criticisms. Our examination affirms that the story, and the totality of reporting it marshals, is sound.”

The note goes on to recount how the publication re-interviewed some of its original sources and reached out to “…three Chinese language experts with impeccable credentials who were not involved in the original story to review Reid’s translation,” who are also anonymous like those consulted in the original piece. ProPublica first focuses on a post made on the WIV website that the initial piece claimed was discussing a biosafety incident at the facility. As we and others discussed, however, this was a news post talking in very inspirational terms about the day-to-day functions of the lab and the safety culture the organization tries to maintain.

However, ProPublica claims this new batch of experts “…all agreed that his [Toy Reid-the translator ProPublica relied on in their piece] version was a plausible way to represent the passage, though two also said they would have translated the words to refer to the dangers of day-to-day lab operations. The third produced a translation that was in line with Reid’s. All agreed the passage was ambiguous. We have updated the story to underscore the complexity of interpreting that dispatch.” The note later states “It remains clear that in 2019, the WIV was addressing serious safety issues while scientists there faced pressure to perform. Risky coronavirus research took place in laboratories that lacked the maximum biocontainment safeguards, according to the interim report.”

Later on, the note returns to this passage and criticisms of its context, explaining that Reid thought it had a defensive tone, saying “Before we published our story, Reid told us he found the passage to have a defensive tone. In the story, we quote Reid as concluding, “They are almost saying they know Beijing is about to come down and scream at them.” The note also says of the original three translators’ work, “All three of their translations were different from one another’s and different from Reid’s. Yet, each agreed that Reid’s translation was one plausible way to translate the passage into English. Our translators looked at the Chinese characters that Reid had translated to read “Every time this has happened” and instead said they read them to mean “on such occasions” or “at every such an occasion.””

The note addresses other criticisms with varying levels of success, including those focused on mis-matched dates in the piece and confusion over patent filings. However, it ignores a number of other criticisms and fails to address key issues raised with these translations. First, pointing to multiple translators coming up with different versions of this passage than the one ProPublica predicated its narrative on is not sufficient to absolve the publication of poor practices. This is especially true as the note provides virtually no context about who these “Chinese language experts with impeccable credentials” are and how much context they were provided. The original translation notes ProPublica provided seemed to ignore entire halves of sentences in an attempt to confirm a certain narrative, which makes this lack of information in the editor’s note particularly concerning.

Second, this note still ignores critical questions about Reid’s methodology and the core of the piece’s argument. The piece claims to have unearthed “dispatches” from the WIV that hinted at biosafety issues, other security problems, and urgent, high-level visits to the facility in light of these supposed incidents. However, as we discussed last time, these were posts uploaded to the general news tab of the WIV website. The passages the ProPublica piece relies on include propagandistic, general descriptions of daily work in a BSL-4, claims that workers are so dedicated that they sacrifice their time off and well-being to make sure the facility is safe, and the constant push of everyone involved to make the WIV safer and better. However, again, even if these were actually dispatches secretively discussing serious problems at the lab, why would they be publicly available on the WIV website?

The crux of this piece is that WIV and the Chinese government covered up a lab leak that led to this horrible, destructive pandemic. Why, then, would they publicly post and maintain these posts about biosafety issues at this facility? The Party and its organs are secretive and interested in controlling narratives to better their image-especially when it comes to high-profile facilities like the nation’s first P4 facility. If ProPublica wants to portray these posts as damning evidence that the WIV had remarkable biosafety issues that allowed SARS-CoV-2 to escape and spread in Wuhan, then the question of why that kind of information would be allowed to remain on the site of such a high-profile facility must be answered.

Finally, this note did not address concerns about exoticism, Sinophobia, and the general overpromise that this unknown State Department political officer who went to Harvard and worked at RAND somehow has this unique, esoteric understanding of Mandarin. There is a line between understanding how the CCP legitimizes itself through narratives and inappropriately presenting China and Chinese people as an especially unique case beyond understanding. Furthermore, the piece largely seems to have overstated the skills and methods of Reid, relying on building him up to be somehow uniquely well-suited for this work and hyping up, of all things, his use of a VPN to access the WIV website. In addition to the spread of false information, these issues point to a concerning trend in public discourse about China that harms the real people who fall victim to the dangerous rhetoric this feeds into. As we talked about last time, shoddy work like this helps nobody. It ultimately empowers those with prejudiced views, muddies public discourse, and mischaracterizes the very real threats to security posed by the PRC.

Other Updates

World AIDS Day

December 1 was World AIDS Day, an annual commemoration aimed at uniting to show support for those living with HIV and to honor those who died from AIDS and related illnesses. Tens of millions of people have died of AIDS-related causes since the epidemic began and HIV still presents a major global health threat today.

Felix Richter explained this week for Statista that “According to estimates from the Joint United Nations Programme on HIV and AIDS (UNAIDS) and the European Centre for Disease Prevention and Control, 10 countries accounted for almost half of all new HIV infections in 2021. South Africa, Mozambique, Nigeria, Tanzania and Uganda alone nearly accounted for nearly one third of the estimated 1.5 million new infections last year, indicating that Sub-Saharan Africa remains the epicenter of the HIV pandemic.”

He continued, “While the number of new infections has dropped from 2.9 million in 2000 to 1.5 million last year, the number of people living with HIV increased from 26 million to more than 38 million over the past two decades. According to UNAIDS, the increase is not only caused by new infections, but also a testament to the progress that has been made in treating HIV with antiretroviral therapy, which has vastly improved the outlook of those infected with HIV.”

Credit: Statista

Mpox

The WHO recently announced that it will begin using “mpox” as its preferred term and a synonym for monkeypox. This decision was made in consultation with global experts because “When the outbreak of monkeypox expanded earlier this year, racist and stigmatizing language online, in other settings and in some communities was observed and reported to WHO. In several meetings, public and private, a number of individuals and countries raised concerns and asked WHO to propose a way forward to change the name.”

WHO will use mpox alongside monkeypox for a year before phasing out use of the latter term. According to WHO, “Considerations for the recommendations included rationale, scientific appropriateness, extent of current usage, pronounceability, usability in different languages, absence of geographical or zoological references, and the ease of retrieval of historical scientific information.”

WHO also stated “The issue of the use of the new name in different languages was extensively discussed.  The preferred term mpox can be used in other languages. If additional naming issues arise, these will be addressed via the same mechanism. Translations are usually discussed in formal collaboration with relevant government authorities and the related scientific societies.”

This reflects a push in recent years to change how diseases are named in recognition of the stigma and harm brought by naming diseases after places, people, and animals. WHO released its “Best Practices for the Naming of New Human Infectious Diseases” in 2015 to help provide guidelines for using more general terms to describe new infectious diseases. This issue was again brought to the forefront amid spikes in attacks targeting Asian people since the COVID-19 pandemic began in Wuhan as racist rhetoric surrounding cultural practices and the disease’s origin flooded public discourse. The FBI documented a 77% increase in hate crimes against Asian people living in the United States from 2019 to 2020, though it is likely these kinds of crimes are chronically under-reported.

“Health+ Long COVID Report”

This Department of Health and Human Services’ report “highlights patients’ experience of Long COVID to better understand its complexities and drive creative responses by government leaders, clinicians, patient advocates and others.” It builds “on the President’s Memorandum on Addressing the Long-Term Effects of COVID-⁠19 and the two previously issued HHS Long COVID reports. The report was commissioned by HHS and produced by Coforma, an independent third-party design and research agency. It provides recommendations on how to deliver high-quality care, and relevant and intentional resources and supports to individuals and families impacted by Long COVID.” Read the report here.

“WHO Guiding Principles for Pathogenic Genome Data Sharing”

This new set of guidelines from WHO outlines best practices for sharing genomic data: “WHO encourages the sharing of pathogen genome data to protect global public health. Sharing of pathogen genome data is critical for preventing, detecting, and responding to epidemics and pandemics at national and international levels, and is in the interest of all Member States. The regular collection and sharing of such data are also important for monitoring and responding to endemic diseases and for tracking antimicrobial resistance to inform policy decisions. Practices and policies for sharing pathogen genome data must be ethical, equitable, efficient, and effective. After wide consultation, WHO has developed these foundational principles, which focus on public health uses, as well as urgent immediate research priorities.”

Toxin and Bioregulator Weapons: Preventing the Misuse of the Chemical and Life Sciences

This new book “…explores how revolutionary developments and convergence of the chemical, life and associated sciences are impacting contemporary toxin and bioregulator research, and examines the risks of such research being misused for malign purposes. Investigating illustrative cases of dual use research of potential concern in China, India, Iran, Russia, Syria and the USA, the authors discuss how states can ensure such research and related activities are not utilised in weapons development. Although toxins and bioregulators are, in theory, covered by both the Biological and Toxin Weapons Convention and Chemical Weapons Convention, this apparent overlap in reality masks a dangerous regulatory gap – with neither Convention implemented effectively to address threats of weaponisation. This book highlights the potentially damaging consequences for international peace and security, and proposes realistic routes for action by states and the scientific community.”

“Verification and Transparency: Learning from Project Coast”

In The Trench‘s fifth issue of the Historical Notes story, Professor Brian Rappert, Ms. Lizeka Tandwa, and Dr. Chandré Gould discuss the history of South Africa’s chemical and biological weapons program. The explain that “This Historical Note discusses how transparency and truth-telling have figured in securing confidence nationally and internationally. Our assessment is that fact-sharing, truth-telling and transparency about the apartheid-era chemical and biological warfare programme were not the key ingredients leading to confidence regarding South Africa’s commitment to the Biological and Toxins Weapons Convention (BTWC). To illuminate this position, we evaluate the roles of truth in (1) the Truth and Reconciliation Commission (TRC) of South Africa, and (2) South Africa’s transparency (or lack thereof) in the BTWC. The authors begin by briefly describing the activities of South Africa’s CBW programme and the questions that linger about it. This serves as an entry to unpacking the roles of truth and confidence, both welcomed and unwelcomed roles.”

“Countering Hybrid Threats in Bulgaria”

JD Maddox, an adjunct professor at the Schar School who teaches courses on countering disinformation, recently delivered the keynote address at an event introducing this policy brief from the Center for the Study of Democracy. The brief explains, “Russia has long prepared its war in Ukraine by deploying the full array of hybrid warfare tools at its disposal in Europe: election meddling and strategic corruption aimed at political parties and media, cyber-attacks on critical infrastructure and disinformation, economic coercion, and targeted assassinations using difficult-to-detect toxic agents, to name a few. Europe has been slow to react, with EU member states failing to anticipate the war in Ukraine even after the Kremlin started preparations for its final act by deliberately reducing gas storage levels in Germany in the autumn of 2021. Some EU and NATO member states and many political party leaders across the continent remain in denial, even as the war approaches a full year of destruction. NATO and European institutions have begun to prepare policy and operational responses to these emerging hybrid threats, but implementation remains slow and uneven.” Maddox also recently released an infographic-“Russia’s Active Measures: Recent CBRN-enabled Influence Operations” that outlines Russia’s efforts across several areas, including cyber.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Two words; “zombie viruses”-that is how researchers have described thirteen viruses collected from permafrost in Siberia in a recent preprint. “One quarter of the Northern hemisphere is underlain by permanently frozen ground, referred to as permafrost. Due to climate warming, irreversibly thawing permafrost is releasing organic matter frozen for up to a million years, most of which decomposes into carbon dioxide and methane, further enhancing the greenhouse effect. Part of this organic matter also consists of revived cellular microbes (prokaryotes, unicellular eukaryotes) as well as viruses that remained dormant since prehistorical times. While the literature abounds on descriptions of the rich and diverse prokaryotic microbiomes found in permafrost, no additional report about “live” viruses have been published since the two original studies describing pithovirus (in 2014) and mollivirus (in 2015). This wrongly suggests that such occurrences are rare and that “zombie viruses” are not a public health threat. To restore an appreciation closer to reality, we report the preliminary characterizations of 13 new viruses isolated from 7 different ancient Siberian permafrost samples, 1 from the Lena river and 1 from Kamchatka cryosol. As expected from the host specificity imposed by our protocol, these viruses belong to 5 different clades infecting Acanthamoeba spp. but not previously revived from permafrost: pandoravirus, cedratvirus, megavirus, and pacmanvirus, in addition to a new pithovirus strain.”

What We’re Watching 🍿

We’re changing it up this week with INTERPOL’s new a̶c̶t̶i̶o̶n̶ m̶o̶v̶i̶e̶ awareness video about the risks of weaponizable chemicals-“The Watchmaker”. “The Watchmaker, is an INTERPOL-produced awareness video highlighting the need for multi-agency cooperation to share knowledge and identify solutions to mitigate risks posed by weaponizable chemicals. It is part of a broader set of activities entitled, Project Crimp, which provides a platform for multi-agency cooperation between law enforcement, government, academia and the chemical industry to share knowledge, experience and share best practice.”

Maximum Containment Labs and Biorisk Management

From the Global Biolabs Initiative: “This webinar will re-launch GlobalBioLabs.org, an interactive web-based map of global maximum containment labs and biorisk management policies, and introduce new data and analysis. Speakers: Dr Filippa Lentzos, King’s College London and Dr Gregory D Koblenz, George Mason University.” This webinar will take place on December 9 at 8 am ET. Register here.

Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics

Join the National Academies for this workshop taking place in a hybrid format December 7-8. “The COVID-19 pandemic catalyzed innovative practices across many sectors to accelerate the development and use of new tools and technologies in response to an emerging infectious disease outbreak. This public workshop will examine lessons learned in creating an environment that strengthens this progress in partnerships, communication channels, and coordination processes to support the rapid development and implementation of new vaccines, therapeutics, and diagnostic tests for future outbreak preparedness. A specific focus will be placed on broadening stakeholder partnerships early and throughout the outbreak preparedness and response process.” Learn more and register here.

Canadian Biosafety Standard, Third Edition Webinar

“The Public Health Agency of Canada and the Canadian Food Inspection Agency are pleased to announce the publication of the Canadian Biosafety Standard, third edition (CBS3). The CBS3 outlines the physical containment, operational practice, and performance and verification testing requirements for facilities where regulated materials are handled or stored. The CBS has been revised to clarify the biosafety and biosecurity intent of all requirements, be risk-, evidence- and performance-based, and be non-prescriptive and technology-neutral. The CBS3 comes into full effect on April 1, 2023. The Public Health Agency of Canada will be hosting a two-part webinar series dedicated to the CBS3. The first webinar will be held on December 7th, 2022, and will provide an overview of key changes in the CBS3 from the previous edition, project milestones, and highlights from the public consultation.” The webinar will be held at 1 pm ET. Register here. Registration is limited for this event, so move quickly if you are interested in attending.

ICYMI- Impacts of Infectious Diseases on the Military: Lessons Learned

From the Homeland Defense and Security Information Analysis Center: “This moderated panel discussion will engage three subject matter experts who have served at the forefront of public health operations in both the military and civilian sectors. Panelists will discuss lessons learned from the COVID-19 pandemic and other health crises, recommended responses for future infectious disease threats, and near- and long-term mitigation steps which the military can employ to combat infectious disease threats. Threats analyzed will include natural and manmade releases of biological threats.” Watch the webinar here.

BIO-ISAC Call for Nominations for Genomic Security and Hardware/Software Security Working Groups

“To support the execution of the Bioeconomy Executive Order, BIO-ISAC has issued a Call for Nominations for its 2023 working groups focused on Genomic Security and Hardware/Software Security.”

“Each workgroup is expected to meet for at least two hours a month for the initial four months and agree to future meetings as required. Consensus building around organization recommendations and regulatory responses expected with likely on-the-record presentation of findings from the working groups. No working group may have more than two representatives from a single firm or entity.  BIO-ISAC membership is required to serve as chair.

The Pandora Report Wants to Hear from Biodefense Program Alumni!

Calling all graduates of the Biodefense Program-do you have any news to share from this year? We want to hear from you! The Pandora Report will be creating a year-in-review for our late December issue, and we want to include updates from current students and alumni alike. It can be anything from promotions, publications, new jobs, etc. that you would like to share. Share your updates with us at biodefense@gmu.edu before December 23 to be featured in the year-in-review and anytime you want to stay in touch.

Introducing the Weekly Pandora Report Trivia Question

You read the Pandora Report every week and now it’s time for you to show off what you know! At the end of each weekly issue, there will now be a trivia question included. The first person to send the correct answer to biodefense@gmu.edu will get a shout out in the following issue (first name last initial). Because this is the first round, we will start off easy-Which country most recently became a State Party to the Biological Weapons Convention?

Pandora Report: 11.11.2022

This week we start by sharing some fun updates from the Biodefense Graduate Program and discussing the current situation with influenza, RSV, and COVID-19 in the United States. We also discuss new publications, including ones that discuss hypothetical BW use in Ukraine, highly pathogenic avian influenza in the US, and a new episode of the Poisons and Pestilence podcast focused on the M device. This issue concludes with details on a number of upcoming and recorded events (including a virtual open house for the Biodefense PhD Program!) and announcements, including open applications for the Biotechnology Innovation & International Security Fellowship at Stanford University’s Center for International Security and Cooperation. Happy Friday and, as always, please wash your hands.

George Mason Biodefense MS Students Tour BSL-3 Facility on Science and Technology Campus

Last month, students in the Biodefense Graduate Program made the trek from Arlington to Manassas, VA to tour George Mason’s Biomedical Research Laboratory (BRL) on our Science and Technology Campus. Check out the Schar School’s article about their tour of the 52,000-square-foot, $50 million, NIAID-funded facility here. If you would like to have this and similar opportunities in the future, check out our upcoming PhD virtual open house coming up this Wednesday at 7 pm EST.

Schar School Biodefense MS Students and Adjunct Professor Scott Wollek joined by Biodefense Graduate Program Director Dr. Gregory Koblentz (center) and Drs. Rachel Pepin and Farhang Alem of the BRL (far right)

If the Time Change Wasn’t Bad Enough…We Might Have a Triple Threat On Our Hands

As the days get shorter and colder, the United States is also experiencing upticks in influenza, RSV, and (of course) COVID-19. Children’s hospitals are already struggling with the burden this is causing and there are further concerns that hospitals across the country will become overwhelmed as we head into winter. In response, some health departments have ramped up drive-thru testing for COVID-19 while also offering drive-thru RSV and flu testing at those same sites. Some suspect this convergence and uncharacteristic spikes in respiratory illnesses may be the result of an immunity gap created by lack of exposure to other illnesses during harsher COVID-19-related restrictions.

CDC reported this week the “cumulative hospitalization rate in the FluSurv-NET system is higher than the rate observed in week 44 during every previous season since 2010-2011.” The agency also estimates that in this flu season so far, there have been at least 2.8 million cases, 23,000 hospitalizations, and 1,300 deaths associated with influenza. This year was also marked by an early increase in seasonal flu activity in the US, following earlier concerns that a rough flu season in the southern hemisphere provided warning of the same coming for the north. The US notably had historically low interseasonal influenza cases in 2020 when people were much more cautious and consistently took actions such as social distancing, masking, increased hand washing, etc.

This year has also brought an increase in cases of respiratory syncytial virus (RSV) infections, with CDC reporting its surveillance “has shown an increase in RSV detections and RSV-associated emergency department visits and hospitalizations in multiple U.S. regions, with some regions nearing seasonal peak levels. Clinicians and public health professionals should be aware of increases in respiratory viruses, including RSV.” The US saw a much higher than normal rate of RSV infections over the summer that then surged throughout September and October. RSV causes mild, cold-like symptoms that most people typically recover from in one or two weeks. However, RSV can be serious in some cases, with infants and older adults at particular risk. In the US, RSV is the most common cause of bronchiolitis and pneumonia in children under the age of one. Annually, the US averages 60,000 pediatric RSV hospitalizations, but this is likely to be exceeded this year.

RSV hospitalization rates by season for children (ages 0-17) in the United States. Source: CDC RSV-NET Interactive Dashboard

While the updated, bivalent COVID-19 vaccines have proven more effective against BA.4/5 subvariants than original offerings, new concerns loom as the so-called “Scrabble variants” spread. While the BA.5 subvariant still accounts for about 40% of US cases, others like BQ.1, BQ.11, BA.4.6, and BF.7 are rising along with XBB and B.1.1.529. If this collection of subvariants is confusing to you, you’re not alone, as Dr. Peter Hotez acknowledged in initially describing them as “Scrabble variants”.

There is debate about how much the general public needs to understand about all these different subvariants. Some argue that the granular details differentiating between these is unhelpful and communication should instead focus on risk. However, others like Dr. Hotez argue it is important that people understand the differences. He points to the updated vaccines having been formulated for the BA.4 and BA.5 subvariants, the latter of which BQ.1 and BQ.1.1 are descendants. This likely means the updated vaccines do offer protection against BQ.1 and BQ.1.1, making it important to communicate these facts to the general public. Others also argue that easier names should be offered to the public so that subvariants do not blend together and cause people to underestimate new emerging strains.

While these new subvariants are new enough that there is no available vaccine efficacy data on them yet, consensus is largely that a “booster is a booster” and that it is still worth getting one if you have not already. Both the bivalent vaccines and antivirals like Paxlovid are expected to remain effective against severe outcomes with these subvariants. However, US vaccine rates with the updated versions have remained underwhelming, with rates by age groups ranging from nearly 27% in adults over the age of 65 to under 12% for adults ages 18-65.

Total population vaccine rates with bivalent booster by state, Source: CDC COVID Data Tracker

The weather is cooling and we are all increasingly spending more time inside at a time with relaxed public health measures in place. These are each viral respiratory infections, so it is important to be vigilant on measures like covering coughs and sneezes, washing hands appropriately, staying home when sick, and so on.

Important to note is that there is currently no vaccine available for RSV, though certain children may qualify to receive preventative injections of the monoclonal antibody product palivizumab during RSV seasons. Furthermore, there is no antiviral for RSV, so treatment is supportive care. There are antivirals for COVID-19 and influenza available and, of course, it is important to be vaccinated for both of these if at all possible. You can schedule appointments to get your seasonal flu shot and updated COVID-19 booster at the same at plenty of locations, many of which can be found through Vaccines.gov’s search tool.

“Les « Frankenvirus » au cœur des débats, après l’émergence du Covid-19”

In this Le Monde article on gain of function research, Biodefense Graduate Program Director Dr. Gregory Koblentz discusses the announcements of 27 new BSL-4 laboratories since the start of the COVID-19 pandemic and what these announcements, in light of loose international standards on biosafety, might mean in terms of increased risks of accidents.

“The World is Prepared for the Unthinkable”

This recent piece in CFR’s Think Global Health discusses the likely consequences of biological weapons use in Ukraine. McCloskey, Nuzzo, and Heymann write “A biological attack in Ukraine or anywhere would have profound and far-reaching political, military, and health consequences. The immediate impact would be to exacerbate the already profound human suffering that is occurring in the country and it would place further strain on already struggling health systems. Depending on the pathogen used, a biological attack could present risks beyond Ukraine. Unlike other weapons, biological agents have the potential to spread widely. Neighboring countries could be at immediate risk, but, as the ongoing COVID-19 pandemic has shown, diseases can travel widely around the globe before they are noticed.”

“Strategic Intelligence Assessment and Data on Domestic Terrorism”

This week the FBI and Department of Homeland Security released their second Strategic Intelligence Assessment and Data on Domestic Terrorism report. Overall, it details a continued increase in domestic terrorism investigations in the US, with the government opening 1,400 investigations in 2020 versus the average of 1,000 seen in previous years. It does note that this was in part because of investigations opened as a result of the January 6 attack on the US Capitol, but also that this anomaly does not fully account for the significant increase in that number. Most of these investigations were related to “…racially or ethnically driven violent extremism, anti-government or anti-authority violent extremism, and civil unrest.”

Other interesting points in the report include the that, as Lawfare explains, “…despite the increased threat, the National Counterterrorism Center (NCTC) does not employ a single analyst focused exclusively on domestic terrorism. One could argue that the NCTC is hamstrung in some respects because its mandate, or at least a narrow reading of its statute, limits its ability to focus on terrorism not related to the international variety of groups like the Islamic State and al-Qaeda. At the same time, the assessment states Homeland Security employs only ten analysts for domestic extremism threats. However, that number represents a meteoric increase from five years earlier, when there was not a dedicated domestic terrorism analyst squad.”

“Flu: When Spillovers Spill Over”

As the authors of this Think Global Health piece explain, the US is currently in the middle of one of the largest outbreaks of highly pathogenic avian influenza (HPAI) in animals in US history. At least 49 million birds from backyard and commercial flocks have been culled so far in 43 states as this year’s outbreaks continue.

The authors write “Case counts and distributions in wild birds have been equally astounding. Department of Agriculture surveillance efforts in 2022 have detected HPAI in wild birds in almost every state in the continental United States, plus Alaska. Active surveillance has found more than 3,300 infected wild birds. This extensive transmission through wild avian species is more pronounced than in previous U.S. epizootics, or animal epidemics; in the 2014-2015 outbreak, fewer than 100 wild birds tested positive for H5, primarily along the Pacific Flyway, one of four major North American migration routes for birds, especially waterfowl. Affected species in this outbreak range from the relatively abundant Canada goose and wild turkey to the more vulnerable bald eagle and snowy owl. How many of these birds are actually symptomatic is difficult to determine, as detections often occur opportunistically through the sampling of dead birds and hunter harvests. Mortality in wild species is varied with some species like gulls, terns, geese, and raptors experiencing higher than usual rates, while songbirds are relatively unaffected, even asymptomatic. The variation in morbidity and mortality makes this virus even harder to track.”

“Atoms are Local”

In this essay Elliot Hershberg, a PhD student in genetics at Stanford and the mind behind The Century of Biology, discusses the industrialization of biotech and proposes the biologization of industry as a preferable alternative. He explains this concept, writing “Biologization of Industry — Many people default to a mindset of industrialization. But, why naively inherit a metaphor that dominated 19th century Britain? Biology is the ultimate distributed manufacturing platform. We are keen to explore and make true future biotechnologies that enable people to more directly and freely make whatever they need where-ever they are.”

“Compendium of Best Practices on the Engagement and Advancement of Women in Chemical Safety and Security”

From the UN Interregional Crime and Justice Research Institute: “The Organization for the Prohibition of Chemical Weapons (OPCW) and the United Nations Interregional Crime and Justice Research Institute (UNICRI), in close cooperation with international partners, stakeholders and practitioners, recognized the asymmetric portrayal of women and men in chemical safety and security; both in global literature and policy debates. To address this gap, amplify women’s voices and promote opportunities to increase their engagement in this field, OPCW and UNICRI, with the generous funding of the European Commission, developed the Compendium on “Engagement and Advancement of Women in Chemical Safety and Security”.”

“The Compendium aims to provide policymakers and practitioners in the field of chemistry with guidance to promote gender inclusivity in the chemical safety and security sector through the identification of best practices in recruiting, training and promoting gender-inclusive careers.”

What We’re Listening To 🎧

Poisons and Pestilence-13 Bonus Episode: The M Device with Simon Jones

Dr. Brett Edwards has released a new episode of his podcast, Poisons and Pestilence, covering the M device (a canister device used to release CW agents) with historian Simon Jones. In addition to the podcast, you can find Jones’ work on the M device here where he explains, “During the closing stages of the military intervention in North Russia in 1919, British chemical munitions were improvised as effective aerial bombs for the first time in history.”

Schar School PhD Virtual Open House Session

Come learn about the Schar School’s doctoral programs (including the Biodefense PhD!) and interact with faculty at this online open house. This event will take place Wednesday, November 16, at 7 pm EST. Register here.

Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics

“The National Academies of Sciences, Engineering, and Medicine’s Forum on Microbial Threats; Forum on Drug Discovery, Development, and Translation; and the Forum on Medical and Public Health Preparedness for Disasters and Emergencies will organize and conduct a public, hybrid workshop on December 7-8, 2022 to explore how innovative approaches in research sparked by COVID-19 can enhance health systems preparedness and responses to emerging infectious diseases. This workshop will consider basic scientific infrastructure and essential capabilities to support medical and behavioral countermeasures that were deployed during the COVID-19 pandemic response. Workshop participants will reflect on critical scientific infrastructure for stakeholder coordination and innovations that can facilitate rapid and effective responses to emerging infectious disease threats.” Register here.

Strategies to Reach Zero Dose Children in Fragile States and Cross-border Contexts in Africa

“CORE Group and Gavi, the Vaccine Alliance invite you to register to attend a webinar where experts will discuss the importance of reaching Zero Dose Children and how addressing the challenges in reaching communities with immunization interventions could diminish disease outbreaks and health system disruptions. The webinar will also provide a platform for discussions on innovative ways to reach zero dose children beyond traditional government partners in fragile contexts. It will be an opportunity le learn more about the Zero-Dose Immunization Programme (ZIP) and will feature speakers from Gavi, the Vaccine Alliance, International Rescue Committee(IRC), CORE Group Polio Project (CGPP) and World Vision.” This event will be hosted virtually on November 15, at 10 am EST. Register here.

ICMYI: 8th African Conference on One Health and Biosecurity

The 8th African Conference on One Health and Biosecurity concluded recently in Lagos, Nigeria. The conference aimed to “…present a unique forum to raise National, Regional and Continental awareness and engage in deep introspection and robust interactions on existing health security measures and how to strengthen them, as the first urgent step toward mitigation of emerging biological threats in Africa.” Recordings from the conference are available on the Global Emerging Pathogens Treatment Consortium (GET) Africa YouTube Channel. You can read the conference’s “Communiqué of 8th African Conference on One Health and Biosecurity themed Strengthening Health Security and Mitigating Biological Threats in Africa”.

ICYMI: Briefings in Preparation for the Ninth BWC Review Conference

Check out the recording for this event on UNIDIR’s YouTube channel. “This virtual event brought together the authors of the latest UNIDIR publications on BWC topics to provide short outlines of the key insights and ideas in their respective reports for State Parties to consider ahead of the Review Conference. These include verification, advances in science and technology, international cooperation, and potential outcomes of the Review Conference. The presentations was followed by a moderated interactive discussion with the participants.”

Biotechnology Innovation and International Security Fellowships at Stanford University

“Stanford is seeking Biotechnology Innovation & International Security Fellows, to be appointed for one year renewable for a second.  Fellows will join a community of scholars hosted by the Center for International Security & Cooperation (CISAC), Bio.Polis, & the Department of Bioengineering, with mentoring by one or more faculty identified by each fellow.  Applications are being accepted thru 2 December 2022.”  Learn more and apply here.

START Announces Upcoming CBRN Data Suite and Portal

The National Consortium for the Study of Terrorism and Responses to Terrorism (START)’s Unconventional Weapons and Technology division recently announced the creation of their CBRN Data Suite and Portal. The data suite is set to open in December and “…includes an event-level and an actor-level dataset. The event-level dataset is based on UWT’s Profiles of Incidents Involving CBRN and Non-state Actors (POICN) database, and is scheduled to be updated through May 2022 by the time the Data Suite and Portal goes live at the end of the year.”

“The actor-level dataset is a newly created dataset modeled after the Chemical and Biological Non-State Adversaries Database (CABNSAD) and the Radiological and Nuclear Non-State Adversaries (RANNSAD) dataset, with the new CBRN Actor dataset subsuming both CABNSAD and RANNSAD. As with the event-level dataset, the actor-level dataset is scheduled to be updated through May 2022 by the time the Data Suite and Portal launch.”

NIST Soliciting Feedback on Project Proposal to Improve Cybersecurity at Water Utility Facilities

The National Institute of Standards and Technology’s National Cybersecurity Center of Excellence (NCCoE) recently released a white paper discussing ways to improve utility management, operations, and service delivery at water utility sites. The paper explains that “The NCCoE has undertaken a program to determine common scenarios for cybersecurity risks among WWS utilities. This project will profile several areas, including asset management, data integrity, remote access, and network segmentation. The NCCoE will also explore the utilization of existing commercially available products to mitigate and manage these risks. The findings can be used as a starting point by WWS utilities in mitigating cybersecurity risks for their specific production environment. This project will result in a freely available NIST Cybersecurity Practice Guide.” Read the announcement and submit feedback here.

Pandora Report: 11.4.2022

Happy Friday! This week focuses heavily on China and Russia, covering the recent ProPublica piece on the Wuhan Institute of Virology, Shanghai’s lockdown, Russia’s failed attempt at creating a UN Security Council committee to investigate its false claims about supposed US biological weapons facilities in Ukraine, and more. We also cover new publications, a new podcast release from the University of Bath’s Dr. Brett Edwards, upcoming events, and an exciting fellowship opportunity from the WHO.

About That ProPublica Piece

Late last week, ProPublica and Vanity Fair released a piece in conjunction with the Senate HELP Committee minority’s interim report, claiming to have unveiled new information from the Wuhan Institute of Virology (WIV) supporting the lab leak theory of COVID-19’s origin. In it, Katherine Eban and Jeff Kao rely heavily on the work of a single self-proclaimed polyglottal State Department political officer to translate Chinese Communist Party (CCP) “party speak,” which he claims native speakers “can’t really follow…” Now, the piece some have described as a train wreck is being heavily criticized for having faulty translations, mis-matched dates, misrepresenting the sources of the documents discussed in it, not understanding how common VPN usage is in China-related research, and more. ProPublica is reportedly scrambling to review critical details of their piece, but is it too late? Let’s talk about some core issues with the article and what they might mean long term.

‘Party Speak’ or Just Lost in Translation?

The first half of the ProPublica piece is dominated by glowing discussion of Toy Reid, a former RAND Corporation employee and East Asia political officer at the US Department of State, covering his blue collar origins and attendance at Harvard. The authors then discuss how Reid spent over a year working for the Senate HELP Committee, using a VPN to search “dispatches” on the WIV’s website from Hart Senate Office Building and his Florida home. They write, “These dispatches remain on the internet, but their meaning can’t be unlocked by just anyone. Using his hard-earned expertise, Reid believes he unearthed secrets that were hiding in plain sight.”

Plain sight is right! These “dispatches” were updates posted to the Wuhan Institute of Virology’s (WIV) homepage on the general news tab. In fact, you can go look through this whole tab here to see mundane entries ranging from a recent day reflecting on the 20th National Congress to a July post about WIV celebrating the 101st anniversary of the Party, to general updates about different trainings and publications related to the institute. Therein lies one of the fundamental problems with this piece-these were not secretive dispatches internal to the Party. These are essentially press releases meant to face outward. Yes, they are laden with mentions of comrades, references to struggles and frontlines, and key Chinese leaders, including Xi Jinping and the recently ousted Li Keqiang. They are, after all, written by Party members in a major facility of the Chinese Academy of Sciences. They are going to have this kind of language by default, especially around times like national congresses and major anniversaries.

To be clear, the CCP does use euphemisms and round-about language at times to describe high-level concepts and goals. In fact, some scholars spend the bulk of their careers conducting political discourse analysis and understanding leaders’ officialease or government-speak. Some do focus on CCP party speak, which has become especially interesting in the Xi years. However, this is definitely not unique to the CCP as one can find scholars dissecting and analyzing any number of world leaders’ speeches and government lexicons. It is also important to recognize that this concept is not some niche or extremely esoteric concept known only to a few in China watching circles. Students studying Chinese politics overwhelmingly have to learn things like “crossing the river by touching the stones” or “socialism with Chinese characteristics” as a Chinese-specific form of Marxism-Leninism throughout the periods of Dengism, Three Represents, Scientific Outlook on Development, and now Xi Jinping Thought. It it core to understanding national agendas throughout different leadership periods.

However, with this comes the understanding that Party documents are laden with this kind of jargon and narrative furthering. This also is not unique to the CCP. In fact, Harry Hodgkinson wrote an entire guide in 1955 on Soviet jargon and unique meanings Communist parties give to particularly terms. While this jargon and overarching nationalistic narratives offer important context for the WIV posts, they do not represent some in-between-the-lines version of Chinese that “even native Mandarin speakers can’t really follow…” Rather, they help explain why the language in the posts seems so dramatic and nationalistic.

What’s in a Narrative?

In October 1949, Mao Zedong declared the official founding of the People’s Republic of China. With Chiang Kai-shek and the remainder of the KMT exiled to the island of Taiwan and the decades long civil war over, Mao was left to figure out how to actually lead the new PRC. Central to this were narratives of overcoming the century of humiliation, protecting the sovereignty and integrity of Chinese territory, bringing justice for China against those who subjugated it, and building a strong, advanced country. These ideas were central to nationalism at the time and drove pushes to modernize like the infamous Great Leap Forward. As Dr. Kerry Brown of King’s College London writes, “That self-designated task of bringing about justice for China was the main justification for the Party’s many mistakes under Mao when the second resolution on its own history was produced a few years after his death in 1981.” Themes of struggle against western imperial powers and self-determination were critical political tools wielded by the Party, even in the face of wildly unpopular, destructive policies.

Though it looks different today, narratives of national struggle and rejuvenation are still important features of CCP rhetoric, even for Party members at a CAS laboratory. Brown discusses the power of narrative in modern China, writing, “For the current dominant leader Xi Jinping, the notion that the Party is a kind of epistemic community, one uniquely placed to carry China forwards to the fulfilment of its great quest for a just outcome to history, is becoming more powerful by the day.  Seen in these terms, the Party is not so much about power per se – but power to deliver this historic outcome. That perhaps explains why, despite the many challenges and problems with its practice and its own history, it still remains so dominant in China.” Today, concepts like the Chinese dream, national rejuvenation, and the goal of becoming fully modernized by 2049 are central themes Party rhetoric uses, even in discussing day-to-day work at different lower-level organizations.

In the context of the Wuhan Institute of Virology posts, this is seen in the framing of work at the lab as some kind of grand struggle. In one of the first WIV posts referenced by ProPublica and Vanity Fair (available here in its original format), the authors claim to have found a dispatch that “…referenced inhumane working conditions and “hidden safety dangers.” On Nov. 12 of that year, a dispatch by party branch members at the BSL-4 laboratory appeared to reference a biosecurity breach: “These viruses come without a shadow and leave without a trace.”

However, as a number of Mandarin speakers and China watchers have pointed out online, this was actually a very general post about how the facility went from humble beginnings at its founding to now being a training hub and “fighting fortress” of China’s research and public health. It is written not unlike other fictional and non-fictional works describing BSL-4 facilities in other countries (The Hot Zone, anyone?)-hours are long in these space suit-like positive pressure suits, the pathogens are unimaginably dangerous, and those doing the work are brave, hardworking, brilliant scientists.

Much of Toy Reid’s interpretation of this post depends on a misinterpretation of “每当这时” (Měi dāng zhè shí, “whenever”) in the context of a description of Party members leading by example whenever handling BSL-4 pathogens. Reid instead took this as “whenever there are biosafety breaches,” and not some inspirational statement about Party members. Other portions of the article focus on visits from Chinese Academy of Sciences officials and seminars on the importance of biosafety and commonly noted issues during safety inspections. However, these were updates about high-level visitors and general efforts to ensure the facility maintained safety standards, much like those any organization anywhere might make.

James Palmer, deputy editor at Foreign Policy and author of Foreign Policy’s China Brief, discussing the normal workplace nature of the WIV posts

The Wuhan Institute of Virology boasts the PRC’s first BSL-4 (P4) facility, which opened in 2018, marking a major milestone for the country. A boastful post about how it came from humble beginnings but, through the work of very dedicated personnel, is now doing important, taxing work and striving to always be better is very par for the course. There is even a corny word play in the post about how Party members “infect” (Gǎnrǎn, “感染”) others with their practical actions and safety-conscious attitudes. As many have now pointed out, this is just the Party bragging about how dedicated their members are, how far the facility has come, and how personnel are constantly working to better themselves and their organization. In other words, it is furthering the Party narrative, not hinting at secret internal problems.

References throughout the posts cited by ProPublica to General Secretary Xi Jinping and his discussion of technology as a weapon make sense in the context of Party-authored news posts. Xi Jinping has achieved power unlike any previous leader, capturing himself a historic third term after the country removed presidential term limits in 2018. Xi Jinping Thought (“Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era”) was also formally enshrined in the Party’s constitution that year, further cementing Xi’s unique power over the Party with the CCP describing it as “Marxism of contemporary China and of the 21 century.” With this context in mind, it makes sense for Party members at WIV to frequently reference Xi and his national goals and speeches. However, Reid instead took this as literal input directly from Xi to the lab following the biosafety incident he claims a previous post references.

Zhihua Chen’s thread on translation and dating issues in the ProPublica article

Finally, even if this was all true-the WIV had a 2019 biosafety incident and Xi Jinping was personally concerned enough to send an urgent message about it to WIV himself-why would any of that be posted on the institute’s website? As was just discussed, the narrative matters a lot in Chinese politics; image is everything and the Party is very secretive as a result. As the country continues to compete internationally in all areas, including the bioeconomy, it does not make sense for the Party to air dirty laundry about a supposed biosafety incident and workers’ concerns in a public space. If the core argument is that China is covering up a lab leak, the question of “Why would the Party allow the facility in question to publicly hint at mismanagement and safety issues on its own website?” must be answered.

Implications

Ultimately, bad faith takes on China, COVID-19, and biosafety hurt us all. There is a fundamental difference between calling for an in-depth investigation, holding the PRC accountable for its failures, working towards making sure we are better prepared for the next time something like this happens, and inappropriately equating mischaracterized and poorly translated press releases to some kind of damning evidence of a lab leak origin of SARS-CoV-2. The US-PRC relationship is in a very dangerous place and, while criticism of the CCP’s handling of COVID-19 is absolutely warranted, this article is likely to become political fodder for the Party. In fact, the Chinese government has already condemned the piece, claiming that it was driven by US politics.

While ProPublica claimed to have corroborated Reid’s work with unnamed “experts” on CCP communications, the swift backlash and ProPublica’s moves to reach out to other translators cast further doubt on the caliber and motivations of those consulted initially. This is in addition to concerns about the experts they claim to have consulted on the WIV’s claims about biosafety and time researchers spend in BSL-4. In the end, one can be both critical of the CCP and its practices while not resorting to an overly hawkish view that leads to finding suspicion in the mundane.

Finally, this points to a need for interdisciplinary collaboration and competent understanding of the political realities of the PRC in assessing issues like biosafety. What may look to someone with little knowledge of Chinese political discourse as alarming messages are actually pretty par for the course in terms of statements and news updates on an official website. Outside of debates on SARS-CoV-2’s origin in the scientific community, scholars in the social sciences and humanities and experts working in all sorts of fields can offer important context that, in this case, marks the difference between recognizing standard Party rhetoric and sounding alarm bells over normal updates on the WIV’s website.

For more on this, including discussions of the scientific debate about COVID-19’s origin as discussed in the Senate report and ProPublica article, check out Michael Hiltzik’s opinion piece on this article in the LA Times and Max Tani’s work in Semafor.

It’s the Happiest Place on Earth, Until You’re Stuck There-Welcome to Shanghai Disney

As China continues to cling to its zero-COVID policy, tourists at Shanghai Disney Resort now find themselves trapped in the park until they can test negative for COVID-19 amid yet another snap lockdown. South China Morning Post explains “…new variants have tested local officials’ ability to snuff out flare-ups faster than they can spread, causing much of the country to live under an ever-changing mosaic of Covid curbs.” The city announced Monday that it was going into lockdown and that visitors to the park would not be allowed to leave “until on-site testing returns a negative result.” SCMP writes, “It added that those who had visited the park since Thursday must obtain three negative Covid tests over three successive days and “avoid participating in group activities.’ The announcement came after Disney said it was “temporarily closing with immediate effect … in accordance with disease control requirements”.”

Turns Out the PRC Is Not the Only Place with Biosafety Issues

The discovery of vials labeled “smallpox” in a Merck & Co. facility near Philadelphia last year, last month’s controversy over Boston University’s NEIDL’s COVID-19 work using chimeric viruses, that time the Department of Defense accidentally mailed live anthrax spores to a US base in South Korea…the US is no stranger to biosafety issues and scares. This is the subject of a three part series of The Intercept, “Experimenting with Disaster,” focused on undisclosed biosafety incidents in the US. The first part focuses on a university lab accident, the second on work with the 1918 flu pandemic’s H1N1 virus, and the third on risky work with avian influenza. The Schar School’s Dr. Gregory Koblentz is quoted throughout the series as he provides context to the political and oversight issues surrounding these and other incidents.

Russia Fails (Again) to Garner International Sympathy for Bogus BW Claims

On Wednesday, the UN Security Council (UNSC) squashed Russia’s attempt to create a formal inquiry into its claims that the US and Ukraine are running a biological weapons program in Ukraine. Of the five permanent UNSC members, only China voted in support of Russia’s draft resolution on the measure. The US, UK, and France all voted against it while the other 10 UNSC members abstained from voting. According to the UN “Through the draft resolution, the 15-member Council would have decided to set up a commission to investigate the complaint of the Russian Federation in the context of the activities of biological laboratories in the territory of Ukraine, as well as present to the 15-member organ a report on the issue containing recommendations by 30 November 2022 and inform the States parties to the Convention at its Ninth Review Conference to be held in Geneva on 28 November–16 December 2022 of the results of the investigation.”

“The draft would also have the Council request the Secretary-General and the Biological Weapons Convention Implementation Support Unit provide, within their respective mandates, all necessary assistance to the commission.”

Cholera Outbreaks on the rise Globally

In case more COVID-19 variants, monkeypox, polio, and Ebola weren’t enough for you this year, the New York Times reports that a “…record number of [cholera] outbreaks have been reported after droughts, floods and wars have forced large numbers of people to live in unsanitary conditions.” So far, outbreaks have been reported in the Caribbean, Africa, the Middle East, and South Asia. NYT also explains “Cholera is typically fatal in about 3 percent of cases, but the World Health Organization says it is killing at an accelerated rate in recent outbreaks, even though it is relatively cheap and easy to treat. It is most often fatal in children, who progress swiftly to severe illness and organ failure.”

However, as case counts grow, vaccine supplies are coming up short. The WHO has already suspended its two-dose recommendation in favor of a single dose regimen that can help stretch supplies. “We have never had to make a decision like this about vaccination before, that’s the severity of this crisis,” Dr. Philippe Barboza, head of the WHO’s cholera team, said.

NYT explains part of why this is an issue, writing “The bulk of the world’s cholera vaccine is made by a South Korean company called EuBiologics. Some 15 percent of the global stockpile was produced by Shantha Biotechnics, a wholly owned Indian subsidiary of the French drugmaker Sanofi, but the company decided two years ago to stop production of its cholera vaccine by the end of this year and end supply by the end of 2023. That planned exit from the market coincides with the spike in demand…Dr. Barboza said that EuBiologics was producing at capacity and working to expand its production, and that another drugmaker would soon begin to produce the vaccine.”

“A Multinational Delphi Consensus to End the COVID-19 Public Health Threat”

Lazarus et al.’s new Nature article discusses findings of a Delphi study focused on the COVID-19 pandemic response: “Despite notable scientific and medical advances, broader political, socioeconomic and behavioural factors continue to undercut the response to the COVID-19 pandemic1,2. Here we convened, as part of this Delphi study, a diverse, multidisciplinary panel of 386 academic, health, non-governmental organization, government and other experts in COVID-19 response from 112 countries and territories to recommend specific actions to end this persistent global threat to public health. The panel developed a set of 41 consensus statements and 57 recommendations to governments, health systems, industry and other key stakeholders across six domains: communication; health systems; vaccination; prevention; treatment and care; and inequities. In the wake of nearly three years of fragmented global and national responses, it is instructive to note that three of the highest-ranked recommendations call for the adoption of whole-of-society and whole-of-government approaches1, while maintaining proven prevention measures using a vaccines-plus approach2 that employs a range of public health and financial support measures to complement vaccination. Other recommendations with at least 99% combined agreement advise governments and other stakeholders to improve communication, rebuild public trust and engage communities3 in the management of pandemic responses. The findings of the study, which have been further endorsed by 184 organizations globally, include points of unanimous agreement, as well as six recommendations with >5% disagreement, that provide health and social policy actions to address inadequacies in the pandemic response and help to bring this public health threat to an end.”

“Lessons Learned from the COVID-19 Outbreak”

New from the RAND Corporation, a volume on COVID-19 that includes chapters on the need to prioritize biosafety and biosecurity, and GOF research: “The coronavirus disease 2019 pandemic that began in late 2019 and continues as of the writing of this Perspective in summer 2022 has been the cause of both tremendous tragedy—in lives lost and economic hardship—and great triumph in the rapid development of effective vaccines. Many nations around the world have scrambled to respond to a once-in-a-century event that has exposed many weaknesses in response planning and capabilities, including those of the United States. Even as the pandemic continues, it is not too early to reflect on the missteps that have been made and lessons that can be learned so that the United States and nations worldwide can be better prepared for the future.”

“This volume contains a collection of essays that explores topics of critical importance toward that aim and identifies actions that can be taken to not only improve pandemic preparedness but also help prevent the occurrence of future pandemics. The essays center on U.S. challenges and experiences, but the solutions, in many cases, require collaborative efforts that reach across national boundaries.”

“The Global Inequality in COVID-19 Vaccination Coverage Among Health and Care Workers”

Nabaggala et al. discuss COVID-19 vaccinations in HCWs in their new article in the International Journal for Equity in Health. Using WHO data, they found that “Despite being considered a priority group, more than a third of countries did not achieve 70% vaccination coverage of their HCWs at the end of 2021. Large inequities were observed with low income countries lagging behind. Additional efforts should be dedicated to ensure full protection of HCWs through vaccination.”

“Bolstering Arms Control in a Contested Geopolitical Environment”

Michael Moodie and Jerry Zhang’s recent issue brief published by the Stimson Center: “For decades, arms control has constituted one of the cornerstone frameworks for global governance and served as a critical tool for bolstering international security and stability. The global arms control regime is now under unprecedented pressure, due to heightened competition between major powers, rapidly deteriorating security environment, and emerging technologies. Nevertheless, cooperation on arms control is important in today’s contested geopolitical environment as it can encourage responsible competition broadly between great powers, avoid the proliferation of advanced weaponry, and reduce the risk of unintended military escalation. This paper recommends three measures to reinvigorate arms control: sustaining long-term engagement between major powers; adopting a multi-stakeholder approach by including smaller states and non-government entities in the process; and reconceptualizing the fundamentals of arms control.”

“Addressing the Global Shortage of Biosafety and Biosecurity Professionals through Education”

The International Federation of Biosafety Associations recently published this white paper discussing their efforts to build undergraduate degree programs designed to create competent biosafety professionals. They write: “Biosafety and biosecurity professionals provide an essential role in safeguarding infectious disease agents in clinical and research laboratories and other settings where biological materials are handled. The COVID-19 pandemic has brought into focus the significant demand on the profession and many countries face an overall shortage of these specialized individuals. Given that biosafety and biosecurity professionals work in laboratories behind the scenes of the frontline response, the profession remains largely unknown to students interested in pursuing a career in the sciences. As such, students tend to be steered towards more visible education paths in the biological and health sciences.”

“To address this gap, the IFBA is leading a multisectoral effort towards a future sustainable workforce by formalizing a biosafety & biosecurity career path within the higher education system. Now is the right time since the recent lived COVID-19 experiences of youth have motivated them to become involved. Over the past 6 months, and with funding support from Global Affairs Canada, the IFBA has been collaborating with Kenya’s Masinde Muliro University of Science and Technology (MMUST) to develop and pilot a new undergraduate BSc degree program specifically in Biosafety and Biosecurity. This new BSc program leverages MMUST’s existing programs in the Department of Medical Laboratory Sciences. All students undertake related core courses in microbiology and related disciplines in the first two years followed by specialized biosafety & biosecurity courses, practical laboratory and field experience and a capstone project in their later academic years.”

“The lessons learned from this pilot program will be used for future program roll out to additional universities across Africa and globally. This project presents a recommended solution towards a sustainable future global workforce of biosafety and biosecurity professionals. Supporting this approach are multisectoral partnerships committed to biosafety and biosecurity education and our common vision of more graduates and young scientists entering the profession.”

“A Plea for Making Virus Research Safer”

Dr. Jesse Bloom’s guest essay in the New York Times offers an overview of notable pathogen research, efforts over the years to make it more secure, and current concerns. In it she writes “The French statesman Georges Clemenceau said, “War is too important to be left to the generals.” When it comes to regulating high-risk research on potential pandemic viruses, we similarly need a transparent and independent approach that involves virologists and the broader public that both funds and is affected by their work.”

“How to Detect a Man-Made Biothreat”

This Wired piece discusses US government funding to develop test that would detect engineered pathogens: “To guard against these potential threats, the US government is funding the development of tests to detect dangerous bioengineered organisms before they have a chance to cause significant harm. The effort was announced in 2017 by the Intelligence Advanced Research Projects Activity, or Iarpa, within the Office of the Director of National Intelligence. In a livestreamed update in October, Iarpa program manager David Markowitz announced that two platforms developed under the program were both 70 percent accurate at identifying the presence of bioengineering. “We simply never know what sample is going to come through the door in a government lab, and we need to be prepared for anything,” Markowitz said during the news briefing.”

“Why Climate Change Matters for Pandemic Preparedness”

Check out this Nature Outlook piece with computational ecologist Xavier Rodó on climate change’s role in pandemic planning: “Numerous studies over more than two decades have demonstrated a robust relationship between climate and the dynamics of human diseases, such as cholera, malaria and dengue. Changes in climate, including both long-term warming trends and short-term climate variability, might affect patterns of disease. Xavier Rodó, a computational ecologist and climate dynamics specialist at the Barcelona Institute for Global Health and the Catalan Institution for Research and Advanced Studies in Spain, spoke to Nature about how climate modelling could be used to help prepare for future disease outbreaks — and the obstacles he has faced in implementing such systems.”

“Chemical Security Experts Call for Multisector Cooperation Against Terrorism”

From INTERPOL: “The devastating impact of chemical weapons and explosives used in acts of terrorism continues to affect civilian populations and is well known for its destructive and long-term harm.”

“Last year over 1,000 improvised explosive device (IED) attacks were conducted by non-state actors, injuring over 7,150 people in more than 40 countries. Many attacks come from chemicals that criminals acquired through weak points in the supply chain – from manufacturing to storage and retail– and made into weapons.”

“To counter this threat, some 220 chemical security practitioners from more than 70 countries met at INTERPOL’s 3rd Global Congress on Chemical Security and Emerging Threats (25-27 October) to find ways of reducing vulnerabilities by enhancing multisector cooperation and collaboration.” Read more here.

What We’re Listening To 🎧

THE RETORT: EPISODE 4 Gain of Function Experiments

The latest episode of Dr. Brett Edwards’ podcast, The Retort, offers “A straightforward introduction to the past decade of discussion of international oversight of gain of function pandemic research,” with Dr. Nariyoshi Shinomiya of Japan’s National Defense Medical College. This episode and previous ones are available on Dr. Edwards’ YouTube channel. His other podcast project, Poisons and Pestilence, also recently reached 7,000 listens. In celebration, he is hosting a t-shirt give away, so be sure to check that out here.

Conversations Before Midnight

The Bulletin of the Atomic Scientists is hosting its Bulletin Annual Gathering on November 9, 2022, at 5 pm CDT virtually. This is the Bulletin’s “signature event” and it aims to allow guests to engage in high-level conversations with influential voices tracking man-made threats. At the event, “Each virtual table has an expert, established and up-and-coming specialists in the fields of nuclear risk, climate change, disruptive technologies, and biosecurity. These discussion leaders include members of the Bulletin’s Science and Security Board, Board of Sponsors, and invited experts from around the world. Below are a few samples for this year’s gathering.”‘ Table experts include our own Dr. Greg Koblentz, so be sure to check out this event’s info page here.

Briefings in Preparation for the Ninth BWC Review Conference

From UNIDR: “The 1972 Biological Weapons Convention (BWC) is a cornerstone in the regime to prevent the hostile use of biology. The Ninth BWC Review Conference will take place in late November 2022 and presents an important opportunity to take stock of the past and chart a course for the future of this increasingly important agreement. In support of preparations for the Ninth BWC Review Conference and beyond, UNIDIR has recently published several reports intended to stimulate thinking on substantive issues related to the BWC.”

“This virtual event will bring together the authors of the latest UNIDIR publications on BWC topics to provide short outlines of the key insights and ideas in their respective reports for State Parties to consider ahead of the Review Conference. These include verification, advances in science and technology, international cooperation, and potential outcomes of the Review Conference. The presentations will be followed by a moderated interactive discussion with the participants.” This event will take place on November 7 at 2 pm CET, online. Learn more and register here.

Infection Prevention and Control: Incorporating Lessons Learned in Managing Special Pathogens

“After nearly three years responding to the COVID-19 pandemic, hospitals and other healthcare facilities have learned many lessons about the management of special pathogens and essential infection prevention and control practices. The U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response’s Technical Resources, Assistance Center, and Information Exchange (ASPR TRACIE) and the National Emerging Special Pathogens Training and Education Center (NETEC) invite you to learn more about some of those lessons. Speakers will share their perspectives on how our approach to outbreaks has changed since the pandemic began. They will address issues such as infection prevention for healthcare workers and patients and mitigating disease spread. Speakers will also highlight newly developed tools and resources. This webinar will take place November 7 at 2:00 pm ET. Register today!”

WHO/AFRO Fellowship Programme on Public Health Emergencies in Africa

“The World Health Organization Regional Office for Africa (WHO AFRO) invites interested and eligible candidates to submit applications for a fellowship programme on improving the management of public health emergencies in Africa under the COVID-19 Incident Management Support Team (IMST).” Learn more and apply here.

Pandora Report: 10.28.2022

Happy Halloween! This week we haves lots of scares for you, including even more misuse of international organizations to further disinformation narratives! This week, we focus on Russia’s request for a UNSC investigation of its bogus BW claims and complaint lodged in accordance with Article VI of the BWC, the Senate Health, Education, Labor and Pensions minority report on SARS-CoV-2 origins, and ongoing debates about the SARS-CoV-2 experiments conducted at Boston University. We also cover new publications, upcoming events, and new announcements ahead of One Health Day.

Russia Criticized Heavily After Calling for UNSC Resolution on “Secret Biolabs in Ukraine”

In yet another massive waste of everyone’s time, Russia has continued to press its false claims that the US runs “secret military biological programs” in Ukraine with the UN Security Council, this time drafting a resolution that would establish a commission (comprised of all 15 UNSC members) to investigate the claims. This comes amid a new wave of “transparently false allegations” on the part of Moscow, most recently regarding alleged Ukrainian plans to use a dirty bomb in its own territory. In response to this latest effort at the Security Council, the UK’s Ambassador to the UN, Dame Barbara Woodward, asked the question on everyone’s mind-“How much more of this nonsense do we have to endure?”

This newest attempt includes an official complaint to the UNSC, filed in accordance with article VI of the BWC, in addition to the request for the formation of a formal commission to investigate the October 24 complaint. The complaints continue to center on efforts between the US and Ukraine, largely under the Cooperative Threat Reduction program, to support public health research and diagnostic facilities, though Russia insists these facilities are not for peaceful purposes.

In a Thursday briefing before the Security Council, the UN Office for Disarmament Affairs (UNODA) reiterated again that it is not aware of any biological weapons programs in Ukraine, echoing its previous statements on the matter made in March and May. In response, Russia’s Ambassador Vassily Nebenzia said, “Do you really think that we’re that naïve?…Do you really think that we think that the Pentagon is going to inform the high representative of the Office of Disarmament Affairs within the UN about their secret biological programs in Ukraine?”

US Ambassador to the UN, Linda Thomas-Greenfield, summarized the absurdity of Russia’s claims, explaining “We hear Russia raise alarms that biological weapons will be delivered by birds and bats and now even mosquitoes. Birds and bats. Russia knows public health laboratories routinely study migratory animal species to assess and counter animal-borne pathogens. Bear in mind, much like Russia, birds and bats don’t tend to observe or respect sovereign borders. Russia’s assertions are absurd for many reasons, including because such species, even if they could be weaponized, would pose as much a threat to the European continent and to Ukraine itself as they would to any other country.”

Thomas-Greenfield also described the meeting as a “…colossal waste of time… an attempt to distract from the atrocities Russian forces are carrying out in Ukraine and a desperate tactic to justify an unjustifiable war.” She later added, “It doesn’t matter how many meetings Russia tries to call on this subject. And it doesn’t matter how hard it ratchets up its propaganda machine. We must not divert UN resources toward a baseless investigation. And we must not allow Russia’s tactics to distract us from its brutal war of aggression.”

Senate HELP Committee Minority Interim Report Released on SARS-CoV-2 Origins

This week, the Senate Health, Education, Labor and Pensions (HELP) Committee Minority oversight staff released their interim report-“An Analysis of the Origins of the COVID-19 Pandemic”. The report makes a number of claims, including “While it remains possible that SARS-CoV-2 emerged as a result of a natural zoonotic spillover, facts and evidence found in previous documented zoonotic spillover events have not, to date, been identified in relation to this pandemic,” “Substantial evidence suggests that the COVID-19 pandemic was the result of a research-related incident associated with a laboratory in Wuhan, China,” and “This investigation’s interim report concludes that SARS-CoV-2 and the resulting COVID-19 global pandemic was, more likely than not, the result of a research-related incident associated with coronavirus research in Wuhan, China.”

The 35-page report does not completely rule out a market origin and, importantly, it does not claim that SARS-CoV-2 was engineered as a bioweapon-a popular conspiracy theory. One interesting element it does focus on is that Chinese scientists began testing their COVID-19 vaccines in humans about a month before the United States did. The report implies this means the Chinese had some sort of advanced (pre-January 11, 2020) access to genomic sequencing, though it does still ask “What additional steps, processes, or novel techniques did AMMS [PLA Academy of Military Medical Sciences] researchers take that advanced the development of their vaccine faster than the Operation Warp Speed timeline?” The report states, “While mRNA vaccine candidates were able to design their vaccine construct in two days, because mRNA vaccines only need the coronavirus’ genetic sequence to make a vaccine and no virus has to be cultivated in labs, traditional vaccine platforms take longer.” It continues, highlighting that the first Operation Warp Speed (OWS) vaccine candidates to enter human clinical trials were non-mRNA vaccines-AstraZeneca-Oxford’s offering and Johnson & Johnson’s, both viral vector vaccines.

It then contrasts the 8 months it took for OWS viral vector candidates to human clinical trials with the 67 days it took one AMMS team to do the same, writing “Given Operation Warp Speed’s success, it is unusual that the two AMMS COVID-19 vaccine development teams were able to reach early milestones in vaccine development even more quickly. The Chen AMMS team beat AstraZeneca-Oxford to phase I clinical trials by 38 days. The Zhou AMMS team built and validated the effectiveness of its COVID-19 candidate vaccine 44 days after the sequence of SARS-CoV-2 was released. The extremely accelerated vaccines development timelines achieved by the AMMS teams pose the following two outstanding questions:”

  • “What additional steps, processes, or novel techniques did AMMS researchers take that advanced the development of their vaccine faster than the Operation Warp Speed timeline?”
  • “If no additional steps were taken to speed up the development timeline, when did researchers in China have access to the genomic sequence? Was it before January 11, 2020? If so, how far in advance of January 11, 2020?”

This argument does not address differences in the regulatory environments of the US and PRC. Rather, it seems to imply that this is evidence the Chinese had advance knowledge of this outbreak with no discussion of drug and therapeutic approval reforms in recent years that aim to improve the country’s ability to compete in pharmaceutical manufacturing globally and incentivizes development of vaccines and drugs for rare diseases. The CCP has identified competition in global biopharmaceutical manufacturing as a top priority, so the implication that the faster timeline to clinical trials supports the lab leak theory is unsatisfactory as presented.

It also does not appear to have even won over prominent supporters of the lab leak theory, including Dr. Richard Ebright, a molecular biologist at Rutgers University. The New York Times explains, “Dr. Ebright, who was interviewed by the report’s authors, said he supported the argument that evidence pointed to a laboratory origin. But the only new element, he said, appeared to be questions raised about how China could have developed a vaccine so quickly, which he did not find persuasive. Otherwise, he said, “there was no information in the report that has not been publicly presented in the media and discussed in the media previously.”

“This image depicted a test tube with viral transport media that contained a patient’s sample to be tested for the presence of SARS-CoV-2, the virus that causes COVID-19.” Source: CDC PHIL

Naturally, this interim report has been heavily criticized. The conclusion reached in this report obviously differs from the two peer-reviewed Science articles published earlier this year that found 1) the Huanan Seafood Wholesale Market was the epicenter of the initial outbreak and 2) that there were at least two distinct spillovers from animals sold at the market. Scientists supporting the market origin still have not identified which animals were infected or where they came from, as no animals were tested before the market was shut down early in 2020. Of this, the report states “Critical corroborating evidence of a natural zoonotic spillover is missing. While the absence of evidence is not itself evidence, the lack of corroborating evidence of a zoonotic spillover or spillovers, three years into the pandemic, is highly problematic.”

Dr. Michael Worobey, Department Head of Ecology and Evolutionary Biology at the University of Arizona and a co-author of both the Science articles, addressed the report with Science news, with the news team writing “Michael Worobey, an evolutionary biologist at the University of Arizona who has co-authored scientific reports examining data from the early days of the pandemic that provide some of the strongest support for a jump from animals to humans, speculates that the timing of the report’s release could be “a cynical effort to try to win Republican votes” in the upcoming midterm congressional and state elections.  Or, Worobey says, “it could just be a bunch of staffers with no ability to understand the science who stumbled across a bunch of misinformation and disinformation-filled tweets.” (“Senator Burr felt enough compelling, open-source information had been gathered during staff’s comprehensive review of the facts that an interim report was appropriate,” a senior aide to the minority staff told Science.)”

After the minority interim report was released, Senator Patty Murray, Chair of the Senate HELP Committee, issued a statement on “continuing bipartisan oversight efforts into the origins of the virus that causes COVID-19” that did not address the minority report. Sen. Murray stated “COVID-19 has caused so much pain, hardship, and loss for people in Washington state, across our country, and all across the globe. As I’ve said time and again, it is absolutely critical we learn the lessons from this pandemic so that we never find ourselves in a similar situation again—and that, of course, includes undertaking a full examination of how COVID-19 first emerged.”

“That’s why I made it a top priority as Chair to craft bipartisan legislation to strengthen our public health and pandemic preparedness systems with the PREVENT Pandemics Act—which, among so many other vital steps, would establish an independent task force to conduct a comprehensive review of COVID’s origins and the federal response to the pandemic. And it’s why, in 2021, I announced a bipartisan oversight effort with Senator Burr into the origins of this virus. The HELP Committee is continuing bipartisan work on this oversight report, and I remain committed to passing the PREVENT Pandemics Act, which advanced out of Committee with overwhelming bipartisan support.”

More on the Boston University Controversy

While the controversy surrounding experiments conducted on SARS-CoV-2 at Boston University has subsided some, attention has shifted to how such research is regulated. The New York Times explains the concerns, writing “But the uproar highlighted shortcomings in how the U.S. government regulates research on pathogens that pose a risk, however small, of setting off a pandemic. It revealed loopholes that allow experiments to go unnoticed, a lack of transparency about how the risk of experiments is judged and a seemingly haphazard pattern in the federal government’s oversight policy, known as the P3CO framework.” It also notes “Even as the government publicly reprimanded Boston University, it raised no red flags publicly about several other experiments it funded in which researchers manipulated coronaviruses in similar ways. One of them was carried out by the government’s own scientists.”

“Colorized scanning electron micrograph of a cell infected with a variant strain of SARS-CoV-2 virus particles (green), isolated from a patient sample.” Source: NIH Image Library

Nature explains the issue further, writing “At issue is whether — and when — researchers modifying SARS-CoV-2 or other deadly pathogens need to keep regulators and funding agencies such as the US National Institutes of Health (NIH) informed about their work, even if the agencies didn’t fund the experiments in question. Studies that make pathogens more transmissible or virulent are sometimes called ‘gain of function’ research.”

The issue now being discussed is if federal guidance is too vague in explaining what disclosures are required after a proposal is approved and research is progressing. Dr. Greg Koblentz told The New York Times “The government should be providing the guidance to help people figure this out,” and explained to Grid that “Pandemic prevention and lab safety rules “only move in fits and starts,” said biodefense professor Gregory Koblentz of George Mason University, pointing to the long list of past controversies. “And we only make progress where there is some crisis, or perceived crisis, that grabs people’s attention.”

Koblentz also commented on the confusion surrounding “gain of function”, telling Grid “‘Gain of function’ — we should retire that term, it really doesn’t help us in that debate,” said Koblentz. “It has become shorthand for a class of research that people are worried about because of the risks it poses, but it is a term that really has outlived its usefulness.” The term garnered attention during a number of political debates, including back-and-forths between Senator Rand Paul and Dr. Anthony Fauci.

Grid also noted that, though many experts disagree on the utility of the term “gain of function, “There’s one point all of the experts who spoke to Grid agreed on — the Boston University chimera experiments do point to a need for stronger federal government oversight of potentially dangerous bugs. The fact that we are still debating whether to review genetically altering known pandemic pathogens, not even potential ones, said Koblentz, “is an indictment of both the self-governance model that the virology community largely supports and the current policy.”

NCT Magazine

In this issue focused on 4th generation chemical weapons, several experts offer their perspective on existing and emerging issues. Drs. Stefano Costanzi and Gregory Koblentz authored a piece for this issue, “Controlling Novichok Nerve Agents After the Skripal and Navalny Incidents”. They cover the history of this family of nerve agents and international disarmament and nonproliferation attempts before discussing the Skripal and Navalny incidents as evidence that both the Chemical Weapons Convention and Australia Group Chemical Weapons Precursors list need to be revised to better address Novichok agents. They conclude “The ability of the CWC and AG to adapt to the new challenge posed by these fourth-generation nerve agents demonstrates the resilience of the chemical weapon nonproliferation regime. However, further measures need to be implemented to reduce the opportunities for proliferators to develop and use Novichok nerve agents. Embracing a family-based approach to listing chemicals of proliferation concern would strengthen the nonproliferation regime and the adoption of technologies such as cheminformatics can facilitate the transition to this new approach to containing the threat posed by chemical weapons.”

“Designation of Three Syrian Military Officials Due to Involvement in Gross Violations of Human Rights”

On the topic of chemical weapons, the US State Department recently designated multiple military officials from the Syrian regime, it declared in a press release this week. The statement reads in part, “Of the atrocities committed by the Assad regime, some of which rise to the level of war crimes and crimes against humanity, few are as inhumane and abhorrent as the repeated use of chemical weapons against civilians.  In August 2013, the Syrian Artillery and Missile Directorate of the Syrian Armed Forces launched rockets carrying the nerve agent sarin, a deadly chemical, on Ghouta, a suburb of Damascus, killing at least 1,400 people, many of them children.  Today, we are taking additional action to promote accountability.”

“The Department of State is designating three Syrian regime military officials involved in these airstrikes, pursuant to Section 7031(c) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022.  Brigadier General Adnan Aboud Hilweh, Major General Ghassan Ahmed Ghannam, and Major General Jawdat Saleebi Mawas were involved in gross violations of human rights, namely the flagrant denial of the right to life of at least 1,400 people in Ghouta. As a result of today’s action, Hilweh, Ghannam, and Mawas as well as their immediate family members are ineligible for entry into the United States.”

“To Fix American’s Biodefense Strategy, Think Smaller”

From Breaking Defense: “It’s a natural reflex for the US government to try to develop strategies to deal with issues as broadly as possible, to handle a wide array of contingencies. But in the op-ed below, Al Mauroni of Air University’s Center for Strategic Deterrent Studies argues that the Biden administration’s biodefense strategy, expanding on past strategies, has grown too cumbersome and is in need of a cure of its own.”

ASPR TRACIE on Major Radiological or Nuclear Incidents

ASPR’s Healthcare Emergency Preparedness Information Gateway (TRACIE) recently released this updated document providing an “overview of health and medical response and recovery needs following a radiological or nuclear incident…” It also outlines resources for planners. Other relevant resources can also be found on the TRACIE CBRN page.

“Preventing and Preparing for Pandemics with Zoonotic Origins”

This piece from the Council on Foreign Relations discusses how factors that drive pathogen emergence and spread should influence decisions on investments in pandemic preparedness and response. It discusses priority pathogens, primary pandemic prevention, and secondary pandemic prevention and pandemic preparedness, concluding that “There is unprecedented support at the highest levels of government to enhance global pandemic prevention and preparedness. The recent decision to create a new fund for pandemics out of the World Bank and the ongoing negotiation for a pandemic agreement within the World Health Organization are potentially transformational. It is critical that comprehensive action be taken quickly through these efforts before the world’s collective attention moves on to the next crisis. Failure to do so means future generations will live less healthy and productive lives than we have today.”

“COVID-19 Genomic UK (COG-UK) Consortium: Final Report”

In this article from RAND Health Quarterly, Marjanovic et al. write in their abstract “The ability to sequence and understand different variants of the SARS-CoV-2 virus and their impact is crucial to inform policy and public health decisions. Soon after the UK went into its first lockdown in March 2020, the CCOVID-19 Genomics UK (COG-UK) Consortium was launched. COG-UK is a collaboration of experts in pathogen genomics including academic institutions, public health agencies, the Wellcome Sanger Institute, NHS Trusts and Lighthouse Labs. RAND Europe evaluated how COG-UK delivered against its objectives, for example how it contributed to advancing scientific knowledge about SARS-CoV-2, informing public health decisions, and providing information that can be used to evaluate the effectiveness of vaccines and treatments. The evaluation also examined the diverse factors that influenced COG-UK progress and impact, including enablers and challenges, and considered implications for the future.”

Coronavirus Vaccines R&D Roadmap

From CIDRAP: “CIDRAP, with support from the Bill & Melinda Gates Foundation and The Rockefeller Foundation, has led an international collaborative effort to develop a coronavirus vaccines research and development (R&D) roadmap (CVR). The CVR aims to serve a strategic planning tool to facilitate R&D, coordinate funding, and promote stakeholder engagement aimed at generating broadly protective coronavirus vaccines.”

“A key component of roadmap development is gathering feedback via a public comment period. The draft CVR is now available for a 4-week public comment period from October 24 – November 18, 2022. Feedback gathered during the public comment period will be used to refine the roadmap, resulting in a final roadmap made available in early 2023.”

“The draft CVR may be downloaded in PDF format. Comments should be submitted via this survey, which will be available through November 18, 2022. The survey offers the opportunity to share general and specific comments on the roadmap; the team welcomes as little or much feedback as you would like to provide.”

“The Future of Infodemic Surveillance as Public Health Surveillance”

In this recent piece from a supplement issue of Emerging Infectious Diseases, Chiou et al. write “Public health systems need to be able to detect and respond to infodemics (outbreaks of misinformation, disinformation, information overload, or information voids). Drawing from our experience at the US Centers for Disease Control and Prevention, the COVID-19 State of Vaccine Confidence Insight Reporting System has been created as one of the first public health infodemic surveillance systems. Key functions of infodemic surveillance systems include monitoring the information environment by person, place, and time; identifying infodemic events with digital analytics; conducting offline community-based assessments; and generating timely routine reports. Although specific considerations of several system attributes of infodemic surveillance system must be considered, infodemic surveillance systems share several similarities with traditional public health surveillance systems. Because both information and pathogens are spread more readily in an increasingly hyperconnected world, sustainable and routine systems must be created to ensure that timely interventions can be deployed for both epidemic and infodemic response.”

COVID Taking the Fun Out of Fungi?

The WHO recently released its first fungal priority pathogens list (FPPL)- “the first global effort to systematically prioritize fungal pathogens, considering their unmet research and development (R&D) needs and perceived public health importance.” The WHO explains that “The WHO FPPL aims to focus and drive further research and policy interventions to strengthen the global response to fungal infections and antifungal resistance. The WHO FPPL list is divided into three categories: critical, high and medium priority. The report presents these categories and proposes actions and strategies for policymakers, public health professionals and other stakeholders; targeted at improving the overall response to these priority fungal pathogens including preventing the development of antimicrobial resistance. Three primary areas for action are proposed, focusing on: (1) strengthening laboratory capacity and surveillance; (2) sustainable investments in research, development, and innovation; and (3) public health interventions.”

This comes amid a spike in certain fungal diseases during the COVID-19 pandemic. Additionally, the report found that “Currently, fungal infections receive less than 1.5% of all infectious disease research funding,” and that “most treatment guidelines are informed by limited evidence and expert opinion.”

Opinion: “To Fight Misinformation, We Need to Teach That Science Is Dynamic”

In this piece for Scientific American, Dr. Carl Bergstrom, Daniel Pimentel, and Dr. Jonathan Osborne discuss public ignorance of the scientific community, identifying ways this can be rectified. They write, “It’s easy to see why so many of us struggle to distinguish trustworthy science from what is flawed, speculative or fundamentally wrong. When we don’t learn the nature of consensus, how science tends to be self-correcting and how community as well as individual incentives bring to light discrepancies in theory and data, we are vulnerable to false beliefs and antiscience propaganda. Indeed, misinformation is now a pervasive threat to national and international security and well-being.”

They discuss the need to develop a population of competent outsiders, explaining “Giving people more facts is insufficient. Instead, we need a populace that can tell which sources of information are likely to be reliable, even if the science itself is beyond what they learned in school, so that they can identify when they need scientific information to make decisions in their own lives. Just as critically, people must understand enough about how science attempts to minimize error. In other words, every member of our society needs to be what science education researcher Noah Feinstein calls a “competent outsider.”

What We’re Listening To 🎧

This Week in Virology 948: Breathless with David Quammen

“David Quammen returns to TWiV to discuss how he wrote his new book ‘Breathless’, a story about the science and the scientists behind the race to understand the pandemic coronavirus SARS-CoV-2.” Listen here.

Conversations Before Midnight

The Bulletin of the Atomic Scientists is hosting its Bulletin Annual Gathering on November 9, 2022, at 5 pm CDT virtually. This is the Bulletin’s “signature event” and it aims to allow guests to engage in high-level conversations with influential voices tracking man-made threats. At the event, “Each virtual table has an expert, established and up-and-coming specialists in the fields of nuclear risk, climate change, disruptive technologies, and biosecurity. These discussion leaders include members of the Bulletin’s Science and Security Board, Board of Sponsors, and invited experts from around the world. Below are a few samples for this year’s gathering.”‘ Table experts include our own Dr. Greg Koblentz, so be sure to check out this event’s info page here.

Briefings in Preparation for the Ninth BWC Review Conference

From UNIDR: “The 1972 Biological Weapons Convention (BWC) is a cornerstone in the regime to prevent the hostile use of biology. The Ninth BWC Review Conference will take place in late November 2022 and presents an important opportunity to take stock of the past and chart a course for the future of this increasingly important agreement. In support of preparations for the Ninth BWC Review Conference and beyond, UNIDIR has recently published several reports intended to stimulate thinking on substantive issues related to the BWC.”

“This virtual event will bring together the authors of the latest UNIDIR publications on BWC topics to provide short outlines of the key insights and ideas in their respective reports for State Parties to consider ahead of the Review Conference. These include verification, advances in science and technology, international cooperation, and potential outcomes of the Review Conference. The presentations will be followed by a moderated interactive discussion with the participants.” This event will take place on November 7 at 2 pm CET, online. Learn more and register here.

Infection Prevention and Control: Incorporating Lessons Learned in Managing Special Pathogens

“After nearly three years responding to the COVID-19 pandemic, hospitals and other healthcare facilities have learned many lessons about the management of special pathogens and essential infection prevention and control practices. The U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response’s Technical Resources, Assistance Center, and Information Exchange (ASPR TRACIE) and the National Emerging Special Pathogens Training and Education Center (NETEC) invite you to learn more about some of those lessons. Speakers will share their perspectives on how our approach to outbreaks has changed since the pandemic began. They will address issues such as infection prevention for healthcare workers and patients and mitigating disease spread. Speakers will also highlight newly developed tools and resources. This webinar will take place November 7 at 2:00 pm ET. Register today!”

From One Health Commission-World Bank Open Call

“Open Call for Experts to serve on the Technical Advisory Panel to the Governing Board of the Pandemic Prevention, Preparedness and Response Financial Intermediary Fund (“PPR FIF”)”- November 3 Deadline

“World Bank has posted a call for experts to serve on the Technical Advisory Panel (TAP) to the Governing Board of the Pandemic Prevention, Preparedness and Response Financial Intermediary Fund (“PPR FIF”).”

“The TAP will comprise a multidisciplinary pool of up to 20 experts, bringing a diverse range of independent technical and financial expertise relevant to PPR FIF-supported projects and activities. To register your interest in being considered for the PPR FIF TAP, please submit documents to ppr_fif_secretariat@worldbank.org using the subject line “Expression of interest for the PPR FIF TAP

Speaking of One Health…November 3 is One Health Day

Mark your calendars for this year’s One Health Day on November 3. One Health Day is an international campaign that was launched in 2016. The One Health Commission explains that “The goal of One Health Day is to bring attention around the world to the need for One Health interactions and for the world to ‘see them in action’. The One Health Day campaign is designed to engage as many individuals as possible from as many arenas as possible in One Health education and awareness events, and to generate an inspiring array of projects worldwide.” If you are hosting an event on this day, you can register your event here with the Commission. A list of registered One Health Day events for 2022 is also available here.

Pandora Report: 10.21.2022

It’s Friday again and this time we are kicking it off with some great news from our program. We then discuss the Biden administration’s new National Biodefense Strategy and the Boston University preprint controversy. As always, we finish the week out with new publications and upcoming events, including an entire issue supplement of Clinical Infectious Diseases dedicated to anthrax. Finally, mark your calendars, because November 3 is One Health Day (more on that in the announcements section).

First, Some Good News from the Biodefense Program!

Biodefense Faculty Member Joins Council on Strategic Risks and Wins Schar School of Policy and Government Distinguished Alumni Award…All in One Week!

This week, Dr. Saskia Popescu, an epidemiologist, prominent infection prevention consultant, an assistant professor at the Schar School, and more (No, seriously, she does all that AND more.) was named a Senior Fellow at the Janne E. Nolan Center on Strategic Weapons at the Council on Strategic Risks. In case that somehow was not enough for one week, she is also being honored today as this year’s Schar School of Policy and Government Distinguished Alumni Award winner. Read all about Dr. Popescu’s hero origin story here on the Schar School site.

Biodefense PhD Student Named Bulletin of the Atomic Scientists Editorial Fellow

Kimberly Ma, a first year Biodefense PhD student and senior analyst with the Preparedness division at the Association of State and Territorial Health Officials, was recently named an Editorial Fellow at the Bulletin of the Atomic Scientists. Over the next year, she will author a number of pieces on biosecurity for the Bulletin, so keep an eye out for her upcoming work!

The Biden Administration Releases New National Biodefense Strategy

This week, the White House announced the release of the new National Biodefense Strategy and President Biden’s intent to sign National Security Memorandum 15-“Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security”. The strategy takes a comprehensive approach, aiming to make improvements in these areas-“detect pandemic and other biological threats, “prevent outbreaks from becoming epidemics and prevent biological incidents before they can happen,” “prepare for pandemics and other biological incidents,” “rapidly respond to outbreaks when they occur,” and “recover from a pandemic or biological incident.”

Among other points about the strategy, the Nuclear Threat Initiative explains that “The new strategy’s requirement that the National Security Council and the Office of Science and Technology Policy conduct an interagency policy review regarding biosafety and biosecurity norms and oversight for life sciences research also is valuable. As the largest funder of bioscience and biotechnology research and development in the world, the U.S. Government has a responsibility to put guardrails in place to prevent laboratory accidents or deliberate misuse of the tools of modern bioscience and biotechnology. Doing so can have a profound direct impact in reducing global biological risks and serve as a valuable example for other funders around the world.”

National Security Memorandum 15, “National Security Memorandum on Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security,” directs the heads of agencies addressed to:

  1. “implement the Biodefense Strategy, as well as related strategies such as the U.S. Global Health Security Strategy, and include biodefense-related activities, including resourcing and achieving the goals of the Biodefense Strategy and the priorities, targets, and actions of its Implementation Plan, within their strategic planning and budgetary processes;
  2. in the event of the determination of a nationally or internationally significant biological incident, implement Federal response efforts in accordance with Homeland Security Presidential Directive 5 of February 28, 2003 (Management of Domestic Incidents), Presidential Policy Directive 8 of March 30, 2011 (National Preparedness), Presidential Policy Directive 44 of November 7, 2016 (Enhancing Domestic Incident Response), and Federal Government response and recovery frameworks and operational plans;
  3. coordinate their biodefense policies with other agencies that have responsibilities or capabilities pertaining to biodefense, as well as with appropriate non-Federal entities;
  4. share information and coordinate decision-making related to the biodefense enterprise; and
  5. monitor, evaluate, and hold their respective agencies accountable for the implementation of section 3(a) of this memorandum.”

The memorandum also states that “To facilitate effective implementation of the Biodefense Strategy, within 90 days of the date of this memorandum and at least quarterly thereafter, the NSC staff Directorate for Global Health Security and Biodefense shall convene lead agencies identified in the Biodefense Strategy’s Implementation Plan at the Assistant Secretary level.  These agencies shall brief the NSC staff on progress towards key milestones and timelines, as well as on critical gaps and barriers to progress.  The NSC staff Directorate for Global Health Security and Biodefense shall provide updates quarterly to the APNSA based off of these briefs, summarizing progress towards the implementation of the Biodefense Strategy by highlighting the extent to which the goals and objectives are being met, outlining major gaps and impediments to timely and effective implementation, and presenting options for overcoming these gaps.  The APNSA shall provide to the President, on an annual basis, a memorandum summarizing these updates.”

Transcripts of the background call on this new strategy are available here, and check out the Council on Strategic Risks discussion of the strategy here.

Boston University Controversy

Last week, researchers from Boston University’s (BU) National Emerging Infectious Diseases Laboratories (NEIDL) posted results from their controversial work on BA.1 variant spike proteins in preprint. As Science explains, “They took the gene for Omicron’s surface protein, or spike protein, which SARS-CoV-2 uses to enter cells and added it to the genome of a “backbone” virus—a variant of SARS-CoV-2 from Washington state that was identified soon after the pandemic first emerged in Wuhan, China, in early 2020. The objective was to tease apart whether Omicron’s spike protein explains why it is less pathogenic (meaning it causes less severe disease). The answer could lead to improved COVID-19 diagnostic tests and better ways to manage the disease, the preprint authors say.”

“This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. A novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19).”; Source: CDC PHIL

By Monday, a UK tabloid, Daily Mail, ran with the story, indicating in their headline that the lab had created a strain of SARS-CoV-2 with an “80 percent kill rate,” and had created a much more dangerous strain of the virus. While the Daily Mail piece is very clearly from a tabloid, this did spark debate online, as this preprint describes what some argue is gain of function research. This work was not approved by the National Institutes of Health, though it was approved by the institutional biosafety committee at NEIDL. Critics argue that this study lacks scientific value and that its potential risks were not properly reviewed before it was conducted. Some, including Francois Balloux, a virologist at University College London, expressed concern over the study’s relevance to human health, noting that findings in mice frequently do not carry over to humans. Others, however, are far less alarmed, generally arguing that the hybrid virus is far less lethal than the original, pointing to the extreme sensitivity of the mice used in the study, and highlighting that similar SARS-CoV-2 variants have already emerged before later fading away.

The university responded to accusations made in the Daily Mail, stating “We want to address the false and inaccurate reporting about Boston University COVID-19 research, which appeared today in the Daily Mail,” said the BU statement. “First, this research is not gain-of-function research, meaning it did not amplify the Washington state SARS-CoV-2 virus strain or make it more dangerous. In fact, this research made the virus replicate less dangerous.” BU also explained that “The animal model that was used was a particular type of mouse that is highly susceptible, and 80 to 100 percent of the infected mice succumb to disease from the original strain, the so-called Washington strain,” says Corley. “Whereas Omicron causes a very mild disease in these animals.” On the topic of funding, BU said the lab “…did not amplify the [backbone] SARS-CoV-2 virus strain or make it more dangerous. In fact, this research made the virus replicate less dangerous,” as reason for not reporting the study to NIH. They also stated this work did not need to be cleared by NIH as it was not directly funded by the agency as the lab used NIAID grants only to pay for tools and platforms.

Science reports that “Emily Erbelding, director of the NIAID division that helped fund the work, said the hybrid virus experiments weren’t described in BU’s grant proposal or progress reports. But she said if BU had informed NIAID about its plans, the institute probably would have evaluated it to determine whether it qualified for review by a special Department of Health and Human Services (HHS) committee.”

NIH also released a statement this week: “The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, did not review nor issue awards for experiments described in a pre-print article on SARS-CoV-2 research at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL). NIH is examining the matter to determine whether the research conducted was subject to the NIH Grants Policy Statement or met the criteria for review under the HHS Framework for Guiding Funding Decisions about Proposed Research Involving Enhanced Potential Pandemic Pathogens (HHS P3CO framework)…”

While the debate is sure to keep raging, it is also likely to add fuel to the ongoing review of federal oversight policies for GoF research led by the National Science Advisory Board for Biosecurity (NSABB). According to Science, “In September, an NSABB task force issued a draft report that recommended the review policy be expanded to sweep in some kinds of research, and some pathogens, that are now exempt. And experts on all sides of the GOF debate have said the criteria for review need to be clearer. The government is expected to release new rules as early as next year. (For more, see this week’s feature in Science.)”

However, as Science has also previously written, “A U.S. clampdown will have no sway over privately funded GOF research or what happens in other countries, which typically lack policies like the P3CO framework. In Japan and most of Europe, for example, oversight is limited to rules on biosafety and, sometimes, biosecurity along with voluntary self-regulation, say biosecurity experts Gregory Koblentz of George Mason University and Filippa Lentzos of King’s College London. It’s too soon to say how a 2020 Chinese biosafety law will affect PPP research, they say.”

“National Security Snapshot: Department of Defense and Intelligence Community Preparedness for Biological Threats”

The Government Accountability Office (GAO) recently released this National Security Snapshot co-authored by Dr. Brian Mazanec, an alumnus of the Biodefense PhD program. This snapshot discusses core issues like biopreparedness and the PRC’s intent to exploit US genetic data. The authors write, “We made several key recommendations to improve how DOD and the Intelligence Community prepare for and respond to biological threats. DOD is taking a number of positive steps, such as coordinating with partners to research and develop vaccines. But, DOD doesn’t have a comprehensive strategy that, for example, shows where biodefense resources are needed.”

“Public Health Preparedness: HHS Should Address Strategic National Stockpile Requirements and Inventory Risks”

GAO also recently released this report discussing the Department of Health and Human Services’ inventory planning reports and their failure to “meet most legal requirements enacted in 2019 or communicate risks associated with not meeting recommended inventory levels. This is partly because HHS hasn’t updated its processes for completing the reports and a key advisory body was inactive.” This report makes a number of recommendations while also noting that HHS’s leadership and coordination of public health emergencies is on the office’s high risk list.

“COVID-19: A Warning – Addressing Environmental Threats and the Risk of Future Pandemics in Asia and the Pacific”

From the UN Environment Programme: “This scientific review begins with the history of humans and zoonoses and provides clarity on the issues of zoonoses and emerging infectious diseases. It then presents the seven anthropogenic drivers of zoonotic disease emergence as well as the concept of viral mixing. After providing rich context, this review continues to outline solutions that address the intricate link between nature and human health and strategies to prevent future zoonotic outbreaks.”

“”It was Compromised”: The Trump Administration’s Unprecedented Campaign to Control CDC and Politicize Public Health During the Coronavirus Crisis”

The House Select Subcommittee on the Coronavirus Crisis recently released its third installment of staff reports detailing the Trump administration’s response to the COVID-19 pandemic. In the report, the committee explains its findings from its investigation into the Trump administration’s “rampant political interference with the federal public health response to the coronavirus pandemic.” Chairman Clyburn released this statement about the report: “The Select Subcommittee’s investigation has shown that the previous administration engaged in an unprecedented campaign of political interference in the federal government’s pandemic response, which undermined public health to benefit the former president’s political goals. As today’s report shows, President Trump and his top aides repeatedly attacked CDC scientists, compromised the agency’s public health guidance, and suppressed scientific reports in an effort to downplay the seriousness of the coronavirus. This prioritization of politics, contempt for science, and refusal to follow the advice of public health experts harmed the nation’s ability to respond effectively to the coronavirus crisis and put Americans at risk. As we continue to recover from the coronavirus crisis, we must also continue to work to safeguard scientific integrity and restore the American people’s trust in our public health institutions.”

Clinical Infectious Diseases “Issue Supplement 3, Anthrax Preparedness”

This issue supplement of Clinical Infectious Diseases is all about anthrax, including articles ranging from “Responding to the Threat Posed by Anthrax: Updated Evidence to Improve Preparedness” to “Risk Factors for Severe Cutaneous Anthrax in a Retrospective Case Series and Use of a Clinical Algorithm to Identify Likely Meningitis and Evaluate Treatment Outcomes, Kyrgyz Republic, 2005-2012”. So, if it has been a while since you were deeply concerned about anthrax, this issue is for you!

“How SARS-CoV-2 Battles Our Immune System”

If you like medical illustrations and interactive timelines, this one is for you. This new story available from Science walks readers visually through SARS-CoV-2’s interaction with the human immune system, offering detailed yet easily understood, general explanations along the way. Readers can even learn about the virus’s different proteins and their specific effects on the immune system.

What We’re Listening To 🎧

This Podcast Will Kill You: Episode 107: Sepsis: It’s a Mess

“Over the years of the podcast, we have often struggled with questions of why: why pathogens act the way they do, why certain people get sick while others don’t, or why we know little about some diseases. This episode is no exception – sepsis certainly inspires many “whys”. But for perhaps the first time on the pod, we find ourselves grappling not only with “why?” but also with “what?”. What, indeed, is sepsis? Ask a dozen doctors and you may get a dozen different answers. Our first goal for this episode is to sift through the various definitions of sepsis and what we know about its pathology to get a firm handle on this deadly consequence of infection. We then turn our sights to a thrilling period of sepsis history – Joseph Lister and his carbolic acid spray – before attempting to address the status of sepsis around the world today. By the end of the episode, your picture of sepsis may not be crystal clear, but hopefully the edges are a little less blurry.” Listen here on Spotify or wherever you listen to podcasts!

Project Responder 6: Evolving Response Environment Webinar

From DHS: “You’re invited to join the Department of Homeland Security (DHS) Science & Technology Directorate (S&T) for a briefing on the Project Responder 6 report, designed to document emergency response capability needs across significant changes in the operating environment. The innovative approach this data collection effort—now in its sixth generation—takes is to bring together S&T’s First Responder Resource Group (FRRG), which includes responders from traditional (fire service, law enforcement, emergency medical services, emergency management) and non-traditional (public health, public works, medical examiner/coroner, search and rescue) response agencies, to focus on identifying and validating needs across disciplines.” Learn more and register here. Download the report here. This event will take place on October 24, at 11 am ET.

Addressing Health Inequities by Strengthening Antibiotic Stewardship

From NCEZID: “Please join The National Center for Emerging and Zoonotic Infectious Disease (NCEZID) on Tuesday, October 25, 2022, at 10 a.m. EDT for the next AMR Exchange webinar on addressing health inequities by strengthening antibiotic stewardship entitled Addressing health inequities by strengthening antibiotic stewardship. The discussion will feature experts from CDC, The Pew Charitable Trusts, the Federal Office of Rural Health Policy, and Emory University School of Medicine who work to strengthen antibiotic use and prescribing and improve the quality of health care across the United States. Please register here.”

South Korea as a Global Vaccine Hub

The Korea Economic Institute of America is hosting this event October 27, at 3 pm EST virtually: “Early in the pandemic, South Korea drew widespread praise for the speed and efficiency of its response to slowing the spread of the virus and saving lives. However, despite this initial success, South Korea faced vaccine nationalism and other access challenges in its effort to secure Covid-19 vaccines. Spurred by these challenges, South Korea established a national strategic policy to become a global vaccine hub, not only to meet the current and future public health needs of its own population but also to assist low- and middle-income countries (LMICs) facing even starker obstacles in accessing safe and effective vaccines.”

“Please join KEI for a discussion with the Thomas Byrne, Claire Callahan, Irene Kyoung, and Salomé Da Silva Duarte Lepez about how global vaccine access and equity was hindered by the shortcomings of national and bilateral vaccine diplomacy and multilateral mechanisms during the Covid-19 pandemic, and how South Korea’s demonstrated capabilities to rise as global vaccine development, manufacturing and training hub will help bolster global public health capacities in the future.” Register here.

The Case for the Use of “Red Lines” in the Governance of Life Sciences Research with David Relman

From CISAC: “The nature of evolving risks in life sciences research, a brief history of risk governance, and the case for the use of so-called “red lines” in the governance of life sciences research will be presented. The goals of this presentation are to elicit discussion about the benefits and pitfalls of red lines, or guardrails, in general, including a historical perspective, and options for public policy recommendations to address concerns about the present and future risks arising from life sciences research.” This event will take place on October 27, at 3:30 pm PT. Register here.

Infection Prevention and Control: Incorporating Lessons Learned in Managing Special Pathogens

“After nearly three years responding to the COVID-19 pandemic, hospitals and other healthcare facilities have learned many lessons about the management of special pathogens and essential infection prevention and control practices. The U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response’s Technical Resources, Assistance Center, and Information Exchange (ASPR TRACIE) and the National Emerging Special Pathogens Training and Education Center (NETEC) invite you to learn more about some of those lessons. Speakers will share their perspectives on how our approach to outbreaks has changed since the pandemic began. They will address issues such as infection prevention for healthcare workers and patients and mitigating disease spread. Speakers will also highlight newly developed tools and resources. This webinar will take place November 7 at 2:00 pm ET. Register today!”

ICYMI: IARPA, Gingko Bioworks and Draper Announce New Technologies to Detect Engineered DNA

This week, Gingko Bioworks, Draper, and IARPA held an event to announce the completion of IARPA’s Finding Engineering-Linked Indicators (FELIX), a program aimed at improving existing biodetection and surveillance capabilities. “The event featured a panel with Catherine Marsh, IARPA Director; David A. Markowitz, IARPA Program Manager; Joshua Dunn, Head of Design, Ginkgo Bioworks; Laura Seaman, Principal Scientist and Machine Intelligence Group Leader, at Draper; and Erin Rosenberger, Senior Member of Technical Staff, Biological Microsystems Group, at Draper. During the panel, the panelists discussed the program findings and also featured a demo of the research results.” A recording of the livestream is available here.

November 3 is One Health Day

Mark your calendars for this year’s One Health Day on November 3. One Health Day is an international campaign that was launched in 2016. The One Health Commission explains that “The goal of One Health Day is to bring attention around the world to the need for One Health interactions and for the world to ‘see them in action’. The One Health Day campaign is designed to engage as many individuals as possible from as many arenas as possible in One Health education and awareness events, and to generate an inspiring array of projects worldwide.” If you are hosting an event on this day, you can register your event here with the Commission. A list of registered One Health Day events for 2022 is also available here.

Pandora Report: 10.14.2022

Happy Friday! This week we discuss the release of the Biden administration’s National Security Strategy and new findings about the prevalence and challenges of long COVID. We also cover a number of new publications, a German podcast episode on the 1979 anthrax outbreak in Sverdlovsk (featuring our own Dr. Sonia Ben Ouagrham-Gormley!), and upcoming events.

Biden Administration Releases National Security Strategy

The Biden administration released its National Security Strategy (NSS)this week, building on the 2021 Interim NSS. This iteration of the NSS re-incorporates climate change as a national security threat, continues to define the threats China and Russia pose to the US, and includes “Triad” with a capital “T” to make sure there’s plenty of discussion about the document here in the Beltway. As the NSS has in the past, this version includes a section dedicated to pandemics and biological threats, which estarts by explaining that “COVID-19 has killed nearly 6.5 million people around the world, including more than 1 million Americans, but the next pandemic could be much worse—as contagious but more lethal. We have a narrow window of opportunity to take steps nationally and internationally to prepare for the next pandemic and to strengthen our biodefense.”

This section also discusses the notion that “no one is safe until everyone is safe,” and acknowledges that “some of our international institutions have fallen short in the past and need to be reformed.” It concludes with a paragraph discussing the need to address risks posed by deliberate and accidental biological risks “including through our ability to rapidly detect, identify, and attribute agents, and to develop medical countermeasures,” by working to strengthen the BWC, prevent terrorist acquisition of BW, and reinforcing “norms against biological weapons’ development and use.”

This comes on the heels of statements released this week by the US State Department and German Federal Foreign Office on the need to better cooperate to reduce biological threats globally. Both statements discuss the multi-faceted nature of these problems, including challenges created by mis- and disinformation and the need for increased global cooperation in the face of these threats, again highlighting the increasing importance of these issues.

Long COVID Gaining Recognition…Finally

This week, Hastie et al.’s article in Nature Communications discussing long COVID made waves in the media and online. The authors conducted a study in a Scottish cohort consisting of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals. Participants were issued questionnaires at 6, 12, and 18 months. The authors found that “Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially.” They also found that “Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms.” Notably, participants with previous symptomatic COVID-19 infections reported long-lasting symptoms like breathlessness, heart palpitations, difficulty focusing, and confusion at rates more than double that of those who were not previously infected. They also reported other related symptoms, like muscle aches and other heart problems.

There were some challenges in the study, however. For example, approximately 90% of participants were white, which is not helpful in trying to better understand risks and burdens of long COVID in other groups. Furthermore, only 4% were vaccinated (most with just one dose) before they were infected. However, this study does more concretely demonstrate the breadth of this problem and what it could mean for future pandemics.

A German study was also published this week in BMJ that found a “considerable burden of long-COVID symptoms, especially fatigue and neurocognitive impairment (“brain fog”), at 6 to 12 months—even among young and middle-aged adults who had mild infections,” according to CIDRAP. This study found that women were at higher risk for developing long COVID and “The researchers said the study revealed long-COVID symptom clusters with individually and societally relevant implications that also affected younger adults with mild initial infections. “Given the individual and societal burden of post-covid sequelae, the underlying biological abnormalities and causes need urgent clarification to define adequate treatment options and develop effective rehabilitation measures,” they concluded.”

Other studies have also linked long COVID to conditions like postural tachycardia syndrome (POTS). In the case of POTS, 41% of people diagnosed with the syndrome already reported a viral infection preceding the onset of POTS symptoms pre-pandemic. Because of this connection, the UK’s National Institute for Health and Care Excellence now even recommends testing for POTS in patients with long COVID. These studies build on mountains of anecdotal evidence from patients and providers alike, demonstrating that long COVID is a very real and serious danger that has already impacted many of us.

The WHO Director General, Dr. Tedros Adhanom Ghebreyesus, recently authored a piece in The Guardian discussing long COVID, what WHO is doing about it, and what countries around the world should do to support those suffering with it. He explains, “Mostly data is only available from high-income countries, which means that we don’t currently have a clear picture on how many people are actually suffering. Current estimates suggest that tens of millions, and perhaps more, have contracted long Covid, and about 15% of those diagnosed with the condition have experienced symptoms for at least 12 months.”

He also discussed the shift in investment strategies this requires of countries, writing “Early in the pandemic, it was important for overwhelmed health systems to focus all of their life-saving efforts on patients presenting with acute infection. However, it is critical for governments to invest long-term in their health system and workers and make a plan now for dealing with long Covid. This plan should encompass, providing immediate access to antivirals to patients at high risk of serious disease, investing in research and sharing new tools and knowledge as they’re identified to prevent, detect and treat patients more effectively. It also means supporting patients physical and mental health as well as providing financial support for those who are unable to work.”

WHO/Europe also issued a factsheet discussing the need for rehabilitation, recognition, and research focused on lingering COVID symptoms that is available here.

WHO Europe Factsheet Discussing Long COVID, Source: https://www.who.int/europe/news/item/10-10-2022-rehabilitation–recognition-and-research-needed-for-people-living-with-long-covid–new-who-europe-factsheet

“COVID Prompts Global Surge in Labs That Handle Dangerous Pathogens”

Smriti Mallapaty’s recent article in Nature News discusses the growing number of BSL-3 and 4 certified facilitates globally and rising concerns about the costs and risks they present. This article covers new facilities across Asia as well as Russia’s promise that it will build 15 new BSL-4 facilities. Mallapaty also quoted GMU’s Dr. Greg Koblentz in the article, writing “Since the COVID-19 pandemic began, plans to build 27 BSL-4 labs have been announced worldwide, say Gregory Koblenz, a biodefence researcher at George Mason University in Arlington, Virginia, and Filippa Lentzos, a biosecurity researcher at King’s College London, who have tracked the number and distribution of BSL-4 facilities globally. “These will likely take several years to design, build and commission,” says Lentzos.”

“Pandemic Origins and a One Health Approach to Preparedness and Prevention: Solutions Based on SARS-CoV-2 and Other RNA Viruses”

In this recent Proceedings of the National Academy of Sciences article, Keusch et al. discuss the importance of One Health in improving and integrating biosafety and biosecurity. Their abstract explains “COVID-19 is the latest zoonotic RNA virus epidemic of concern. Learning how it began and spread will help to determine how to reduce the risk of future events. We review major RNA virus outbreaks since 1967 to identify common features and opportunities to prevent emergence, including ancestral viral origins in birds, bats, and other mammals; animal reservoirs and intermediate hosts; and pathways for zoonotic spillover and community spread, leading to local, regional, or international outbreaks. The increasing scientific evidence concerning the origins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is most consistent with a zoonotic origin and a spillover pathway from wildlife to people via wildlife farming and the wildlife trade. We apply what we know about these outbreaks to identify relevant, feasible, and implementable interventions. We identify three primary targets for pandemic prevention and preparedness: first, smart surveillance coupled with epidemiological risk assessment across wildlife–livestock–human (One Health) spillover interfaces; second, research to enhance pandemic preparedness and expedite development of vaccines and therapeutics; and third, strategies to reduce underlying drivers of spillover risk and spread and reduce the influence of misinformation. For all three, continued efforts to improve and integrate biosafety and biosecurity with the implementation of a One Health approach are essential. We discuss new models to address the challenges of creating an inclusive and effective governance structure, with the necessary stable funding for cross-disciplinary collaborative research. Finally, we offer recommendations for feasible actions to close the knowledge gaps across the One Health continuum and improve preparedness and response in the future.”

Science published a news article discussing this paper, writing “‘Our paper recognizes that there are different possible origins, but the evidence towards zoonosis is overwhelming,” says co-author Danielle Anderson, a virologist at the University of Melbourne. The report, which includes an analysis that found the peer-reviewed literature overwhelmingly supports the zoonotic hypotheses, appeared in the Proceedings of the National Academy of Sciences (PNAS) on 10 October.”

The article continued with “The panel’s own history reflects the intensity of the debate. Originally convened as a task force of the Lancet COVID-19 Commission, a wide-reaching effort to derive lessons from the pandemic, it was disbanded by Columbia University economist Jeffrey Sachs, the commission’s chair. Sachs alleged that several members had conflicts of interest that would bias them against the lab-origin hypothesis.”

“WHO’s Response to COVID-19 – 2022 Mid-Year Report”

“This mid-year report provides a consolidated update on WHO’s response to the COVID‐19 pandemic between January and July 2022, against the objectives laid out in the Strategic Preparedness and Response Plans (SPRP) for 2021 and 2022.”

“With the aim of ending the acute phase of the pandemic by the end of the year, WHO, in collaboration with partners, has supported countries to further strengthen their surveillance systems; ensure more equitable access to tests, treatments, and essential supplies worldwide; make health systems more resilient; and reduce exposure to the disease by empowering and enabling communities.”

“The report highlights the role of WHO at the global, regional, and local levels, and across the key elements of an effective emergency response – from implementation and operational support, to developing evidence and research, and providing strong coordination and planning. By working with partners, including multi-agency and multi-partner operational platforms, regional and national public health and scientific institutes, governments, communities, donors, UN organizations and NGOs and the private sector, WHO helped bring the world together to provide direct technical and operational support to countries implementing their national COVID-19 response plans.”

“Epidemics That Didn’t Happen”

On a much more cheerful note, check out Prevent Epidemics’ online feature, “Epidemics That Didn’t Happen”. This page explores six epidemics that were prevented thanks to solid cooperation and good public health responses, including averted epidemics of Ebola, Nipah, cholera, rabies, influenza, and dengue. As the page notes, these cases present common themes, including “Speed is essential,” “Well-coordinated action at the local level is crucial to preventing epidemics,” “Community engagement pays off,” and “Health care workers need to be trained, supported, and provided with access to resources and assistance to stop epidemics.”

“Russia’s Alleged Bioweapons Claims Have Few Supporters”

Jez Littlewood and Dr. Filippa Lentzos recently published this piece in this Bulletin of the Atomic Scientists discussing the outcome of September’s Article V Formal Consultative Meeting requested by Russia. They write “For the fourth time this year, Russia accused the United States and Ukraine of being in non-compliance with the Biological and Toxins Weapons Convention (BTWC)—and once again found little support for its allegations. At the conclusion of the Article V Formal Consultative Meeting in September, no other state formally accused these two nations of non-compliance. Russia stands alone in its allegations, with limited support from eight other states. In contrast, more than five times as many backed the United States and Ukraine in rejecting the allegations; the meeting ended with a procedural report that noted no consensus regarding the outcome.”

“Addressing Inaccurate and Misleading Information About Biological Threats Through Scientific Collaboration and Communication in Southeast Asia”

From the National Academies: “Misinformation about outbreaks, epidemics, and pandemics is a decades-old problem that has been exacerbated by the rise of the internet and the widespread use of social media. Some false claims may be addressed through sound scientific analysis, suggesting that scientists can help counter misinformation by providing evidence-based, scientifically defensible information that may discredit or refute these claims. This report explains how scientists can work collaboratively across scientific disciplines and sectors to identify and address inaccuracies that could fuel mis- and disinformation. Although the study focused on a scientific network primarily in Southeast Asia, it is relevant to scientists in other parts of the world. A companion “how-to-guide”, available in print and in digital form, outlines practical steps that scientists can take to assess mis- or disinformation, determine whether and how they should address it, and effectively communicate the corrective information they develop.”

“Counterfeit PPE: Substandard Respirators and Their Entry Into Supply Chains in Major Cities”

This recent article from Urban Crime was co-authored by the Schar School’s Dr. Louise Shelley and discusses challenges in ensuring legitimate PPE is available and what this means for definitions of threats to human life. The abstract reads “Over 58 million counterfeit respirators of substandard quality unable to protect individuals from infection have been seized globally since the start of the COVID-19 pandemic. These seizures have primarily occurred in urban warehouses and ports around the world according to analysis of public and corporate data shared with the authors. The presence of tens of millions of respirators in storage facilities prior to distribution demonstrates that urban areas are key elements of illicit supply chains. Data suggests that the concept of urban insecurity needs to be reconsidered in light of illicit supply chains for counterfeit respirators and their role in facilitating disease transmission in urban areas. The analysis presented in this article suggests that threats to human life should not be confined narrowly to violent acts or the consumption of drugs. Human life can also be threatened through the massive distribution of counterfeit N95 masks during a pandemic, a problem that has become more acute with more contagious mutations of COVID-19.”

Dr. Shelley is the Omer L. and Nancy Hirst Endowed Chair and a University Professor at George Mason University. She is in the Schar School of Policy and Government and directs the Terrorism, Transnational Crime and Corruption Center. She is a leading expert on the relationship between terrorism, organized crime, and corruption as well as human trafficking, transnational crime, and terrorism with a particular focus on the former Soviet Union. She also specializes in illicit financial flows and money laundering. 

What We’re Listening To 🎧

Waffen der Wissenschaft – Die Spur der Sporen

For our German-speaking readers, a Viertausendhertz podcast episode on the 1979 outbreak of anthrax in Sverdlovsk: “Im Frühjahr 1979 sterben in der geschlossenen sowjetischen Stadt Sverdlovsk Dutzende Menschen an Milzbrand. Ein ungeheurer Verdacht kommt auf: Handelt es sich um einen Unfall mit Biowaffen? Der Forscher Matthew Meselson und der Journalist Peter Gumbel erzählen von ihren Nachforschungen vor Ort. Das Team spricht außerdem mit den Biowaffen-Experten Filippa Lentzos, Sonia Ben Ouagrham-Gormley und Andrew Weber.”

Translation: “In the spring of 1979, dozens of people died of anthrax in the closed Soviet city of Sverdlovsk. A tremendous suspicion arose: was it an accident involving biological weapons? The researcher Matthew Meselson and the journalist Peter Gumbel discuss their investigations on site. The team also speaks with bioweapons experts Filippa Lentzos, Sonia Ben Ouagrham-Gormley, and Andrew Weber.”

Event Summaries

Check out event summaries written by Geoffrey Mattoon, a Biodefense MS student, for two recent events from the Council on Strategic Risks-“Building Capacities for Addressing Future Biological Threats” and “The American Pandemic Preparedness Plan: One Year of Progress & the Path Forward”.

Schar School Master’s and Certificate Virtual Open House

Join us for next week’s Master’s and Certificate Virtual Open House on Wednesday, October 19, at 7 pm ET, to learn more about the Schar School of Policy and Government and the Biodefense Graduate Program. The online session will provide an overview of our programs, student services, and admissions requirements. Our admissions staff will be available afterward to answer any questions you may have. Register here!

Infection Prevention and Control: Incorporating Lessons Learned in Managing Special Pathogens

“After nearly three years responding to the COVID-19 pandemic, hospitals and other healthcare facilities have learned many lessons about the management of special pathogens and essential infection prevention and control practices. The U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response’s Technical Resources, Assistance Center, and Information Exchange (ASPR TRACIE) and the National Emerging Special Pathogens Training and Education Center (NETEC) invite you to learn more about some of those lessons. Speakers will share their perspectives on how our approach to outbreaks has changed since the pandemic began. They will address issues such as infection prevention for healthcare workers and patients and mitigating disease spread. Speakers will also highlight newly developed tools and resources. This webinar will take place November 7 at 2:00 pm ET. Register today!”

Disinformation: An Emerging War Weapon

“Hosted by the National Defense University Foundation and Moderated by President and CEO, James Schmeling, join us for this interactive virtual discussion. Brief Talk Description: Explore how Russia, China and other entities use misinformation, disinformation, and malinformation as weapons of war and their impact on global security and American democracy.” This online webinar will be hosted on October 20 at 12 pm EST. Register here.

Reflections on Science Communication & Human Rights Amid Public Health Emergencies

“On October 20 (10:30-11:30 am ET),  join Dr. Bina Venkataraman, Editor-at-Large for The Boston Globe, and Dr. Chris Beyrer, Director of Duke University’s Global Health Institute, for a virtual discussion of science communication during public health emergencies, the role of public health researchers and journalists in advancing human rights, and emerging lessons from the COVID-19 pandemic.”

“The conversation will be moderated by Prof. Helle Porsdam, Professor of Law and Humanities and UNESCO Chair in Cultural Rights, Centre for Interdisciplinary Studies of Law, Faculty of Law, University of Copenhagen.” Register here.

Third International Summit on Human Genome Editing

The Third International Summit on Human Genome Editing will take place March 6-8, 2023, at the Francis Crick Institute, London, UK. “Building on previous events held in Washington, DC (2015) and Hong Kong (2018), this Summit will continue the important dialogue around human genome editing. It will facilitate a global discussion on somatic and germline genome editing, including developments in clinical trials and genome editing tools such as CRISPR/Cas9. Earlier this year a three-part series of online events Looking Ahead to the Third Human Genome Editing Summit discussed some of the key topics of the meeting. The three-day summit is being organised by the Royal Society, the UK Academy of Medical Sciences, the US National Academies of Sciences and Medicine and The World Academy of Sciences.”

“Find out more about the Summit’s Planning Committee, chaired by Professor Robin Lovell-Badge FRS FMedSci. Further information about the Summit agenda will be released soon, and registration to attend the event in person and online is now open.”

Pandora Report: 10.7.2022

The three day weekend is almost here and we have enough content to keep you busy the whole time! This week we cover updates on the Biden administration’s response to the growing Ebola outbreak in Uganda, continued concerns about polio in New York, and international containment efforts. We also discuss a ton of new publications, including multiple new books and articles from our own program alumni. As always, upcoming events and announcements round us out for the week.

Ebola in Uganda, US on Alert

The Biden administration announced this week that all travelers entering the United States from Uganda will be redirected to airports where they can be screened for Ebola virus disease (EVD). Physicians were also warned to be on the lookout for potential cases entering the country. According to The New York Times, “The director of the Centers for Disease Control and Prevention ordered the airport screenings, and the State Department issued an alert saying the measures would apply to all passengers, including U.S. citizens… Screenings were expected to begin on Thursday for some passengers, but the travel restrictions will not go into effect until next week, according to an official familiar with the plan, who stressed that both the restrictions and the alert to doctors were issued as precautions.”

Passengers entering the US from Uganda will be redirected to New York City’s John F. Kennedy International Airport, New Jersey’s Newark Liberty International Airport, Chicago’s O’Hare International Airport, Hartsfield-Jackson Atlanta International Airport, and Dulles International Airport near Washington, D.C. According to the administration, 62% of passengers entering the country from Uganda already arrive through these airports. They will undergo temperature checks and complete questionnaires before continuing to their final destinations.

According to the advisory, “On September 20, 2022, the Ministry of Health of Uganda officially declared an outbreak of EVD due to Sudan virus (species Sudan ebolavirus)in Mubende District, Central Uganda.”

“The first confirmed case of EVD was a 25-year-old man who lived in Mubende District and quickly identified as a suspect case of viral hemorrhagic fever (VHF) and isolated in the Mubende Regional Referral Hospital. Blood collected from this patient tested positive for Sudan virus by real-time reverse transcription polymerase chain reaction (rRT-PCR) on September 19, 2022, at the Uganda Virus Research Institute (UVRI). The patient died the same day, and a supervised burial was performed by trained staff wearing proper personal protective equipment (PPE). Further investigation into this case revealed a cluster of unexplained deaths occurring in the community during the previous month. As of October 6, 2022, a total of 44 confirmed cases, 10 confirmed deaths, and 20 probable deaths of EVD have been identified in Uganda.”

Much of this is reminiscent of the 2014-2016 outbreak, during which the US reported the first case outside Africa in a Liberian national who traveled to Dallas through four different airports without being stopped. At the time, NPR explained that “Ebola symptoms can lay dormant for two to 21 days, and during that time, the disease wouldn’t show up on a blood test, let alone a thermometer. There was no way to know that this particular passenger was at risk. The good news, says Thomas Frieden, director of the CDC: “Ebola doesn’t spread before someone gets sick, and he didn’t get sick till four days after he got off the airplane. So we do not believe there is any risk to anyone who was on the flight at that time.” Fever is one of the first symptoms to appear, so for now, thermometers remain a good way of catching infected travelers.”

The Liberian patient, Thomas Eric Duncan, died on the morning of October 8 at Texas Health Presbyterian Hospital in Dallas, a little over two weeks after he arrived in the US from West Africa. Two nurses who treated him, Nina Pham and Amber Vinson, were infected too, though they both later recovered. The hospital was later criticized in an independent report detailing miscommunication, poor information handling, and a lack of focus on patient safety that contributed to Duncan’s initial misdiagnosis and the nurses’ exposure. Later in October 2014, a medical aid worker who had volunteered in Guinea was hospitalized in New York City with suspected EVD, which was later confirmed by CDC. This patient also later recovered. An additional seven others were treated in the US after they were exposed and became ill while in West Africa, the majority of whom were medical workers. They were transported to the US on chartered aircraft. All but one recovered.

According to CDC, “The 2014-2016 Ebola epidemic was the first and largest epidemic of its kind, with widespread urban transmission and a massive death count of more than 11,300 people in Guinea, Liberia, and Sierra Leone. The epidemic took a devastating toll on the people of West Africa. Ending it took an extraordinary international effort in which the U.S. government played a major role.”

However, unlike this and other recent outbreaks, the cases in Uganda are of the Ebola Sudan strain. The WHO explains of this strain that “According to the International Classification of Disease for filoviruses (ICD-11) released in May 2019, Ebola disease is now sub-categorized depending on the causative virus. Outbreaks of Ebola disease caused by Sudan virus are named Sudan Virus Disease (SVD) outbreaks. Prior to May 2019 all viruses causing Ebola disease were grouped together. Based on the results of laboratory tests, this outbreak is caused by Sudan virus.”

“Sudan virus disease is a severe, often fatal illness affecting humans. Sudan virus was first reported in southern Sudan in June 1976, since then the virus has emerged periodically and up to now, seven outbreaks caused by SUDV have been reported, four in Uganda and three in Sudan. The estimated case fatality ratios of SVD have varied from 41% to 100% in past outbreaks.”

The WHO also explains that “The diagnosis of SVD can be difficult, as early nonspecific manifestation of the disease may mimic other infectious diseases such as malaria, typhoid fever and meningitis. Confirmation is made using numerous diagnostic methods including RT-PCR. Supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms improve survival.”

Importantly, in contrast to the Zaire strain, there are no licensed vaccines or therapeutics for this strain of Ebola. The CDC’s HAN advisory explains that “This is the fifth outbreak of EVD caused by Sudan virus in Uganda since 2000. The current outbreak is in the same area as Uganda’s most recent EVD outbreak caused by Sudan virus, which occurred in 2012. During the 2012 outbreak, limited secondary transmission was reported, and the outbreak was effectively contained.”

“This image depicted Quarantine Public Health Officer, Máire Kirley, awaiting the arrival of an aircraft during a Live Full-Scale Ebola exercise at Minneapolis-St. Paul International Airport, in April 2017. This Department of State-led exercise tested our nation’s ability to repatriate Americans exposed to, or sick from Ebola while in foreign countries, upon their return to the United States, and transfer them to appropriate care. Partners from local, state, federal, healthcare, EMS, and non-governmental organizations (NGOs) collaborated and participated in this exercise.” Source: Arnold Vang, CDC Public Health Image Library

Marco…Polio (Again)

In 1921, FDR contracted poliomyelitis at 39 years old, becoming seriously ill before eventually recovering, though he remained paralyze from the waist down for the rest of his life. He was by no means unique-the early 20th century saw thousands upon thousands of Americans infected with the virus. The disease left an average of 35,000 Americans disabled annually throughout the 1940s. In just 1952 alone, 60,000 American children were infected; thousands were left paralyzed while over 3,000 died. Late summer was commonly known as “polio season” back then. However, as the years went on, the United States began vaccinating for this disease widely, ridding the country of wild cases by 1979. In the last 50 years, polio has increasingly come to feel for many in the US like a thing of the past and a problem only for far away countries where it is endemic.

Today, however, New York is grappling with its first polio case since 1990 (you know…as it also tries to juggle monkeypox, COVID-19, and the threat of imported Ebola cases). In July this year, a young man reported to an ER in a New York City suburb with weakness in his lower legs, having experienced a fever, stiff neck, and other symptoms for several days prior. This person is unvaccinated for polio, and it is believed his samples appear related to those from countries that use oral polio vaccine. While one case of vaccine-derived polio would be shocking enough in the US today, it gets worse. Wastewater surveillance in New York State has detected the virus in Rockland County (where the case was diagnosed this summer), Orange and Sullivan Counties, and, as of late last month, Nassau County on Long Island. It has also been detected in New York City itself. The AP explains of the detection in Nassau County that “The sample is genetically linked to the polio case from Rockland and provides further evidence of expanding community spread, state health officials said.”

“On polio, we simply cannot roll the dice,” state Health Commissioner Dr. Mary T. Bassett said in a prepared statement. “If you or your child are unvaccinated or not up to date with vaccinations, the risk of paralytic disease is real. I urge New Yorkers to not accept any risk at all.”

While New York Governor Kathy Hochul has declared a disaster to increase resources allocated to her state’s effort to contain polio, this is likely part of a much larger problem. While 92.5% of children in the US have received three or more doses of the polio vaccine by the age of two, overall rates are declining nationally. For example, in Rockland County, NY, just 60% of residents were vaccinated for polio by August 1 of this year. CDC’s data shows that the national childhood vaccination rate for US kindergarteners declined 1% between 2019 and 2021, from 95% to 94%. While 1% may seem small, this means that about 211,000 kindergarteners in the US did not have all required vaccines in 2021, up from about 201,000 in 2019. This was even with enrollment in 2021 down 10% total. It is no small matter.

The pandemic has contributed to declining vaccination rates, particularly earlier on as people shied away from visiting their doctors for routine and preventative care. WHO announced earlier this year that about 25 million infants missed lifesaving vaccines in 2021 primarily because of disruptions caused by COVID-19. However, experts also worry that vaccine hesitancy is driving this and that it may lead to a future resurgence of previously controlled diseases like polio, pertussis, and measles. In the case of polio, large numbers of paralytic cases are unlikely, even if large numbers of unvaccinated people catch the disease. However, this is a very much vaccine preventable disease, making this problem particularly frustrating.

While this issue in the US is a concerning set-back, global eradication and containment efforts continue. Today, two of three strains of wild poliovirus have been eradicated globally. As a result, WHO is working with members states to help reduce the number of countries holding samples of polioviruses to a minimum and helping destroy unnecessary stocks. The WHO’s Global Polio Eradication Initiative recently released an update on Canada’s efforts to improve safeguards for work with poliovirus, explaining “As one of 25 countries retaining the eradicated type 2 poliovirus strain, Canada is putting in place the necessary safeguards to minimize this risk. In fact, the country is the first to have one of its facilities move to the second stage of WHO’s Containment Certification Scheme, through receiving an ‘Interim Certificate of Containment’, or ICC.”

“There are three stages of containment certification and ICC is the second,” said Liliane Boualam, WHO containment technical officer and co-chair of the GPEI’s Containment Management Group. “Effectively, this means the facility in question has been audited against WHO containment guidance by its National Authority for Containment, and has met a certain threshold of containment requirements. The validity of the ICC is limited to three years and the facility has two options: to either address any non-conformities identified through the audit, so as to be compliant with WHO containment guidance (GAP), or to decommission the facility and destroy or transfer virus materials to another (facility) undergoing certification within those three years,” she added. “WHO and GPEI commend Canada and its facility for being the first to achieve ICC status, and we look forward to their next steps, and progress by other countries retaining (polio)virus,” she said.”

“We are very pleased to have this Canadian facility advance to the next step in the containment certification process,” said Andréanne Bonhomme, Director, Biosafety and Biocontainment Operations at the Public Health Agency of Canada, and National Authority for Containment chair. “Canada appreciates the responsibility that comes with the ongoing handling and storage of poliovirus, and is committed to ensuring safe and secure containment of these viruses as essential functions continue,” she added.”

The piece continued by explaining hurdles in sticking to the international schedule: “Containment of type 2 poliovirus came into effect in 2016, following the declaration of its eradication in 2015. In 2018, WHO Member States recognizing the importance of the work, committed to acceleration of containment action globally. Significant advances have been made however many countries are behind on implementation timelines*. In part, the pandemic complicated matters, diverting resources away from containment and slowing implementation.”

“COVID-19 certainly hindered poliovirus containment efforts,” said Professor David Salisbury, chair of the Global Commission for the Certification of Eradication of Poliomyelitis and final signatory for containment certification certificates. “Encouragingly, we have seen improvements since individual country situations have stabilized, but progress is considerably behind schedule and we need to reprioritize this important work,” he added. “The goal is to have all facilities retaining polioviruses to have achieved full containment certification by 2026 and this means a great amount of work, and indeed much catching-up, needs to take place now,” he added.

Tech Wars: Transforming U.S. Technology Development

Dr. Daniel Gerstein (a GMU Biodefense PhD alumni) recently published his latest book, Tech Wars. “Tech Wars offers a narrative to describe the technology competition being waged throughout the world today and offers some thoughts on how the U.S. must adapt to be successful in this rapidly evolving, technology rich environment. Early in the book, the question of whether we will characterize this as a competition, conflict, or war was considered. In the end, I have chosen to depict it as a tech war to signify the magnitude and urgency of the issue at hand.”
“Today, the U.S. is not prepared for waging this war. Absent fundamental changes, our current science and technology advantages will continue to erode. To respond to this urgency, new strategies, organizational changes and resource allocations to our research and development (R&D) enterprise will be required to better posture us to take advantage of the opportunities and respond to the challenges that are on the horizon. Tech Wars provides recommendations for focused approaches to research, development, and innovation to promote U.S. economic prosperity and national security well into the latter decades of the 21st century.” You can order a copy here.

Understanding Cyber-Warfare: Politics, Policy and Strategy

Drs. Christ Whyte (GMU Political Science PhD, 2017) and Brian Mazanec (GMU Biodefense PhD, 2014) have updated their popular textbook on cyber conflict, Understanding Cyber-Warfare: Politics, Policy and Strategy; Routledge will be publishing the second edition in early 2023.  As with the first edition, the textbook offers an accessible introduction to the historical, technical, and strategic context of global cyber conflict. The 2nd edition has been revised and updated throughout, with three new chapters.  Whyte and Mazanec’s book has received praise from senior leaders, with General Michael V. Hayden, former Director of the Central Intelligence Agency and National Security Agency, saying “‘This book is a great contribution to the cyber canon and offers a comprehensive reference for both students and policymakers. The authors cover down on the many dynamic facets of cyber conflict, providing a strong foundation for anyone interested in this critical aspect of international relations.”  James R. Clapper, former Director of National Intelligence also offered praise, calling the book “An authoritative tutorial on the arcane complexities of cyber warfare. This edition updates a previous version and makes the book more contemporary. It is a must-read for those who are serious about mastering this unique medium of combat, in all its dimensions.” You can preorder a copy here.

“The New Science that Could Help Spot the Next Pandemic Before It Begins”

Dr. Yong-bee Lim (yet another Biodefense PhD alumni!) recently published his latest article as an Editorial Fellow with The Bulletin of the Atomic Scientists. In it he discusses new and developing ways to monitor emerging infectious disease risks and the benefits of threat-agnostic biodefense. He writes, “As the world continues to face biological event after biological event, significant action must be taken to curtail the worst potential outcomes. New and evolving technologies leveraged towards pathogen-agnostic approaches to biodefense and public health may offer new ways to detect, characterize, and mitigate the risks associated with the emergence of novel pathogens in a wide variety of settings, from farm fields and cities to overseas military bases and hospitals. Some useful technologies and ideas—like pathogen agnostic biodefense–are still in their infancy, others, like whole-genome sequencing remain costly and out of reach, especially in poorer countries.”

“What’s Old Is New Again: Cold War Lessons for Countering Disinformation”

In this article for the Texas National Security Review, Calder Walton discusses how modern strategies to combat disinformation can be informed by history, focusing on the KGB’s targeting of race relations at the 1984 Olympics in Los Angeles and KGB claims that the US engineered the human immunodeficiency virus. He writes “This paper makes three principal arguments. First, applied history is a valuable field of public policy research, as demonstrated by the history of intelligence, disinformation, and international security. Second, the history of Soviet disinformation targeting U.S. domestic racial protests and Washington’s use of bioweapons to cause pandemics shows how and why hostile foreign states use disinformation to attack liberal democracies. Contrary to past and present claims about foreign malign “hidden hands” in U.S. domestic affairs, in fact the Soviet Union’s disinformation strategy, and its impact, were limited: It targeted and amplified existing divisions within American society, doing nothing more than magnifying them. Third, the U.S. government devised policies for countering Soviet disinformation about race and pandemics that are still applicable, even in today’s digital information landscape, where cyber interconnectivity and the prevalence of social media mean that citizens and policymakers drink from a daily firehouse of information. Although the digital revolution has offered unprecedented capabilities through which states can disseminate disinformation, the history of what came before is still relevant and applicable. In fact, it is impossible to understand contemporary foreign state disinformation strategies without appreciating their past. This will become an increasingly important subject as societies become more interconnected this century. The digitized 21st century will witness “infodemic” events, producing so much information that it will be difficult, if not impossible, for audiences to distinguish facts from state-sponsored lies.”

“Fear and Loathing in Moscow: The Russian Biological Weapons Program in 2022”

In this piece for the Bulletin of the Atomic Scientists, Dr. Robert Petersen, an analyst at Denmark’s Centre for Biosecurity and Biopreparedness, offers a comprehensive overview of the history of the Soviet and Russian BW threat, modern Russian biodefense concerns, and the probable state of Russian BW research and development today. He writes, “The Russian accusations and the fears they evoked raise an important question: What is the status of Russia’s own biological weapons program? The Russian government inherited a substantial part of the Soviet biological weapons program following the collapse of the Soviet Union, and what happened to this large program is a mystery. According to the US State Department, the Russian government continues to have a biological weapons program, and the US government did impose sanctions on several Russian military-biological facilities in 2021.”

He continues with, “Although Russia is highly secretive with regard to its biological research enterprise, and there is no definitive proof of an extant bioweapons program, the public record strongly suggests that Russia has maintained and modernized the surviving parts of the Soviet biological weapons program. For instance, the Russian government repeatedly admitted and then, in subsequent years, repeatedly denied inheriting a large part of the Soviet biological weapons program. Also, there are public signs of continuing research into biological weapons (including non-lethal biological weapons) at several locations in Russia. Meanwhile, discussion and policy decisions regarding so-called genetic weapons demonstrate the Russian leadership’s obsession with the idea of a new generation of advanced bioweapons.”

Breathless: The Scientific Race to Defeat a Deadly Virus

David Quammen is back in his latest book, Breathless, which covers the emergence of COVID-19. Erin Garcia de Jesús explains in her review that “The book is a portrait of the virus — SARS-CoV-2’s early days in China, how decades of science helped researchers craft effective vaccines within a year, the arrival of highly mutated variants. It’s not about the societal upheaval or the public health failures (and successes). While Quammen acknowledges the importance of those aspects of the pandemic, he chooses to focus on the “firehose” of scientific studies — both good and bad — that drove our understanding of COVID-19.”

“Protecting U.S. Technological Advantage”

The National Academies recently released this free eBook discussing the importance of technology innovation and leadership for US national security-“U.S. leadership in technology innovation is central to our nation’s interests, including its security, economic prosperity, and quality of life. Our nation has created a science and technology ecosystem that fosters innovation, risk taking, and the discovery of new ideas that lead to new technologies through robust collaborations across and within academia, industry, and government, and our research and development enterprise has attracted the best and brightest scientists, engineers, and entrepreneurs from around the world. The quality and openness of our research enterprise have been the basis of our global leadership in technological innovation, which has brought enormous advantages to our national interests.”

“In today’s rapidly changing landscapes of technology and competition, however, the assumption that the United States will continue to hold a dominant competitive position by depending primarily on its historical approach of identifying specific and narrow technology areas requiring controls or restrictions is not valid. Further challenging that approach is the proliferation of highly integrated and globally shared platforms that power and enable most modern technology applications.”

“To review the protection of technologies that have strategic importance for national security in an era of openness and competition, Protecting U.S. Technological Advantage considers policies and practices related to the production and commercialization of research in domains critical to national security. This report makes recommendations for changes to technology protection policies and practices that reflect the current realities of how technologies are developed and incorporated into new products and processes.”

“Visualizing Potential Pathogen Early Warning for Force Health Protection and Biothreat Response”

“A layered biosurveillance strategy is an essential component of a biodefense strategy for detecting and deterring infectious disease cases and other biological threats. The Council on Strategic Risks has detailed key elements of a biosurveillance network and their interoperability in providing force health protection on a military installation. Additionally, we explore the workflow of an infectious disease outbreak and how the biosurveillance network would be put into practice across the U.S. government.” 

“Dr. Natasha Bajema of the Converging Risks Lab and Brian G. Payne of aTON created these illustrations as a unique visual tool for understanding the scope of equipment, strategy, and people necessary for a successful biosurveillance network.” Learn more and access the illustrations here.

“Baseline Biosurveillance and Early Detection Windows” Credit: Council on Strategic Risks

“Anticipating Rare Events of Major Significance”

This abbreviated proceedings of a workshop is available from the National Academies. It explains that “The Intelligence Community Studies Board of the National Academies of Sciences, Engineering, and Medicine convened a 1- day classified workshop on March 2, 2022, to discuss the Defense Threat Reduction Agency’s (DTRA’s) methodologies and rare event anticipatory models and share insights from the unclassified Workshop on Anticipating Rare Events of Major Significance held on December 17 and 21, 2021. A major goal of both workshops was to examine the methodologies and experiences of other disciplines in dealing with significant rare events with a view to aiding DTRA in examining and further developing its own methodologies to address rare events of particular concern to that agency. In accordance with procedures established by the National Academies for classified activities, this abbreviated version is an unclassified summary of a classified Proceedings of a Workshop—in Brief.”

“Long-Term Impacts of COVID-19 on the Future Academic Careers of Women in STEM”

The National Academies also recently released this proceedings of a workshop-“On March 23-24, 2022, the National Academies of Sciences, Engineering, and Medicine held a virtual workshop to explore the long-term impact of COVID-19 on the future careers of women in STEM. Workshop participants represented multiple sectors (i.e., higher education, government, and non-profit) as well as various career paths and stages (e.g., assistant, associate, and full professors; graduate students; program officers; directors; and policy advisors). The two-day workshop convened experts and leaders to outline a national research agenda that ensures academic institutions and federal agencies are able to monitor and mitigate the long-term negative impacts of the pandemic on the career trajectories, job stability, and leadership roles of women – especially women of color — in STEM. This publication highlights the presentation and discussion of the workshop.”

“The Influenza Imperative: An Urgent Need to Leverage Lessons from COVID-19 to Prepare for a Global Response to Seasonal and Pandemic Influenza”

The National Academy of Medicine recently released this paper discussing the findings of the Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response in 2020 initiative’s workshop. The authors explain the aims of it, writing “The National Academy of Medicine convened an initiative on Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response in 2020 to collect, understand, and leverage lessons learned from COVID-19 to ensure more robust and nimble preparedness for pandemic and seasonal influenza in the future (NAM, n.d.). By the end of 2021, the Initiative convened a three-day global workshop; and produced a workshop summary and four consensus studies focused on vaccine research and development, globally resilient supply chains, public health interventions, and global coordination and financing (NAM, 2022; NASEM and NAM, 2022a; NASEM and NAM, 2022b; NASEM and NAM, 2022c; NASEM and NAM, 2022d; NAM 2021). This manuscript aims to briefly summarize the four consensus studies, identify areas of focus among the 96 recommendations presented in the studies, and prioritize a small number of these recommendations for immediate action. This manuscript is authored by members of the Initiative’s international committee, which oversaw all of the activities outlined above.”

“Hazardous and Toxic Chemicals on the Move: Under-regulated, Vulnerable, and Dangerous”

Cupitt et al. recently authored an explainer for the Stimson Center discussing security challenges posed by the growing global chemical trade and the threat of chemical terrorism. They explain that “Whether they are fatal events, ecological disasters, or “normal accidents”, the mishandling of hazardous substances during the transport stage poses a serious and perpetual risk to the international community. This is especially true when considering the danger of intentional misuse rather than accidental mishandling.” They offer seven recommendations for states to strengthen transportation security and supply chain verification as well.

“Biological Weapon Monitoring in Iraq”

This new issue of “Historical Notes” is authored by Dr. Gabriele Kraatz-Wadsack, a former weapons inspector with the UN Special Commission (UNSCOM) in Iraq and later Chief of the Weapons of Mass Destruction Branch – UN Office for Disarmament Affairs. In it, “she describes the only instance of international monitoring in the biological weapons (BW) area. It draws on her first-hand experience to launch and manage biological ongoing monitoring in Iraq from 1995 through 1998 both within the country and from UNSCOM Headquarters.” She explains that “The monitoring and verification experience in Iraq illustrates that in-country verification, especially through on-site inspections could generate more timely and more accurate information than from any other source and could also serve as the strongest deterrent to proscribed activities. Unannounced on-site inspections by knowledgeable inspectors were the most powerful tool that was greatly reinforced by the deployment of resident teams inside Iraq. Such inspections credibly increased the probability of timely detection of proscribed activities at any site in Iraq. The success was ultimately due to the commitment, knowledge, skills and dedication of the people who carried out inspection and monitoring activities.”

“Dual-Use Research Needs International Oversight”

In this Nature Correspondence piece, Whitby et al. discuss current challenges and opportunities to better address DURC oversight. They write, “An international system of oversight for dual-use research could usefully be introduced. It could be incorporated, for instance, into the Tianjin Biosecurity Guidelines for Codes of Conduct for Scientists, to be considered at the upcoming Ninth Review Conference of the Biological Weapons Convention (see L. Wang et al. J. Biosaf. Biosecurity 3, 82–83; 2021). The post-pandemic period offers a timely opportunity to raise awareness of dual-use research and for training personnel in ethical reviewing.”

“Needed: Stricter Screening of Gene Synthesis Orders, Customers”

Dr. Gigi Gronvall discusses in this opinion piece for STAT News California’s new law requiring California State University to “…develop systemwide guidance for buying gene synthesis products from companies that screen their orders to minimize the risk of misuse, and requests that the entire University of California system do the same.” She explains that “This will create a competitive advantage for companies that take biosecurity seriously. Widespread screening will make it more difficult for potential nefarious actors to access genetic material that could be used to construct pathogenic viruses, including smallpox, Ebola, or influenza, so this is an important step for biosecurity.” She concludes “The U.S. government and other governments must quickly adopt similar common-sense regulations to normalize the screening process and prevent gene synthesis products from falling into the wrong hands.”

“The Next Pandemic is Right Around the Corner: Let’s Keep It There”

In this opinion piece, Drs. Andre M. Goffinet, Helen E. Mundler, Sebastien Viret, and Roland Wiesendanger propose the creation of a United Nations International Pandemic Pathogens Agency. They write “It is our collective responsibility to ensure that technology is applied for the common good. To cite the most celebrated case, research in nuclear physics led to the discovery of nuclear fission and the development of nuclear reactors, but also to nuclear weapons. Nuclear technology is burdened with deep and obvious moral and ethical issues that led the United Nations to create the International Atomic Energy Agency.”

“The hugely disruptive Covid19 pandemic should trigger an analogous response addressing the risks inherent to research on enhanced pathogens with pandemic potential—hereinafter ePPP.”

“We propose the creation by the UN of an International Pandemic Pathogen Agency, the IPPA…”

“Navigating the Paradox of the Silent Pandemic”

Dr. Alexander Ghionis, a Research Fellow in Chemical and Biological Security at the University of Sussex’s Science Policy Research Unit, recently authored this opinion piece discussing the AMR’s growing threat and the need to improve antibiotic research in addition to stewardship culture. He writes, “Antimicrobial drugs, including antibiotics, are the backbone of modern medicine. They are a primary treatment for a spectrum of ailments, from infected wounds to chest infections, sexually transmitted infections to pneumonia. They underpin treatments for people with compromised immune systems, for example those living with HIV or undergoing cancer treatments. Antibiotics have captured the public’s imagination as a fix-all drug.”

“Primate Hemorrhagic Fever-Causing Arteriviruses are Poised for Spillover to Humans”

In this new Cell article, Warren et al. discuss how SHFV replication in human cells suggests potential for zoonotic transmission. Their summary explains that “Simian arteriviruses are endemic in some African primates and can cause fatal hemorrhagic fevers when they cross into primate hosts of new species. We find that CD163 acts as an intracellular receptor for simian hemorrhagic fever virus (SHFV; a simian arterivirus), a rare mode of virus entry that is shared with other hemorrhagic fever-causing viruses (e.g., Ebola and Lassa viruses). Further, SHFV enters and replicates in human monocytes, indicating full functionality of all of the human cellular proteins required for viral replication. Thus, simian arteriviruses in nature may not require major adaptations to the human host. Given that at least three distinct simian arteriviruses have caused fatal infections in captive macaques after host-switching, and that humans are immunologically naive to this family of viruses, development of serology tests for human surveillance should be a priority.”

“An Updated Review of the Scientific Literature on the Origin of SARS-CoV-2”

Dr. Jose Domingo’s updated lit review on the origin of SARS-CoV-2 is now available as a free PMC article here. Its abstract reads “More than two and a half years have already passed since the first case of COVID-19 was officially reported (December 2019), as well as more than two years since the WHO declared the current pandemic (March 2020). During these months, the advances on the knowledge of the COVID-19 and SARS-CoV-2, the coronavirus responsible of the infection, have been very significant. However, there are still some weak points on that knowledge, being the origin of SARS-CoV-2 one of the most notorious. One year ago, I published a review focused on what we knew and what we need to know about the origin of that coronavirus, a key point for the prevention of potential future pandemics of a similar nature. The analysis of the available publications until July 2021 did not allow drawing definitive conclusions on the origin of SARS-CoV-2. Given the great importance of that issue, the present review was aimed at updating the scientific information on that origin. Unfortunately, there have not been significant advances on that topic, remaining basically the same two hypotheses on it. One of them is the zoonotic origin of SARS-CoV-2, while the second one is the possible leak of this coronavirus from a laboratory. Most recent papers do not include observational or experimental studies, being discussions and positions on these two main hypotheses. Based on the information here reviewed, there is not yet a definitive and well demonstrated conclusion on the origin of SARS-CoV-2.”

What We’re Listening To 🎧

Public Health On Call-#527: The White House’s National Action Plan On Long COVID

From Johns Hopkins: “The Biden administration’s action plan for responding to long COVID is a good start, but much more is required to truly address the impacts of this “mass disabling event” on health, safety, and the economy. Journalist Ryan Prior and inaugural White House Director for Disability Policy Kim Knackstedt talk with Stephanie Desmon about what is included in the nation’s long COVID plan, what was left out, and how the plan could pave the way for responding to other chronic illnesses.” Listen here.

The John Batchelor Show-#Ukraine: The Other Kinds of #WMD. Andrea Stricker, FDD

Listen to John Batchelor discuss WMD threats and Russia’s war in Ukraine with the Foundation for the Defense of Democracies’ Andrea Stricker, research fellow and deputy director of the nonproliferation and biodefense program at FDD. Stricker also recently authored a policy brief, “U.S. Must Show Russia There is No Impunity for Chemical Weapons Use,” alongside FDD’s Anthony Ruggiero.

Interested in Studying Biodefense? Come to Our Information Session!

Are you a Pandora Report reader who just can’t get enough? Consider applying to the Schar School’s Biodefense Program, which offers several graduate certificates, an MS in Biodefense (both in-person and online), and a PhD in Biodefense if you’re really into this. On October 11 at 12 pm ET you can join us virtually to learn more about admissions for the MS and graduate certificates, including info on the application process, student experiences, and graduate outcomes. Register here.

Competing Equities: Biorisk and Global Health

Join TEXGHS for their free October lecture featuring Dr. Taylor Winkelman-Cagle on October 11 at 1 pm CDT. “Biological events have far-reaching impacts that extend beyond borders and defy human efforts at containment. Whether a biological event is a spillover from land use change or an accidental release from a lab, every nation on Earth has equities in the bio-related activities of everyone else. How do we balance these? How do we set the table, so to speak?”

“The focus of this talk will be the intersection of international politics and global health, with an eye to practical, pragmatic solutions and an honest evaluation of the obstacles and barriers that exist (and why some need to remain).” Learn more and register here.

Disinformation: An Emerging War Weapon

“Hosted by the National Defense University Foundation and Moderated by President and CEO, James Schmeling, join us for this interactive virtual discussion. Brief Talk Description: Explore how Russia, China and other entities use misinformation, disinformation, and malinformation as weapons of war and their impact on global security and American democracy.” This online webinar will be hosted on October 20 at 12 pm EST. Register here.

Reflections on Science Communication & Human Rights Amid Public Health Emergencies

“On October 20 (10:30-11:30 am ET),  join Dr. Bina Venkataraman, Editor-at-Large for The Boston Globe, and Dr. Chris Beyrer, Director of Duke University’s Global Health Institute, for a virtual discussion of science communication during public health emergencies, the role of public health researchers and journalists in advancing human rights, and emerging lessons from the COVID-19 pandemic.”

“The conversation will be moderated by Prof. Helle Porsdam, Professor of Law and Humanities and UNESCO Chair in Cultural Rights, Centre for Interdisciplinary Studies of Law, Faculty of Law, University of Copenhagen.” Register here.

Third International Summit on Human Genome Editing

The Third International Summit on Human Genome Editing will take place March 6-8, 2023, at the Francis Crick Institute, London, UK. “Building on previous events held in Washington, DC (2015) and Hong Kong (2018), this Summit will continue the important dialogue around human genome editing. It will facilitate a global discussion on somatic and germline genome editing, including developments in clinical trials and genome editing tools such as CRISPR/Cas9. Earlier this year a three-part series of online events Looking Ahead to the Third Human Genome Editing Summit discussed some of the key topics of the meeting. The three-day summit is being organised by the Royal Society, the UK Academy of Medical Sciences, the US National Academies of Sciences and Medicine and The World Academy of Sciences.”

“Find out more about the Summit’s Planning Committee, chaired by Professor Robin Lovell-Badge FRS FMedSci. Further information about the Summit agenda will be released soon, and registration to attend the event in person and online is now open.”

Dr. Leonard Cole Dead at 89

Dr. Leonard Cole, famous for pioneering terror medicine and chronicling an Army biological weapons program from the 50s and 60s, died on September 18 in Ridgewood, NJ. He was 89 years old.

“NTI Announces Dr. Piers Millett as Inaugural Executive Director of New International Biosecurity Organization, IBBIS”

From the Nuclear Threat Initiative: “NTI is pleased to announce the appointment of Dr. Piers Millett as the founding executive director of the International Biosecurity and Biosafety Initiative for Science (IBBIS), a new organization that will work collaboratively with global partners to strengthen biosecurity norms and develop innovative tools to uphold them…“Our vision for IBBIS is to build a world in which bioscience can flourish safely and responsibly,” said NTI Co-Chair and CEO Ernest J. Moniz. “Piers brings tremendous credibility and expertise to help stand up this vitally important new organization at a time when biological risks are growing.” Read more here.

“Engineering Biology for Climate and Sustainability: A Research Roadmap for a Cleaner Future” Goes Live

The Engineering Biology Research Consortium recently launched its latest roadmap, “Engineering Biology for Climate and Sustainability: A Research Roadmap for a Cleaner Future.” They explain “Engineering Biology for Climate & Sustainability: A Research Roadmap for a Cleaner Future is a critical assessment of opportunities for engineering biology to contribute to tackling the climate crisis and long-term sustainability of products and solutions for health and well-being of Earth and its inhabitants. This roadmap identifies novel approaches, objectives, and aims for engineering biology research in climate change mitigation and adaptation that can help to lower greenhouse gases, reduce and remove pollution, and promote biodiversity and ecosystem conservation. This roadmap also identifies opportunities for engineering biology-enabled, sustainable replacements and alternatives in the food and agriculture sector, transportation and energy sectors, and for materials and industrial processes. The roadmap’s opportunities and objectives are laid out as short-, medium-, and long-term milestones, to address the challenges of climate change and sustainability with both urgency and persistent ambition and vision for the development and translation of engineering biology tools to technologies and products for the current and next-generation bioeconomy.”

Pandora Report: 9.23.2022

Happy fall! It’s finally time to enjoy all things pumpkin spice free of judgement. We will save the judgement for professional matters. Speaking of which…does a pandemic end when the US president says it does? Nope! We kick off this week discussing why the COVID-19 pandemic may be ending but is certainly not over. We also discuss new US export limits on fentanyl to Russia, highlights from the UNGA, and more.

When Does a Pandemic End?

Early this week, President Biden stated that “The pandemic is over,” on “60 Minutes.” He continued by saying “We still have a problem with COVID. We’re still doing a lot of work on it…but the pandemic is over. If you notice, no one’s wearing masks. Everybody seems to be in pretty good shape. And so I think it’s changing.”

“Everybody” is definitely not “in pretty good shape.” There were 25,202 American COVID-19 patients in hospitals across the country the day that President Biden made this statement. The week before his appearance on the show had a 59,856 case 7-day average in the United States, down 71,190 from the week before. This number is also likely low given how many in the US now use at-home testing without reporting positives to public health authorities. Worse, the US averaged 358 COVID-19 deaths that 7-day period, with our national total sitting at 1,047,020 Americans dead from COVID-19 as of September 14. According to estimates by Brookings, around 16 million working-age Americans suffer from long COVID right now, bringing potentially devastating economic and social impacts. While the situation today is better off than the US was with COVID-19 earlier in the pandemic, it is far from over.

Politico wrote of the president’s statement “White House officials on Sunday downplayed Biden’s comments as simply an attempt to reflect where the U.S. is at now, according to Adam— that is, still dealing with Covid but not gripped by a pandemic that is all-consuming. But whether Biden’s phrasing was a gaffe or intentional, the president’s precise words matter for pandemic policy and public health messaging as the U.S. continues its battle with Covid.”

Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital and dean of the National School of Tropical Medicine at Baylor College of Medicine, told CBS “It didn’t make sense from a policy perspective…I don’t want to take away from the fact that the president overall has done a good job as the leader fighting Covid. But you can’t really say the statements are just careless because he said it — I mean, I listened to it — he made a point of saying it twice.”

Politico continued, writing “His remarks also won’t help with the country’s already-struggling booster uptake, Hotez said. The FDA and CDC just authorized a new Covid booster shot, and the White House has pushed Americans to roll up their sleeves for the Omicron-specific vaccine. Earlier this summer, Covid shots became available for young children, but the vaccination rate remains abysmal: Just under 325,000 young children are fully vaccinated across the U.S., according to the CDC.”

The US has also experienced a surge in cases driven by a new variant each winter since 2020. While the US has rolled out bivalent vaccines ahead of the coming winter, only time will tell if this trend will continue, an especially concerning fact given the likelihood of an especially bad flu season on the horizon for the northern hemisphere. Experts like Dr. Hotez remain especially concerned that a new variant is coming and will again wreak havoc in the US.

Hotez and others have also pointed out this is not going to help the president secure the $22.4 billion in additional COVID-response funding the administration is seeking. Predictably, Biden’s declaration triggered partisan response in Congress, with some members demanding that this statement should end measures like DoD’s vaccination requirements and pandemic student loan relief. “This is not a statement you make when you’re trying to persuade the Congress to allocate funds,” Hotez said. “For public health, scientific, policy reasons — not the way to go. He hit the trifecta.”

However, some experts do agree with President Biden’s statement, arguing the US is no longer in the emergency state it was earlier in the pandemic. NPR wrote of Biden’s statement, “It is a reasonable thing to do as we collectively move on from this emergency footing that we’ve been on for the last couple of years, and try to navigate a new normal,” said Dr. Bob Wachter, chair of UCSF’s Department of Medicine. “It’s an appropriate way of thinking about the threat as it stands today.”

So, when does a pandemic end? It definitely isn’t when the US president suddenly says it does, but the answer is still complicated. A pandemic can be considered over when the disease becomes endemic, but that transition isn’t well defined and there is no clear authority to make that judgement call. A pandemic happens when a disease spreads across large regions or world wide, so there is no single leader in charge of declaring it over. Furthermore, the WHO recently refused to say whether or not it will formally recognize an end to the COVID-19 pandemic. A WHO spokesman told CNN “”WHO does not have a mechanism for declaring or ending a “pandemic…’ Instead, he said, WHO will continue to assess the need for the public health emergency, and an expert committee meets every three months to do that.” While the WHO says the world is nearing the end of the COVID-19 pandemic, the Director General still stressed this week that “being able to see the end, doesn’t mean we are at the end.”

This is reflected in US health policy, even as officials stress the country is no longer in the emergency stage. “We are no longer in the emergency phase of the pandemic…we haven’t yet defined what endemicity looks like,” Dr. Ashwin Vasan, NYC Health Commissioner, said at an event with HHS Secretary Xavier Becerra this week. Ultimately, while the situation in the United States is undoubtedly better and improving, this is not the time to let up on the gas.

US Limits Exports of Fentanyl to Russia…and Well Plates?

The US Department of Commerce’s Bureau of Industry and Security (BIS) announced last week that the bureau is applying further restrictions on Belarus and Russia. This move also “…strictly limited the export of fentanyl and related chemicals to Russia, saying that they “may be useful” as chemical weapons to support Russia’s “military aggression,” The Washington Post reports. Under this new rule, fentanyl sales to Russia and Belarus will now require special licensing. This echoes actions taken by the EU this summer to control exports of fentanyl and other related exports to Russia. The 2002 Nord-Ost siege, when Chechen terrorists seized the Dubrovka Theater, culminated with Russian forces filling the theater with an aerosol made from carfentanil and remifentanil, both fentanyl derivatives. This action killed over 100 hostages in the theater in addition to the insurgents, and demonstrated Russia’s interests in these weapons.

In addition to measures controlling quantum computing-related hardware and other matters, the rule released last week specifically “Expands the scope of the Russian industry sector sanctions to add items potentially useful for Russia’s chemical and biological weapons production capabilities and items needed for advanced production and development capabilities that enable advanced manufacturing across a number of industries.” This includes export restrictions on a number of kinds of laboratory equipment that BIS has determined are not manufactured in Russia. The report explains this logic, reading “Therefore, the implementation of restrictive export controls on this equipment by the United States and our allies will economically impact Russia and significantly hinder Russia’s CBW production capabilities.” This list includes items like fermenters and compressors ‘‘specially designed to compress wet or dry chlorine,
regardless of material of construction,” but also well plates and PCR instruments, offering interesting insight into the state of biotech and life sciences research in Russia.

United Nations General Assembly Highlights

The UN General Assembly wraps up its 77th session today following several days of high level engagement, including a speech from President Volodymyr Zelensky of Ukraine. Here are some global health security-related highlights from this session:

Food Security– During a side event on Tuesday, leaders from across Europe, the Americas, and Africa called for immediate funding and action to address the growing food security crisis that has been worsened by Russia’s war in Ukraine. AP reports that “Speaking at a Global Food Security Summit on the sidelines of the annual U.N. General Assembly, the leaders demanded an end to the war, with each calling it a needless “aggression” and Spain’s prime minister accusing Russian President Vladimir Putin of trying to “blackmail” the world with hunger by causing severe disruptions in the export of Ukrainian grain.”

““Russia must end its illegal war against Ukraine, which has certainly been an essential source of the world’s food supply,” Spanish Prime Minister Pedro Sanchez told the gathering. “The truth is that Putin is trying to blackmail the international community with a large part of the world’s food needs. We cannot combat hunger without peace. The world is expecting much from us. Let’s act together, and let’s act now.””

The Global FundThe Global Fund to Fight AIDS, Tuberculosis and Malaria hosted its replenishment conference this week with President Biden, seeking to close its $18 billion funding gap for the next few years. However, the Fund only accumulated $14.25 billion in pledges, though the organization stated it expects the gap will close as more donations come in. The UK and Italy notably delayed their pledges. Sarah Champion discussed this in The Guardian, writing “As the Independent Commission for Aid Impact, the UK’s aid watchdog, stated in its recent report: the Global Fund is the project covered by the government’s Overseas Development Assistance (ODA) that has the greatest value for money. With this in mind, it is hard to believe that the government is choosing to ignore the facts and not fully commit to this cause.”

Non-Communicable Diseases– WHO Director General Dr. Tedros Adhanom Ghebreyesus also released a new report, “Invisible Numbers: The true extend of noncommunicable diseases and what to do about them,” urging world leaders to take action on NCDs, which annually are responsible for 17 million premature deaths and cause nearly three quarters of all global deaths. The report’s description explains “Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and genetic, and their presence is global. Every year 17 million people under the age of 70 die of NCDs, and 86% of them live in low- and middle-income countries (LMICs).”

Sudan Strain Responsible for Ebola Outbreak in Uganda

Uganda has reported the probable Ebola-related death of a one-year-old , with 11 more suspected cases, one confirmed case, and six more probable cases identified in the country. The WHO reported that Uganda declared an outbreak after a 24-year-old man died after showing symptoms. Samples taken from him were later identified as the relatively rare Sudan strain of Ebola virus, marking the first time this strain has been found in the country. Uganda borders the Democratic Republic of Congo, which recently reported a new case after experiencing its fourteenth outbreak earlier this year. Uganda’s last Ebola outbreak was driven by the Zaire strain in 2019, though the country’s deadliest Ebola outbreak came in 2000, leaving over 200 dead.

The WHO released a statement from Dr. Matshidiso Moeti, WHO Regional Director for Africa, in which she explained “Uganda is no stranger to effective Ebola control”, she said. “Thanks to its expertise, action has been taken to quickly to detect the virus and we can bank on this knowledge to halt the spread of infections.” The WHO also explained that “Existing vaccines against Ebola have proved effective against the Zaire strain but it is not clear if they will be as successful against the Sudan strain,” in its statement.

“FDA Repeatedly Adapted Emergency Use Authorization Policies To Address the Need for COVID-19 Testing”

The HHS Office of Inspector General released this report this week on FDA’s use of its EUA authority to authorize COVID-19 tests early in the pandemic. The OIG report found that:

“The failure of the Centers for Disease Control and Prevention (CDC)’s first test rollout revealed vulnerabilities in the Federal approach to testing early in the COVID-19 pandemic. It is typical for CDC to be the first to receive an EUA, and FDA expected that the CDC’s test would meet the early testing needs of the nation. However, CDC’s first test was unusable for many for weeks while no other test was authorized. Furthermore, due in part to its limited engagement with the public health labs that were using CDC’s test, FDA was slow to realize that testing by public health labs was far more limited than it initially expected. To address problems with the first authorized COVID-19 test, FDA worked with CDC, including allowing CDC to modify the terms of its original EUA. However, preventing a similar problem from occurring in future emergencies would require actions outside of FDA’s authority alone.

In using its EUA authority, FDA also made calculated decisions to increase availability of COVID-19 testing, but these decisions often came at a potential cost to test quality. FDA authorized tests using lower levels of evidence to support developers struggling to access clinical samples. FDA’s policies allowed diagnostic and serology tests to get on the market quickly; however, that resulted in some problematic tests on the market, requiring further action by FDA.

FDA’s decision to accept all EUA requests resulted in a record number of submissions-often low-quality and from developers lacking experience with FDA’s processes. In response, FDA took steps to support developers and ease its workload, which included issuing EUA guidance, updating templates (submission guides for developers requesting EUA), and adjusting its EUA review process, among others. Some developers still reported being frustrated and confused.”

“Health Care and the Climate Crisis: Preparing America’s Health Care Infrastructure”

The House Ways and Means Committee recently released its report analyzing responses to an RFI sent to hospitals, health systems, and health care providers to “better understand how climate events have impacted the health sector, as well as steps the health care industry is taking to address its role in mitigating the climate crisis.” The committee explains that “Health Care and the Climate Crisis: Preparing America’s Health Care Infrastructure includes an overview of the role the U.S health system plays in the climate crisis. Part One provides an overview of the problem, description of Chair Neal’s 2022 Request for Information (RFI), and summary statistics from an analysis of survey respondents. Part Two examines how the climate crisis and the prevalence of extreme weather events impact health care organizations. Part Three describes how health care organizations are assessing their climate impact and working to reduce their respective carbon footprints. Part Four summarizes findings and provides a discussion of implications. Part Five is an appendix with survey methodology, limitations, and supplemental tables.”

“Strengthening the Biological Weapon’s Convention’s Contributions to Global Health Security”

This Think Global Health piece discusses false Russian BW allegations and the recent invocation of Article V of the BWC. The authors explain “Russia’s disinformation regarding Ukrainian biological laboratories is intended to distract and divide global attention concerning its reprehensible actions in Ukraine and to generate post hoc justification for its invasion. Russian invocation of Article V risks tainting the BWC consultation mechanism and abusing it to air political grievances and foment distrust. And, like the 1997 consultations, BWC parties reached no consensus, highlighting major challenges to the mechanism in the face of complex geopolitical tensions.”

“Harnessing the Power of Science and Technology Communities for Crisis Response”

The RAND Corporation recently released this Perspective, co-authored by Dr. Daniel M. Gerstein, a Biodefense PhD Program alumnus, discussing DHS’s “…ability to leverage science and technology communities to support the use of science, technology, innovation, and analytical capabilities during crisis response.” The abstract explains, “RAND researchers conducted a literature review and discussions with subject-matter experts to understand how these capabilities have been used during past national security crises and how they could be used in the future. In this Perspective, the researchers offer a conceptual framework for employment of the science and technology communities’ capabilities during crisis response. They also present five imperatives that should be considered for providing technical support during a crisis and a concept for how to institutionalize that support. These critical elements form the basis for providing quality technical support to crisis leadership.”

“What is the Future of the Global Health Security Agenda?”

The Pandemic Action Network released this piece last week discussing the future of GHSA, explaining “The GHSA is now at an inflection point. While GHSA has built a strong community, the COVID-19 pandemic has also stress-tested domestic and global health systems and raised questions about the reach, relevance, and impact of this partnership. Despite its success as a forum for collaboration and incubator for health security concepts and networks, GHSA has been less visible as part of the global response to the COVID-19 pandemic, missing an important opportunity to activate its coordination mechanisms to support global policy discussions on the future of the global health security architecture.”

What We’re Listening To 🎧

This Podcast Will Kill You “Episode 105 Down in the Mumps”

From TPWKY: “We’ve covered measles, we’ve taken on rubella, and now we’re finishing up the classic MMR vaccine by exploring the other M: mumps. To some listeners, mumps may be a painful childhood memory while to others it’s just a letter in a vaccine they were too young to remember getting. But by the end of this episode, we promise that you’ll all be much more familiar with this strange little virus. How does the mumps virus make you sick and give you that classic swollen face look? What is so bad about the mumps that Maurice Hilleman decided to snag a mumps sample from his sick daughter to make a vaccine? Where do we stand with mumps today and what do declining vaccination rates have to do with those not-so-great numbers? Tune in to hear our take on all these questions and many more in this classic TPWKY episode.” Listen here.

National Biodefense Science Board Public Meeting

The National Biodefense Science Board (NBSB) is hosting its next public meeting on September 29 at 11 am ET. “This public meeting of the NBSB will focus on several topics, including the collection, analysis, and sharing of operational health data and/or development and implementation of systems to ensure the availability of virtual healthcare (telehealth, telemedicine, etc.) during a disaster. The NBSB is particularly concerned with the impacts of COVID-19 on rural and underserved communities, including the ways in which those communities succeeded or were challenged in conducting a public health response, and ways in which HHS can support strengthening of systems, technologies, and partnerships that will lead to improvements in data collection and virtual care during disasters.” Learn more and register here.

Introducing the Global Guidance Framework for the Responsible Use of the Life Sciences: Mitigating Biorisks and Governing Dual-Use

The WHO is offering this open webinar on 3 October 2022, 13:30-14:30 CEST, where an expert panel will introduce the recently released global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research and discuss its applications for different stakeholders. The panel will include a number of WHO experts as well as Drs. Anita Cicero and Filippa Lentzos. Learn more and register here.

Interested in Studying Biodefense? Come to Our Information Session!

Are you a Pandora Report reader who just can’t get enough? Consider applying to the Schar School’s Biodefense Program, which offers several graduate certificates, an MS in Biodefense (both in-person and online), and a PhD in Biodefense if you’re really into this. On October 11 at 12 pm ET you can join us virtually to learn more about admissions for the MS and graduate certificates, including info on the application process, student experiences, and graduate outcomes. Register here.

iGEM Responsibility Conference: Navigating the Future of Synthetic Biology

“For the first time ever, iGEM’s Responsibility Program is running a dedicated Responsibility Conference on the margins of this year’ s Grand Jamboree. The theme is ‘Navigating the future of synthetic biology’. The event is taking place from 26-27 October 2022 at the Paris Expo, Porte de Versailles, Paris, France. Join policy makers, technical experts, and other experts from around the world in exploring: Safe, secure, & responsible synbio beyond containment; Negotiating competing ideas of doing good; Applied biosafety & biosecurity; Lessons for governance of emerging technologies. If you are interested in taking part in this exciting new event, please register your interest online here, or contact us directly at responsibility@igem.org.”

Pathogens Project Launched

This week, “a group of scientists and public health leaders, convened by the Bulletin of the Atomic Scientists, launched an international taskforce to consider trends and oversight of high-risk pathogen research. This follows the WHO’s recent release of the “Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research.”

“Over the next few months, the initiative on “Creating the Framework for Tomorrow’s Pathogen Research” will discuss risk assessment and mitigation, including lab-based outbreak risks.   A public-facing conference in Geneva, Switzerland on April 19-21, 2023, will include task force members, policy leaders, journalists, scientists, and civic leaders, among others, and will produce a summary report with recommendations for a comprehensive global approach to management of extremely high-risk biological research.”

Read more about the project here.

Pandora Report: 9.16.2022

It has been a busy week and this issue reflects that! We kick this issue off with updates on the conclusion of the Biological Weapons Convention Article V Formal Consultative Meeting in Geneva before getting into everything from the United States’ inclusion on the WHO’s list of countries with circulating vaccine-derived polio (yikes) and new US government health security leadership and funding. As always, there are enough new publications, podcasts and upcoming events to keep you way too busy until next Friday.

BTWC Consultative Meeting Wraps Up

Last Friday, the Biological Weapons Convention Article V Formal Consultative Meeting requested by Russia concluded in Geneva. The meeting was held in response to Russia’s claims that the US supports biological weapons development in Ukraine. The US State Department issued a statement accusing Russia of abusing the consultative meeting process by using it as an international stage to further spread disinformation. The statement reads in part, “The United States delegation, led by Special Representative Kenneth D. Ward, effectively exposed Russia’s disinformation tactics and dispelled Russia’s spurious allegations seeking to malign peaceful U.S. cooperation with Ukraine.”

“In the presence of delegations from 89 countries, the United States and Ukraine presented a thorough, in-depth series of presentations that strongly refuted Russia’s absurd and false claims of U.S. biological weapons development and bio-labs in Ukraine. Technical experts from the U.S. and Ukrainian delegations unambiguously explained their cooperation and U.S. assistance related to public health facilities, biosafety, biosecurity, and disease surveillance as part of the broader U.S. Cooperative Threat Reduction Program. The United States and Ukraine also highlighted how such activities are consistent with—and further support—the provisions of the BWC, particularly Article X, which promotes cooperation and assistance by States Parties. States Parties affirmed and supported the United States in this regard, with over 35 of the 42 countries that spoke noting the importance of such work.”

Belarus, China, Cuba, Nicaragua, Russian Federation, Syrian Arab Republic, Venezuela, and Zimbabwe also submitted a joint statement on Friday, showing that the Russians just aren’t ready to give this up-“We have to conclude that the questions as to the military biological activities conducted by the United States in the context of the functioning of biological laboratories on the Ukrainian territory still remain unresolved. We have not received exhaustive explanations that could completely allay the doubts concerning the said activities and thus straighten out the situation that had prompted the Russian side to convene the Consultative meeting under BTWC Article V. This is regrettable.”

The statement later continued, “In addition, given the outcomes of the Consultative meeting as well as to facilitate the resolution of the existing situation, we call for making use of all opportunities available within the framework of the BTWC, including the mechanism under Article VI of the Convention.”

Article VI of the convention is the provision of “Right to request the United Nations Security Council to investigate alleged breaches of the BWC, and undertaking to cooperate in carrying out any investigation initiated by the Security Council.”

Though China’s Xi Jinping has yet to officially back Russia’s claims, his representative at the consultative meeting, Li Song, said “China was “deeply concerned” about the allegations and called for an independent international investigation of the United States’ activities involving biological research,” according to the New York Times. “My delegation believes that a series of specific questions raised by Russia have not yet received pointed response from the U.S.,” Li said in a statement provided by the UN Office of Disarmament Affairs.

What Purpose Does This Disinformation Serve?

While Soviet and, later, Russian disinformation surrounding US BW programs (or the lack thereof) is nothing new, it is important to understand what purposes it serves. With Russian claims about supposed US BW work in Ukraine doing everything from developing an ethnic bioweapon to target Russians to training birds to deliver biological weapons, these claims are broad and have far-reaching consequences. For starters, these claims help the Russians justify and legitimize the invasion of Ukraine to their people by offering a threat to the homeland that justifies the severe cost this has had for the country.

However, claims like this also damage public health, especially since the facilities targeted by this disinformation, both in Ukraine and other countries assisted by the United States’ Cooperative Threat Reduction program, are those with important public health missions. This was the case when allegations were aimed at the Richard G. Lugar Center for Public Health Research in Tbilisi, Georgia, home to the Georgian National Center for Disease Control and Prevention and US Army Medical Research Directorate-Georgia. The Lugar Center was instrumental in Georgia’s management of the COVID-19 pandemic in 2020, shoring up diagnostic capability for the country. Targeting facilities with such important missions, especially when they are well-documented to be working on strictly peaceful work, undermines their legitimate service to the public and their role in protecting health security globally.

Furthermore, the RAND Corporation’s John V. Parachini explains, “It’s tempting to write off such claims as cartoonish propaganda. But Russia is also making similarly outrageous claims to the United Nations and other international forums, and that’s more serious. Such maneuvers could dangerously undermine international arms control agreements.” He also explains of Russia’s Permanent Representative to the UNSC Vassily Nebenzia’s claims about Ukraine that “What the ambassador failed to mention was that Russian scientists visited these same laboratories in the past and never noted anything like what Russian officials now claim. Moreover, the United States had been collaborating with Russia in the same way—providing similar assistance to Russia to refocus the activities of former Soviet biological weapons laboratories, until Russia pulled out of the program in 2014, the same year it invaded Crimea.”

United States Added to WHO’s List of Countries with Circulating Vaccine-Derived Poliovirus

At one point in the 1940s, polio disabled an average of over 35,000 Americans annually. However, thanks to a robust vaccination push, the Pan American Health Organization announced in 1994 that “…three years had passed since the last case of wild polio in the Americas. A three-year-old Peruvian boy, Luis Fermín, had the last registered case there.” There have been no cases of polio originating in the US caused by wild poliovirus since 1979. However, wild poliovirus has been brought into the country by travelers, with the last occurrence in 1993.

This week, “CDC…announced that polioviruses found in New York, both from the case of paralytic polio in an unvaccinated adult in Rockland County and in several wastewater samples from communities near the patient’s residence, meet the World Health Organization (WHO)’s criteria for circulating vaccine-derived poliovirus (cVDPV) – meaning that poliovirus continues to be transmitted in Rockland County, NY, and surrounding areas.”

The press release continued, “CDC is working closely with WHO, the Pan American Health Organization (PAHO), and other international public health partner organizations. As previously reported, the virus’ genetic sequences from the patient from Rockland County, NY, and wastewater specimens collected in New York have been linked to wastewater samples in Jerusalem, Israel, and London, UK, indicating community transmission. The viral sequences from the patient and from three wastewater specimens had enough genetic changes to meet the definition of a vaccine-derived poliovirus (VDPV).  These two things – one individual with VDPV and at least one detection of a related VDPV in an environmental sample – meet WHO’s definition of cVDPV, and CDC submitted this data to WHO for inclusion on its list of countries with cVDPV. There are global recommendations for countries with cVDPV2 outbreaks to protect people from polio, and the United States is taking all appropriate actions to prevent new cases of paralysis.”

While polio spreading in wealthy countries is concerning, check out Leslie Roberts’ article in Science news-“Polio is back in rich countries, but it poses a far bigger threat to developing world”.

US Announces Investments in Bioeconomy and Commits to Improving Biosecurity…Sorta?

Late this week, the White House announced $2 billion in “new investments and resources to advance President Biden’s National Biotechnology and Biomanufacturing Initiative.” The funding aims to expand domestic biomanufacturing, help bring new bio-products to market, train future generations of biotechnologists, and “drive regulatory innovation to increase access to products of biotechnology,” among other goals. However, the fact sheet also discusses the goal to “reduce risk through investing in biosecurity innovations,” which states that “DOE’s National Nuclear Security Administration [(NNSA)] plans to initiate a new $20 million bioassurance program that will advance U.S. capabilities to anticipate, assess, detect, and mitigate biotechnology and biomanufacturing risks, and will integrate biosecurity into biotechnology development.”

This has drawn some criticism as $20 million towards biosafety is a small amount of the (1%) of the overall $2 billion in funding announced, particularly with the growing need to address gaps in global biosafety. Furthermore, its placement under the NNSA has brought some concern, particularly as the Office of Defense Nuclear Proliferation, which “works globally to prevent state and non-state actors from developing nuclear weapons or acquiring weapons-usable nuclear or radiological materials, equipment, technology, and expertise,” will be tasked with overseeing the program.

US Government Gets New Health Security Leadership

Dr. Renee Wegrzyn Appointed First Director of Advanced Research Projects Agency for Health (ARPA-H)

President Biden appointed Dr. Renee Wegrzyn, a biologist currently at Gingko Bioworks, to lead the recently created Advanced Research Projects Agency for Health (ARPA-H). Biden proposed the creation of the Advanced Research Projects Agency for Health to “improve the U.S. government’s ability to speed biomedical and health research. Public Law 117-103 was enacted on March 15, 2022, authorizing the establishment of ARPA-H within the U.S. Department of Health and Human Services.”

STAT reports, “Wegrzyn, 45, currently works at Boston-based Ginkgo Bioworks, a company focused on biological engineering, but has prior experience in two government agencies Biden has said he hopes to emulate with ARPA-H — the Pentagon’s Defense Advanced Research Projects Agency and the Intelligence Advanced Research Projects Activity.” STAT also explains that “Wegrzyn is one of four former DARPA officials that STAT reported in July had been interviewed for the ARPA-H job by White House science adviser Francis Collins. She will not need Senate confirmation for her role but is sure to face scrutiny from lawmakers who have questioned the need for a new health agency, arguing it could replicate efforts at the National Institutes of Health.”

FDA Names Dr. David Kaslow New Director of Office of Vaccines Research and Review

Dr. David Kaslow, Chief Scientific Officer for Essential Medicines and Head of Center for Vaccine Innovation and Access at PATH, will become the FDA’s new director of the Office of Vaccines Research and Review on October 11. “Dr. Kaslow has more than 35 years of experience in vaccine research and development. He joined PATH in 2012 as Director of PATH’s Malaria Vaccine Initiative (MVI), leading the development of well-tolerated and effective vaccines against malaria. Prior to joining PATH, he was a Vice President of Vaccines and Infectious Disease at Merck Research Laboratories, while serving in key advisory positions with MVI and the Bill & Melinda Gates Foundation.” He was also the founder of the NIH’s Malaria Vaccine Development Unit.

His predecessor, Dr. Marion Gruber, retired last year and her deputy, Dr. Philip Krause, left the FDA a month later in November. According to the New York Times, “One reason is that Dr. Gruber and Dr. Krause were upset about the Biden administration’s recent announcement that adults should get a coronavirus booster vaccination eight months after they received their second shot, according to people familiar with their thinking.” Biopharma Dive explains further that “Shortly after the departures were announced, both were listed as co-authors of an article published in The Lancet that then argued against broad rollout of COVID-19 vaccine boosters, at a time when the Biden administration was preparing to begin a booster campaign.”

World Bank and WHO Launch Financial Intermediary Fund (FIF) for Pandemic Prevention, Preparedness, and Response

This week, World Bank and WHO announced the establishment of the FIF for pandemic prevention, preparedness, and response. “The fund will provide a dedicated stream of additional, long-term financing to strengthen PPR capabilities in low- and middle-income countries and address critical gaps through investments and technical support at the national, regional, and global levels. The fund will draw on the strengths and comparative advantages of key institutions engaged in PPR, provide complementary support, improve coordination among partners, incentivize increased country investments, serve as a platform for advocacy, and help focus and sustain much-needed, high-level attention on strengthening health systems.” The first round of calls for investments to be funded by the FIF will be available in November this year.

United Nations General Assembly Passes Resolution A/76/L.76%20

The UNGA earlier this month passed Resolution A/76/L.76%20 calling on the 78th UNGA to hold a high-level meeting on pandemic prevention, preparedness, and response. Among other things, the resolution states, “Recognizing that health is a precondition for and an outcome and indicator of all three dimensions – economic, social and environmental – of sustainable development and that, despite progress made, challenges in global health, including major inequities and vulnerabilities within and among countries, regions and populations, still remain and demand persistent and urgent attention,…

  1. Decides to hold a one-day high-level meeting, to be convened by the President of the General Assembly in collaboration with the World Health Organization, and at the level of Heads of State and Government, by no later than the last day of the general debate of the Assembly at its seventy-eighth session, to adopt a succinct political declaration aimed at, inter alia, mobilizing political will at the national, regional and international levels for pandemic prevention, preparedness and response;
  2. Recommends that the President of the General Assembly appoint two co-facilitators to present options and modalities for the high-level meeting, as well as the political declaration.”

The Lancet-“COVID-19 Response: A Massive Global Failure”

With COVID-19 deaths the lowest they have been since March 2020, the Lancet released its much anticipated commission report and accompanying infographic this week discussing global failures in responding to the COVID-19 pandemic and recommendations for improvement. The report explains “The Commission delivers a number of recommendations that are divided into three main areas. First, practical steps to finally control and understand the COVID-19 pandemic. Second, realistic, feasible, and necessary investments to strengthen the first line of defence against emerging infectious agents in countries by strengthening health systems and widening universal health coverage. Third, ambitious proposals to ignite a renaissance in multilateralism, integrating the global response to the risk of future pandemics with actions to address the climate crisis and reversals in sustainable development.”

“Global Guidance Framework for the Responsible Use of the Life Sciences: Mitigating Biorisks and Governing Dual-Use Research”

This week, the WHO released the Global guidance framework for the responsible use of the life sciences, which calls on leaders and other stakeholders to “mitigate biorisks and safely govern dual-use research, which has a clear benefit but can be misused to harm humans, other animals, agriculture and the environment.” According to the WHO’s press release, “This is the first global, technical and normative framework for informing the development of national frameworks and approaches for mitigating biorisks and governing dual-use research,” and “The Framework addresses the decades-long challenges of preventing the accidental and deliberate misuse of biology and other life sciences, as well as how to manage governance and oversight to both accelerate and spread innovation, while mitigating negative impacts. The life sciences are increasingly crossing over with other fields, such as chemistry, artificial intelligence and nanotechnology, which changes the landscape of risks, with those that span multiple sectors and disciplines more likely to be missed.” The Schar School’s Dr. Gregory Koblentz contributed to several of the working groups formed in the creation of this framework.

“100 Days of Monkeypox: Evaluating the U.S. Response to the Emerging Global Outbreak”

Dr. Daniel P. Regan, a biomedical engineer and a Fellow at the Janne E. Nolan Center on Strategic Weapons, recently authored this Council on Strategic Risks briefer on the United States’ first 100 days dealing with monkeypox. The brifer “…details the early dynamics of the outbreak, evaluates the testing, vaccination, and therapeutic rollout, and provides an outlook and analysis meant to help the United States prevent and address similar biological threats.”

“Differential Technology Development: A Responsible Innovation Principle for Navigating Technology Risks”

This article, available as a pre-print on SSRN, discusses differential technology development  and its potential benefits for private and government research funding and technology regulations. The abstract reads “Responsible innovation efforts to date have largely focused on shaping individual technologies. However, as demonstrated by the preferential advancement of low-emission technologies, certain technologies reduce risks from other technologies or constitute low-risk substitutes. Governments and other relevant actors may leverage risk-reducing interactions across technology portfolios to mitigate risks beyond climate change. We propose a responsible innovation principle of “differential technology development”, which calls for leveraging risk-reducing interactions between technologies by affecting their relative timing. Thus, it may be beneficial to delay risk-increasing technologies and preferentially advance risk-reducing defensive, safety, or substitute technologies. Implementing differential technology development requires the ability to anticipate or identify impacts and intervene in the relative timing of technologies. We find that both are sometimes viable and that differential technology development may still be usefully applied even late in the diffusion of a harmful technology. A principle of differential technology development may inform government research funding priorities and technology regulation, as well as philanthropic research and development funders and corporate social responsibility measures. Differential technology development may be particularly promising to mitigate potential catastrophic risks from emerging technologies like synthetic biology and artificial intelligence.”

“Over Half of Known Human Pathogenic Diseases Can be Aggravated by Climate Change”

While Mora et al.’s August article re-confirms what we intuitively know, it offers a sobering reminder and quantification of the immense risks unchecked climate change brings. Their abstract explains “It is relatively well accepted that climate change can affect human pathogenic diseases; however, the full extent of this risk remains poorly quantified. Here we carried out a systematic search for empirical examples about the impacts of ten climatic hazards sensitive to greenhouse gas (GHG) emissions on each known human pathogenic disease. We found that 58% (that is, 218 out of 375) of infectious diseases confronted by humanity worldwide have been at some point aggravated by climatic hazards; 16% were at times diminished. Empirical cases revealed 1,006 unique pathways in which climatic hazards, via different transmission types, led to pathogenic diseases. The human pathogenic diseases and transmission pathways aggravated by climatic hazards are too numerous for comprehensive societal adaptations, highlighting the urgent need to work at the source of the problem: reducing GHG emissions.”

Dr. Jennifer Doudna Authors Piece on the Benefits of Gene Editing

Dr. Jennifer Doudna, a pioneering American biochemist who received the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier for their work on CRISPR gene editing, recently authored a piece in the Atlantic, “Starting a CRISPR Revolution Isn’t Enough,” discussing the great strides and improvements that the technology has experienced in recent years. She covers the origins of modern biotechnology from the 1970s onwards before moving on to the growing CRISPR economy, which was valued at $5.2 billion in 2020, and what investments she thinks governments and research organizations need to make today to ensure the benefits of the technology are broad in application. She also cautions that “Powerful technology, of course, comes with the potential for misuse, and CRISPR’s powers raise important questions…These strategies could help fight the spread of invasive species and devastating diseases such as malaria, but without careful assessment and governance, they could also pose a risk to whole ecosystems.”

She further elaborates on this in her discussion of the “CRISPR babies” scandal that resulted from He Jiankui’s work editing the genomes of viable human embryos that later became twin children. She explains the need for regulations to prevent such use of the technology, writing “Without these guardrails, we may not only harm humans and our environment, but also risk societal backlash against the very technologies that could preserve and improve our health and make our planet more livable.”

While Dr. Doudna focuses primarily on the benefits of this technology, it does bring significant security concerns as discussed by the Schar School’s Dr. Sonia Ben Ouagrham-Gormley in her award-winning paper, “From CRISPR babies to super soldiers: challenges and security threats posed by CRISPR,“ and by Dr. Gregory Koblentz and his co-authors in their report, “Editing Biosecurity: Needs and Strategies for Governing Genome Editing“.

“Conspiracy Theories About COVID-19 Help Nobody”

Dr. Angela Rasmussen, a virologist at the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan, and Dr. Michael Worobey, department head of Ecology and Evolutionary Biology at the University of Arizona, recently published an argument piece in Foreign Policy discussing how COVID-19 conspiracy theories harm us all. They focus on ” the idea that SARS-CoV-2, the virus that causes COVID-19, was engineered in a laboratory” and the appointment of Dr. Jeffrey Sachs, who they describe as “a Columbia University economist with no expertise in virology, evolution, epidemiology, or public health,” as the chair of the Lancet‘s COVID-19 commission.

They write, “Although biosafety and biosecurity are of paramount importance, especially to virologists who actually handle these dangerous pathogens, they are irrelevant to the zoonotic origin of SARS-CoV-2 and polarize an ongoing discussion that must occur in a multidisciplinary, bipartisan way. Fictional origin stories that politicize regulating essential research only serve to remove the science from a necessarily scientific discourse…The suspicion cast on virologists and epidemiologists is profoundly harmful.”

Rasmussen and Worobey were co-authors of the two Science papers released this summer that strongly supported the idea that SARS-CoV-2 is zoonotic in origin and initially infected people naturally at the Huanan Seafood Wholesale Market in Wuhan-“The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2” and “The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic.” They also authored an opinion piece discussing this work in plain language for the Globe and Mail in July that is available here.

What We’re Listening To 🎧

Radiolab: 40,000 Recipes for Murder

The Schar School’s Dr. Sonia Ben Ouagrham-Gormley was interviewed on NPR’s Radiolab. The episode, 40,000 Recipes for Murder, asks the question, “Two scientists realize that the very same AI technology they have developed to discover medicines for rare diseases can also discover the most potent chemical weapons known to humankind. Inadvertently opening the Pandora’s Box of WMDs. What should they do now?” Listen here.

The Retort Episode 3: The Evolving Chemical and Biological Weapon Challenge

In this episode, Dr. Edwards talks with Dr. Jean Pascal Zanders, founder of The Trench, about developments leading to modern CBW, the development of modern international law, and current and emerging challenges in this area. Read Dr. Zanders blog about it here and watch/listen to the episode here.

Interested in Studying Biodefense? Come to Our Information Session!

Are you a Pandora Report reader who just can’t get enough? Consider applying to the Schar School’s Biodefense Program, which offers several graduate certificates, an MS in Biodefense (both in-person and online), and a PhD in Biodefense if you’re really into this. On October 11 at 12 pm ET you can join us virtually to learn more about admissions for the MS and graduate certificates, including info on the application process, student experiences, and graduate outcomes. Register here.

Monkeypox: Have We Learned Anything from COVID-19?

“The Scowcroft Institute of International Affairs at the Bush School of Government & Public Service at Texas A&M University will host a panel discussion entitled Monkeypox: Have we learned anything from COVID-19?, featuring moderator Dr. Gerald Parker and panelists Drs. Robert Carpenter, Syra Madad, Jennifer A. Shuford, and Bob Kadlec. Dr. Gerald Parker will moderate a panel of experts, including Drs. Robert Carpenter, Syra Madad, Jennifer A. Shuford, and Bob Kadlec, as they explore the Monkeypox outbreak. Recently declared a public health crisis by the federal government, Monkeypox is the thing on everyone’s mind. The panel will answer questions such as: Are we making the same mistakes with Monkeypox as we did with COVID-19? How can we do better with this and future pandemic threats? Is this something we need to be concerned about? And more. This will be a hybrid event. It will take place in person in Hagler Auditorium in the Annenberg Presidential Conference Center and virtually via zoom, (link available upon registration) and will start promptly at 5:30 PM CT.” Register online to attend.

Building Capacities for Addressing Future Biological Threats

On Tuesday, September 20 from 9:00am–10:30am ET, the Council on Strategic Risks (CSR) will host a webinar entitled “Building Capacities for Addressing Future Biological Threats.” n this webinar, experts will discuss the changing biological threat landscape and some key avenues to improve preparedness and response capabilities for addressing future biological threats. The webinar will begin with a keynote address from Dr. David Christian Hassell. As Deputy Assistant Secretary in the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services, Dr. Hassell will share his expertise and vision on how the United States may continue to build on successes and opportunities to address future biological threats. A panel discussion will follow Dr. Hassell’s address featuring Dr. Pardis Sabeti, Professor at the Center for Systems Biology at Harvard University, who will share her ongoing work in biosurveillance and pathogen early warning and Dr. Akhila Kosaraju, CEO and President of Phare Bio, who will discuss the role of the private-sector in developing medical countermeasures and other technologies for reducing biological threats. You can register to attend here.

iGEM Responsibility Conference: Navigating the Future of Synthetic Biology

“For the first time ever, iGEM’s Responsibility Program is running a dedicated Responsibility Conference on the margins of this year’ s Grand Jamboree. The theme is ‘Navigating the future of synthetic biology’. The event is taking place from 26-27 October 2022 at the Paris Expo, Porte de Versailles, Paris, France. Join policy makers, technical experts, and other experts from around the world in exploring: Safe, secure, & responsible synbio beyond containment; Negotiating competing ideas of doing good; Applied biosafety & biosecurity; Lessons for governance of emerging technologies. If you are interested in taking part in this exciting new event, please register your interest online here, or contact us directly at responsibility@igem.org.”

Post-Pandemic Recovery: From What, For Whom, and How?

“The Johns Hopkins Center for Health Security invites you to a webinar on “Post-Pandemic Recovery: From What, For Whom, and How?” to be held on October 4 and October 6, 2022, 12:00-2:30pm ET. During this online symposium, we will engage a broad community of practitioners in discussions about operationalizing a holistic process of post-pandemic recovery: What systems can local jurisdictions set up and strengthen that sustain the long view on getting through and past the pandemic, reverse the social determinants of uneven impacts, and develop resilience to future public health emergencies?

On Day 1, representatives from diverse sectors will diagnose tangible harms from COVID-19 (urgent and enduring), prescribing remedies that can facilitate a comprehensive post-pandemic recovery. On Day 2, community advocates and practitioners will describe their experiences in planning for post-pandemic recovery in their jurisdictions, sharing lessons learned for peers elsewhere. A full list of speakers can be found in the agenda. The symposium kicks off a larger project, sponsored by the Open Philanthropy Project, that supports local decision makers in assessing COVID-19 recovery efforts.” Please register here.

National Science Advisory Board for Biosecurity Virtual Meeting

The National Science Advisory Board for Biosecurity (NSABB), chaired by Dr. Gerald Parker, Associate Dean for Global One Health at Texas A&M University, will host a virtual meeting on September 21 at 1 pm ET. The meeting will include a working group update on Potential Pandemic Pathogen Care and Oversight (P3CO) policy review and more with an opportunity for public comments. Read the preliminary draft findings and recommendations here and access the webcast here.

ICYMI: September 1 White House Webinar on the Annual Report of the American Pandemic Preparedness Plan

Earlier this month, the Biden administration hosted a webinar to discuss the first Annual Report of the American Pandemic Pandemic Preparedness Plan. Check it out on the White House YouTube channel.

Smithsonian’s Outbreak: Epidemics in a Connected World Exhibit to Close October 3

The Smithsonian Museum of Natural History’s temporary exhibit, Outbreak, is scheduled to close permanently next month following its four-year run. The exhibit helps guests “Learn how to think like an epidemiologist—find the connections between human, animal, and environmental health in an interactive simulation; Reflect on personal memories and photos from disease survivors and frontline healthcare workers; and Work cooperatively with other visitors to contain an outbreak before it spreads further in a multi-player game.” While this exhibit is closing, the Smithsonian plans to offer a new One Health webinar series this fall and you can still apply to be granted access to the DIY version of the exhibit for show anywhere in the world! Also, if you can’t make it to DC in time for the closure, check out the virtual tour available here.